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QUILL ON SCALPEL
This section provides a medium through which Canadian surgeons can declare themselves, briefly 
and informally, on the day-to-day affairs of surgery.
Surgery for Morbid Obesity — 
Where Are We Going?
Surgery for morbid obesity is pre­
dicated on the fact that obesity is a 
life-threatening condition for which 
there is no successful nonoperative 
treatment. Over the past two decades, 
we have gone from jejunocolic to sev­
eral modifications of jejunoileal by­
pass, to gastric bypass and finally, to 
at least a dozen variations of gastric 
partitioning (gastroplasty) procedures.
In this issue of the Journal (page 
283), Deitel and colleagues review 
their experience with intestinal by­
pass and gastric partitioning. Over a 
9-year period, 174 patients were oper­
ated on. Initially, jejunoileal bypass 
was used exclusively (64 patients) and 
thus the authors have longer follow-up 
data for this group. An average weight 
loss of 35% is certainly acceptable, 
particularly because weight regain­
ing did not occur. However, we 
do not know how many of the 64 
individuals had this acceptable weight 
loss.
The authors are apparently fas­
tidious in their follow-up because they 
were not bothered by the multitude 
of well-known metabolic complica­
tions associated with this procedure. 
Apparently, regular clinic visits kept 
the problems to a minimum. One by­
pass had to be reversed and two re­
vised. The implication is that the 
other 61 patients are well and being 
followed. However, this is not specif­
ically stated and one wonders if the 
authors really have perfect (100%) 
follow-up. If this is not the case, the 
paucity of metabolic complications 
and low incidence of reversal cannot 
be properly assessed. Similarly, the 
authors use expressions such as 
“some” and “generally” in discussing 
serial liver biopsies. Not one patient 
had serious liver disease. While it is 
known that fatty infiltration improves 
with time after jejunoileal bypass, 
particularly if protein is administered, 
more precise data would have been
appropriate. The authors were ap­
parently able to control diarrhea — 
the greatest problem after jejunoileal 
bypass. They stated that diarrhea 
after 1 year was not a problem and 
that it was easily controlled with 
medical treatment. This conflicts 
sharply with the world literature, 
which shows progressive, intractable 
diarrhea in up to 45% of the patients 
in the early postoperative period, 
persisting after 1 year in nearly 20% 
of patients and being the main cause 
for reversal of the bypass.
Gastric partitioning was performed 
in 110 patients. The authors used the 
simple technique of Pace and col­
leagues to solve a real surgical dilem­
ma. Gastric bypass was a time-con­
suming, dangerous technique whereas 
removal of three or four staples from 
a TA90 stapler produced a simple 
gastroplasty that could be performed 
by anyone. Many surgeons jumped on­
to the bandwagon and used this opera­
tion, only to obtain similarly dismal 
results when patients were followed 
up for 1 year or longer. Deitel and 
colleagues operated on 56 patients 
before realizing that weight loss with 
this technique was inadequate. One 
wonders if they could have operated 
on a smaller number of patients and 
followed them up before undertaking 
such a large number.
Subsequently, 54 patients had re­
inforcement of the 12-mm stoma with 
a “nonexpanding” imbricating suture. 
Our experience and that of others 
clearly indicates that a running, sero­
muscular suture around the gastro- 
gastrostomy does not guarantee per­
fect results. Although there was a 
mean 31% weight loss at 1 year, only 
five patients were followed up for 
more than 12 months. We predict that 
with a longer follow-up Deitel and his 
colleagues will see more patients with 
dilated stomas and inadequate weight 
loss or weight gain.
There are four causes for inade­
quate weight loss: three are technical 
— stomal dilatation, pouch dilatation 
and staple-line disruption; the other is 
patient compliance — one cannot 
assume that the mere placement of 
two rows of staples across the stom­
ach will cure a lifetime addiction to 
food! Each of the technical problems 
can occur at the time of operation or 
subsequently, when they are generally 
related to poor patient compliance. 
Admittedly, stomal dilatation is the 
single greatest problem because most 
surgeons doing this operation are 
careful to make a small pouch and 
to apply the stapling instrument twice 
rather than once. However, reinforc­
ing sutures are not the final solution. 
Despite initial problems with Marlex 
wrapped around the stoma, more sur­
geons are returning to this technique 
because of the persistent and trouble­
some problem of stomal dilatation. 
Incidentally, most deaths have been 
related to aggressive attempts to nar­
row the stoma because such attempts, 
with or without Marlex, devascularize 
the stomach and lead to leaks. In this 
regard, the paucity of serious com­
plications and absence of deaths in 
Deitel’s series is commendable.
Deitel and colleagues reoperated on 
five patients, again without serious 
mishap, although note should be 
made, in passing, that the mortality 
for gastroplasty revisions is nearly 
4%. As stated, dilatation of the stoma 
is the commonest cause of inadequate 
weight loss or weight regain. If a 
properly constructed, nonobstructing 
stoma can enlarge, is it not reasonable 
to presume that one which is too 
small will also distend with time? A 
feeding jejunostomy, routinely in­
serted during gastric partitioning, per­
mits one to wait for 6 months or even 
longer in patients with stomal obstruc­
tion and avoids the necessity for early 
reoperation. Such patients go home
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feeding themselves through the jeju- 
nostomy. When they remain in hos­
pital, the temptation to tackle the 
problem surgically is too great even 
for the most conservative surgeon.
Bariatric surgical data should al­
ways include absolute failure rates 
rather than average weight lost. For 
example, if  two patients, each weigh­
ing 140 kg, had gastroplasties and one 
lost 50% (70 kg) while the other lost 
only 10% (14 kg), the average per­
centage lost would be 30% with a 
failure rate of 50%! Similarly, data 
should be presented as a percentage 
of weight lost (or, alternatively, as a 
percentage of excess weight lost) and 
not as kilograms lost. Using the pre­
ceding example, the average weight 
loss was 70 +  14 -f- 2 =  42 kg 
but with a 50% failure rate. Kilo­
grams lost are even more misleading 
when patients weighing over 140 kg 
(who tend to have, but do not necessar­
ily sustain, huge weight losses in the 
early postoperative months) are com­
pared with less obese patients weigh­
ing between 90 and 140 kg. Each re­
port should list the number of patients 
with inadequate results, with failures
defined as those patients who have 
lost less than 15% of their initial 
weight, at a minimum follow-up of 
24 months, with patients lost to fol­
low-up being included as failures. 
Adequate follow-up is essential. Many 
patients who lose much weight ini­
tially, fail to correct the poor eating 
habits that led to the operation and 
hence will regain lost weight if not 
seen monthly for dietary and exercise 
counselling.
Taking Deitel’s gastroplasty group 
as a whole, one can illustrate the im­
portance of looking critically at data. 
They did 110 gastroplasties over an 
unstated period o f time. The first 56 
patients were all failures because 
weight loss was inadequate and the 
procedure was abandoned. In the sec­
ond group of 54 patients, only 5 were 
followed up for more than 1 year and 
the percentage of patients lost to fol­
low-up is not given. Our data show 
a minimum technical failure rate of 
20% at 24 months —  it is higher if 
one includes patients who refuse to 
return for follow-up or those who re­
quire revision for inadequate weight 
loss. So, at least 11 patients (20%
of 54) from Deitel's second group of 
patients will likely be failures in addi­
tion to all 56 patients from the first 
group. This adds up to 67 failures out 
of 110 for a m inim um  failure rate of 
61% at 1 year.
On a more positive note, one must 
appreciate that certain modifications 
are necessary during the temporal de­
velopment of surgical procedures. 
With time, we may come closer to 
perfection with gastric partitioning. 
Also, the success of nonoperative 
treatment for morbid obesity is less 
than 5%. Hence, even a failure rate 
of 60% in a surgical series still leaves 
40% of patients operated on with 
adequate weight loss —  an eightfold 
improvement over conservative ther­
apy.
J oel  B. F r e e m a n , m d , fr c s[c ], facs 
H eather  B u r c h e t t , rn




Editors’ note.— The response of Deitel 
and colleagues to this editorial appears 
in the Correspondence section of this 
issue (page 348).
Alkaline Reflux Gastritis
In this issue (page 337) Tasse and col­
leagues describe the collective experi­
ence of the Hopital St-Luc, Montreal, 
in the operative management of pa­
tients putatively afflicted with the 
elusive (perhaps illusory) syndrome of 
alkaline reflux gastritis.
In one respect, this report is un­
usual because more than one third 
of the patients subjected to remedial 
operation had not undergone an ear­
lier procedure involving the creation 
of a gastroenteric stoma. Indeed, in 
three, no previous intra-abdominal 
surgery o f any sort had been per­
formed. Under these circumstances, 
the diagnosis appears to have been 
established by the histologic dem­
onstration of a “ primary (as opposed 
to a secondary) reflux gastritis” •— 
a distinction of which I was previously 
unaware —  associated with the pres­
ence o f typical symptoms, typical en­
doscopic findings and, presumably, 
the absence of other demonstrable 
abnormalities o f the upper gastrointes­
tinal tract or biliary tree.
In most respects, however, this re­
port gives one a sense o f deja vu be­
cause it echoes the findings of so 
many of the earlier surgical series 
addressing the syndrome: for select­
ing patients for operation, a heavy 
reliance is placed on the presence or 
absence of typical symptoms and of 
those endoscopic and histologic in­
dices supposedly specific for reflux: 
there is no quantitative assessment 
of reflux volume or composition per 
se; near universal failure of a variety 
of nonoperative treatment regimens 
is followed by near-universal success 
on short-term follow-up when upper 
intestinal content is shunted away, at 
least in theory, from the gastric mucus 
membrane by creating a Roux-en-Y 
limb. Indeed, the superlative results 
described in the present study, when 
added to those of earlier surgical re­
ports, make it extremely tempting 
to declare an unequivocal Q.E.D. for 
the syndrome under consideration.
This would be a mistake. In the 
first instance, for reasons that are not 
entirely clear, these results contrast 
sharply with those reported in two
recent series, equally carefully anal­
ysed. In one, patient selection was just 
as rigorous, yet the outcome was very 
different: only two thirds of patients 
subjected to remedial operation had 
complete or even partial relief of 
symptoms. Furthermore, when symp­
tomatic, endoscopic or histologic 
predictors of success or failure were 
sought, few could be reliably iden­
tified on a statistical basis. Outcome 
seemed almost random in this regard. 
In the second study,2 even less salu- 
tory results were reported: only 47% 
of patients achieved a satisfactory 
result from diversion. Patients with 
delayed gastric emptying preopera- 
tively fared especially poorly, un­
doubtedly because a Roux-en-Y limb 
itself can cause marked and trouble­
some delays in gastric emptying.3 It 
is of interest that 5 (22%) of the 23 
patients in Tasse’s series demonstrated 
gastric stasis postoperatively, although 
none required further operation. 
Most importantly, the objective in­
dices that Tasse and associates accept 
as being specific to the syndrome may
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not be as specific as many have 
claimed.4 The typical endoscopic find­
ings of mucosal edema and erythema 
almost invariably disappear following 
diversion, but, as noted, patients do 
not invariably improve. In those who 
do, the histologic features of the re­
sidual gastric pouch have been re­
ported to revert towards normal,5 to 
remain the same5 or to worsen,7 de­
pending upon the histologic criteria 
used. The capacity of the residual 
gastric pouch to secrete hydrochloric 
acid, bile staining of the mucosa, even 
the demonstration of enterogastric 
reflux during endoscopy, all have been 
shown to be inaccurate predictors of 
outcome. Given these ambiguities and 
discrepancies, it is not surprising that 
some have questioned the very exist­
ence of the syndrome.8
In my opinion, the clinical diagnosis 
of alkaline reflux gastritis will be 
rendered scientifically acceptable and, 
therefore, clinically useful only after 
four general conditions have been 
satisfied. First, a wider appreciation 
must be gained of which symptoms 
can reasonably be ascribed to excessive 
enterogastric reflux. Tasse and col­
leagues may have hit upon them: 
the simultaneous complaints of mild 
burning epigastric pain associated 
with bilious vomiting. These are the 
only symptoms that are regularly in­
duced when endogenous upper in­
testinal content from typically symp­
tomatic patients is instilled into their 
residual stomachs'9 or are predictably 
relieved when reflux has been quan­
titatively eliminated by operation.5,7
Second, the existence of a specific 
clinical syndrome based on the rela­
tion between symptoms and excessive 
reflux must be rigorously established, 
by demonstrating that the syndrome 
always occurs in the presence of 
excessive reflux, never occurs in the 
absence of excessive reflux, is elimi­
nated by eliminating excessive reflux 
and is induced by inducing excessive 
reflux. None of the major clinical 
series purporting to assess the syn­
drome even begin to address these 
conditions because not one has studied 
a simultaneous cohort of asymptomat­
ic patients.
Third, the precise etiologic factors 
in upper intestinal content that are 
responsible for inducing symptoms 
(if, indeed, symptoms and reflux are 
related) must be clearly identified. 
As Tasse and colleagues indicate, 
several reasonable candidates are 
available although none can be im­
plicated with certainty at present.
Finally, and most importantly, ob­
jective and discriminative diagnostic
maneuvers must be developed to dis­
tinguish reliably those patients who 
have the syndrome from those who 
do not. Promising approaches are the 
use of provocative testing with either 
concentrated sodium hydroxide10 or 
autologous intestinal content,0 the 
measurement of intragastric bile-acid 
concentration5 and the direct assess­
ment of reflux volume by gamma 
scintigraphy following the injection of 
hydroxyiminodiacetic acid (HIDA) 
labelled with technetium-99m.u Be­
cause methodologies for these last 
two tests are well described and they 
can be done at most major hospital 
centres, I believe no patient should be 
subjected to remedial operation until 
an objective assessment of reflux 
volume is obtained by one or both of 
these modalities.
Until these conditions are satisfied, 
the syndrome of alkaline reflux gas­
tritis cannot be considered a proven 
clinical entity and the prudent surgeon 
should approach remedial therapy, 
particularly in the absence of previ­
ous gastric surgery, with considerable 
circumspection.





1. Boren CH, Way LH: Alkaline reflux gas­
tritis: a reevaluation. Am 1 Surg 1980; 
140 : 40-6
2. Davidson ED, Hersh T : The surgical 
treatment of bile reflux gastritis. Ann Surg 
1980; 192: 175-8
3. Hocking MP, Vogel SB, Falasca CA,
Woodward ER: Delayed gastric emptying 
of liquids and solids following Roux-en-Y 
biliary diversion. Ann Surg 1981; 194:
494-501
4. Ritchie WP jr : Alkaline reflux gastritis: 
a diagnosis in search of a disease? J Clin 
Surg (in press)
5. Idem: Alkaline reflux gastritis: an ob­
jective assessment of its diagnosis and 
treatment. Ann Surg 1980; 192 : 288-98
6. Malagelada JR, Phillips SF, H iggins JA,
Shorter RG, van Heerden JA, Adson 
MA: A prospective evaluation of alkaline 
reflux gastritis: bile acid binding agents 
and Roux-en-Y diversion (abstr). Gastro­
enterology 1979; 76: 1192
7. Hoare AM, McLeish A, Thompson H, 
Alexander-W illiams J: Selection of pa­
tients for bile diversion surgery: use of 
bile acid measurement in fasting gastric 
aspirates. Gut 1978; 19: 163-5
8. Meyer JH: Reflections on reflux gastritis. 
Gastroenterology 1979; 77: 1143-5
9. Meshkinpour H, Marks JW, Schoenfield
LJ, Bonnoris GG, Carter S: Reflux gas­
tritis syndrome: mechanism of symptoms. 
Gastroenterology 1980; 79: 1283-7
10. Warshaw AL: Intragastric alkali infusion: 
a simple, accurate provocative test for 
diagnosis of symptomatic alkaline reflux 
gastritis. Ann Surg 1981; 194: 297-304
11. Tolin RD, Malmud LS, Stelzer F, M enin 
R, Makler PT jr , Applegate G, F isher 
RS: Enterogastric reflux in normal sub­
jects and patients with Billroth II gastro­
enterostomy. Measurement of enterogastric 
reflux. Gastroenterology 1979; 77: 1027-33
BOOKS RECEIVED
This list is an acknowledgement of 
books received. It does not preclude 
review at a later date.
A B C de chirurgie plastique et esthe- 
tique. Roger Amar. 81 pp. Must. 
Masson, Paris, 1981. Prix non men- 
tionne, broche. ISBN 2-225-74426-2.
Amputation Surgery and Rehabilitation: 
The Toronto Experience. Edited by 
John P. Kostuik and Robert Gillespie. 
448 pp. Must. Churchill Livingstone, 
Edinburgh; Academic Press Canada, 
Don Mills, Ont., 1981. $62.40. ISBN 
0-443-08024-0.
Aneurysms: Diagnosis and Treatment.
Edited by John J. Bergan and James 
S.T. Yao. 670 pp. Must. Grune & 
Stratton, Inc., New York; Academic 
Press Canada, Don Mills, Ont., 1982. 
$70.85. ISBN 0-8089-1440-5.
Angiography of Spinal Column and 
Spinal Cord Tumors. Rene Djindjian. 
258 pp. Must. Thieme-Stratton Inc., 
New York; J.B. Lippincott Company 
of Canada, Toronto, 1981. Price not 
stated. ISBN 0-86577-025-5.
Cancer Medicine. James F. Holland and 
Emil Frei III. 2465 pp. Must. Lea & 
Febiger, Philadelphia. 1982. $168
ISBN 0-8121-0603-2.
Chirurgie 81. Resumes des Tables Ron- 
des des Forums et Communications 
du 83e Congres Frangais de Chirurgie. 
Paris, 21 au 24 Septembre 1981. Tex- 
tes publies sous la direction de J.-Cl. 
Patel. 184 pp. Must. Masson, Paris, 
1981. Prix non mentionne, broche. 
ISBN 2-225-75010-6.
Endodontic Surgery. Edited by Donald 
E. Arens, William Ray Adams and 
Rolando A. DeCastro. 238 pp. Must. 
Harper & Row, Philadelphia; J.B. 
Lippincott Company of Canada, To­
ronto, 1981. Price not stated. ISBN 
0-06-140267-2.
Frontiers in General Surgery. Edited by 
D.W. Jirsch. 390 pp. Must. F.A. Davis 
Company, Philadelphia, 1982. $35.
ISBN 0-8036-5028.
General Surgery Therapy. Edited by 
Oliver H. Beahrs and Robert W. 
Beart, Jr. 509 pp. Must. John Wiley 
& Sons, New York, 1981. $65. ISBN 
0-471-09548-6.
Genitourinary Reconstruction with Pros- 
theses. L.V. Wagenknecht, W.L. Fur- 
low and J. Auvert. 213 pp. Must. 
Thieme-Stratton Inc., New York; J.B. 
Lippincott Company of Canada, To­
ronto, 1981. Price not stated. ISBN 
0-86577-028-X.
Management of Medical Problems in 
Surgical Patients. Mark E. Molitch. 
795 pp. F.A. Davis Company, Phila­
delphia, 1982. $40. ISBN 0-8036-
6286-6.
Manual of Cardiac Surgery II. Bradley 
J. Harlan, Albert Starr and Fredric 
M. Harwin. 347 pp. Must. Springer- 
Verlag New York, Inc., 1981. $125. 
ISBN 0-387-90563-4.
continued on page 257
VOLUME 25, NO. 3, M AY 1982 /  THE CANADIAN JOURNAL OF SURGERY 249
Enteral nutrition begins in the 
recovery room ...
»  ~ . f ,  f j  'tne>%€w
Vivonex Jejunostomy Kit
All you need to perform a 
needle-catheter jejunostomy in one 
complete, economical kit.
Each kit contains:
-  hinged easy access tray
-  90 cm (36”) 5 Fr radiopaque polyurethane catheter
-  100 cm ‘soft tip’, stainless steel, flexible guidewire
-  No. 14 gauge, thin-wall, non-coring needles (2)
-  No. 20 gauge, needle cannula with female adapter hub
-  catheter/adapter sleeve for nonshearing, leak- and 
kink-proof connection
-  specially designed anchoring catheter retainer to 
prevent accidental dislodgement
-  instruction sheet
______
REVIEW ARTICLE
Carcinoma of the Sigmoid: a Complication 
of Ureterosigmoidostomy
J ules  Charron , md , frcs[c ]* and Rejea n  D e l is l e , MDf
The case of a 58-year-old man who 
had carcinomatous change in the 
sigmoid colon many years after 
ureterosigmoidostomy prompted the 
authors to review the French and 
English literature on the subject. They 
found 47 cases in addition to their 
own, and noted a dramatic increase 
in the last 10 years, even though 
ureterosigmoidostomy is now seldom 
used. The latency of this complication 
makes it pertinent today.
In the hope of determining the 
etiology of the complication, the 
authors studied the relation between 
the initial lesion for which the 
diversion was carried out and the 
nature of the colonic tumour that 
ensued, and have attempted to draw 
some conclusions. None of the current 
theories of pathogenesis seem 
satisfactory.
By underlining the early clinical 
manifestations, the authors attempt to 
promote earlier diagnosis and better 
chances of survival for patients with 
carcinoma of the colon after 
ureterosigmoidostomy.
L’apparition chez un homme de 58 
ans de changements carcinomateux 
dans le colon sigmoi'de, plusieurs 
annees apres une uretero-sigmoidos- 
tomie a incite les auteurs a fouiller 
la documentation medication francaise 
et anglaise sur le sujet. ils y ont 
decouvert 47 cas additionnels et ont
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note une augmentation spectaculaire 
au cours des 10 dernieres annees, 
en depit du fait que I’uretero-sig- 
moidostomie soit rarement utilisee. La 
periode de latence de cette complication 
en fait actuellement un sujet fort 
pertinent.
Dans I’espoir de determiner 
I’etiologie de cette complication, 
les auteurs ont etudie le rapport 
pouvant exister entre la lesion initiale 
pour laquelle la derivation fut pratiquee 
et la nature de la tumeur colique qui 
a suivi, et ils ont tente d’en tirer 
des conclusions. Aucune des theories 
actuelles sur la pathogenese de 
cette atteinte ne semble 
satisfaisante.
Soulignant les manifestations 
cliniques precoces, les auteurs 
essaient de favoriser un diagnostic 
plus hatif et d'ameliorer les chances 
de survie des patients atteints d’un 
cancer du colon apres une 
uretero-sigmoi'dostomie.
Because the bowel wall adjusts read­
ily to the constant presence of urine, 
bowel has been used extensively as a 
means of urinary diversion.1,2 It has 
been used as a bladder and ureter 
substitute for almost a century and is 
the only tissue capable of transport­
ing and storing urine with a mini­
mum of complications.
Transplanting the ureters into the 
sigmoid colon is perhaps the oldest 
technique of closed urinary diversion. 
Its complications are well known 
and their prevention and man­
agement are well defined. However, 
the sigmoid mucosa, after a long 
period, becomes vulnerable to carci­
nomatous change. We recently treated 
a patient with carcinoma of the sig­
moid colon after ureterosigmoidos­
tomy and this prompted us to review 
the literature on the subject. We
found an apparent increase in the 
incidence of carcinomatous change. 
Although the earliest case reported 
was by Hammer3 in 1929, half of the 
48 cases reported to date were found 
in the last 10 years (Table I). The 
incidence of this complication is im­
possible to determine and is obviously 
low, but we have been struck by the 
apparent delay in making the diag­
nosis, betraying a lack of awareness 
of the complication.
The mechanism by which ureterosig­
moidostomy may cause carcinoma of 
the colon is presumptive and cannot 
be proven, even on a statistical basis, 
because of the paucity of cases. But 
the tendency of these lesions to devel­
op near the anastomotic site and the 
occasional transitional cell carcinoma 
is strongly suggestive of a carcino­
genic role of ureterosigmoidostomy.
Although the ileal conduit is now 
preferred as a means of urinary 
diversion, the latency of carcinoma 
resulting from ureterosigmoidostomy 
makes this complication a matter of 
current interest, since patients oper­
ated on more than 20 years ago may 
only now be vulnerable.
In an attempt to define the various 
facets of this complication, we re­
port a recent case and analyse those
T ab le  1— In c id e n ce  of C a rc in o m a tou s  
C h a n ge  in th e  S igm o id  after U re te ro s ig ­
m o idostom y
Period
No. o f
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reported in the French and English 
literature.
Case Report
A 58-year-old white man had a his­
tory of chronic pain in the left flank 
and renal insufficiency from progressive 
hydronephrosis. He had refused opera­
tion for his bladder exstrophy until, at 
38 years of age, he accepted an “in­
ternal” urinary diversion. A bilateral 
ureterosigmoidostomy was carried out 
using a Coffey I technique. Pyelo- 
nephritic changes were already present 
bilaterally and a small caliceal stone 
was identified on the left side. The 
blood urea nitrogen value was 49 mg/dl 
(17.5 urea, mmol/1).
Renal stones eventually developed 
bilaterally; a right pyelolithotomy and
FIG. 1—Intravenous pyelogram show­
ing dilatation of left collecting system 
and distribution of contrast medium in 
left colon and sigmoid.
a left nephrolithotomy had to be done.
At the age of 45 years he was again 
admitted to hospital because of colicky 
abdominal pain and vomiting, compati­
ble with partial occlusion of the intestine. 
The blood urea nitrogen level was 42 
mg/dl (15.0 urea, mmol/1) and there 
was mild acidosis.
Roentgenography after a barium 
enema revealed a mass, 4 cm in great­
est dimension, in the lumen of the 
sigmoid, possibly at the level of the 
ureterosigmoid anastomosis. However, 
there were no signs of obstruction on 
the intravenous pyelogram, which 
showed good excretion of dye on both 
sides. Pyelonephritic changes had pro­
gressed slightly. The acute episode of 
occlusion subsided and the patient was 
discharged without further investigation. 
He was seen at irregular intervals for 
the following 12 years, when he com­
plained again of abdominal pain. An 
intravenous pyelogram showed severe 
obstruction at the left ureterosigmoid 
anastomosis, demonstrated only by a 
drip infusion of dye (Fig. 1). The blood 
urea nitrogen level was 47 mg/dl (16.8 
urea, mmol/1), creatinine 1.8 mg/dl 
(159 ,umol/l) and hemoglobin 10.2 g/dl. 
The patient again refused surgical treat­
ment. He was discharged and was not 
seen again until the present admission 1 
year later.
He complained of persistent pain in 
the left flank, anorexia and weakness. 
Laboratory findings were as follows: 
serum creatinine 2.5 mg/dl (221 u.mol/1), 
chloride HO mmol/1 and carbon dioxide 
13.2 mmol/1, blood urea nitrogen 48 
mg/dl (17.1 urea, mmol/1) and hemoglo­
bin 10.1 g/dl. Intravenous pyelography by 
drip infusion showed progression of the 
pyelonephritic changes of the right kidney 
and an almost inactive left kidney.
The patient finally accepted operation 
in the hope that his pain would be 
alleviated. A double-barrelled cutaneous 
ureterostomy was chosen because the 
difficult personality of the patient made 
it imperative to do a diversion that was 
most likely to reduce the obstruction 
and necessitate the least postoperative 
care. Because the ureters were wide and
tortuous from chronic distension, we 
thought that a bowel conduit might not 
relieve the obstruction adequately, and 
the patient would not accept a second 
procedure.
At operation the ureterosigmoid 
anastomoses were identified with sur­
prising ease. The left anastomosis was 
very firm on palpation and suggested 
the presence of an impacted stone. The 
right anastomosis appeared soft and 
supple. The left anastomosis was widely 
resected, including a 3-cm segment of 
ureter and a large segment of sigmoid. 
A similar procedure was carried out on 
the right side.
The left ureter was brought out through 
a tunnel under the parietal peritoneum 
and the right ureter was brought out 
alongside the sigmoid mesentery; the 
possibility of volvulus was diminished by 
tenting a long segment of posterior peri­
toneum to the abdominal wall around the 
ureter.
A frozen section of the excised speci­
men from the left side showed a fibrotic 
and chronically inflamed lesion; there 
was no neoplasm. However, the perma­
nent microscopic section revealed a 
moderately differentiated adenocarcinoma 
of the sigmoid colon, with superficial 
muscular invasion. This confirmed our 
earlier suspicion of a neoplasm (Figs. 
2 and 3).
The patient refused more extensive 
bowel surgery. The findings on roent­
genography after a barium enema and 
proctoscopy were normal. Kidney func­
tion was improved and the patient 
adapted remarkably well to the cutane­
ous ureterostomy.
Discussion
In the English and French litera­
ture we found, in addition to our own 
case, 47 cases of carcinoma of the 
colon in patients who had undergone 
a bilateral ureterosigmoidostomy for 
urinary diversion. Although the ana­
stomotic technique may have varied, 
in no instance was an isolated segment 
of bowel used initially, thus permitting
FIG. 2—Moderately differentiated adenocarcinoma originat­
ing from colonic mucosa. Area of submucosal scarring suggests 
site of ureteric anastomosis (hematoxylin-phloxine-saffron stain, 
reduced by 49% from X 25).
FIG. 3—Invasion of muscle layers of colon by adenocarci­
noma (hematoxylin-phloxine-saffron stain, reduced by 49% 
from X 250).
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free contact of urine with normal in­
testinal contents.
The cases could be divided into 
four groups:
•  Thirty patients who underwent 
diversion for a benign condition (e.g., 
exstrophy of the bladder, urinary in­
continence, trauma) and subsequently 
had carcinoma (Table II3'“ ).
•  Ten patients who underwent 
diversion for a benign condition and 
subsequently had an adenoma (Table
J J J 4 , 1 0 ,1 4 ,1 7 ,2 4 ,2 6 -28 )
•  Six patients who had diversion 
for a primary malignant condition and 
then had carcinoma (Table iv9'29'32).
•  Two patients who had diversion 
for a primary malignant condition 
and who later had an adenoma (Table^ 33,34^
A male predominance of 2 to 1 in 
the benign group is in keeping with 
a much higher incidence of exstrophy 
of the bladder in men, as is the some­
what similar sex ratio in the group 
with malignant disease, where carci­
noma of the bladder is much more 
common in men.
The age of the patients at the time 
of the initial operation is irrelevant 
and did not seem to influence the 
length of the latent period. However, 
it is important to note that this period 
varied from 10 to 46 years if the 
initial lesion was benign, but was 
much shorter, a few months to 9 
years, if the initial lesion was malig­
nant. This could be explained by the 
fact that patients with cancer are
Table II—Carcinoma of the Sigmoid Arising at or near Site of Bilateral 
Ureterosigmoidostomy for a Benign Condition







Side of ureter 
involved by cancer
Hammer, 19293 Bladder exstrophy M 50 10 Trigone
Dixon and Weismann, 19484 Bladder exstrophy M 3 30 Left
Wilson, 1957s Urinary incontinence F 16 31 Left
Aldis, 1961° Bladder exstrophy F 18 15 Left
Sugg,19627 Bladder'exstrophy F 5 15 Left
Kozak and associates, 1966s Bladder exstrophy M 2 15 Left
Urdaneta and associates, 19669 Bladder exstrophy F 4 29 —
Interstitial cystitis F 21 17 Right
Kille and Glick, 196710 Urinary incontinence 
secondaryto 
epispadias
M 10 16 Left
Richter and Ginsberg, 196711 Bladder exstrophy F 2 23 Left
Oetjen and associates, 197012 Bladder exstrophy M 3 23 Left
Whitaker and associates, 197113 Rupture of posterior 
urethra
F 7 15 Left
Bladder exstrophy M 31 27 Right
Bladder exstrophy M 19 20 Bilateral
Brekkan and associates, 197214 Bladder exstrophy F 3 20 Right
Bladder exstrophy M 6 38 Right
Bladder exstrophy M 6 41 Trigone
Tank and associates, 197315 Bladder exstrophy M 9 46 Bilateral
Mueller and Thornbury, 197316 Bladder exstrophy M 9 46 Bilateral
Lien,197317 Traumatic ruptureof 
urethra
M 7 26 —
Preissig and associates, 197418 Gunshot wound M 8 26 Left
Shapiro and associates, 197419 Bladder exstrophy F 14 —
Harguindey and associates, 197520 Bladder exstrophy M 2 24 —
Rivard and associates, 197521 Bladder exstrophy M 15 23 —
Carswell and associates, 197622 Bladder exstrophy F 21 234 Right
Besancenez and associates, 197623 Bladder exstrophy M 4 25 Right
Potet and associates, 197724 Bladder exstrophy M 7 25 Right
Parsons and associates, 197725 Bladder exstrophy M 3 26 —
Bladder exstrophy M 14 334 Right
Present case Bladder exstrophy M 38 20 Left
Table III—Benign Adenoma of Sigmoid Arising at or near Site of 
Bilateral Ureterosigmoidostomy for a Benign Condition









Dixon and Weismann, 19484 Bladder exstrophy M 3 30 Right
Markowitz and Koontz, 196626 Bladder exstrophy M 1 14 Left
Bladder exstrophy F 2 15 Right
Bladder exstrophy M 1 18 Right
Kille and Glick, 196719 Urinary incontinence M 4 15 —
with epispadias
Haney and McGarity, 197127 Bladder exstrophy F 6 38 Left
Brekkan and associates, 197214 Bladder exstrophy F 3 20 Left
Lien,197317 Bladder exstrophy F l i 234 —
Lasser and Acosta, 197528 Bladder exstrophy M 10 27 Bilateral
Potet and associates, 197724 Bladder exstrophy F 9 25 Bilateral
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more susceptible to carcinogens.35
The histopathologic types of tu­
mour varied little. There were only 
four varieties: 33 adenocarcinomas, 
12 adenomas, 2 transitional cell car­
cinomas and 1 scirrous carcinoma. 
The nature of the initial lesion re­
quiring urinary diversion bore no rela­
tion to the kind of neoplasm devel­
oping at the anastomotic site. Adeno­
carcinomas occurred with bladder 
exstrophy as well as with transitional 
cell carcinoma of the bladder and 
adenomas developed with either of 
these lesions, even with urinary in­
continence.
Statistical evidence of a cause-ef­
fect relation between long-term urete- 
rosigmoidostomy and carcinoma of 
the colon has been suggested by the 
work of Urdaneta and associates.9 
According to United States statistics, 
the incidence of carcinoma of the 
colon in persons 45 years of age is 
24 per 100 000.9 However, the 83 
patients with ureterosigmoidostomy 
operated on by Urdaneta’s group 
showed an incidence of 13 300 per 
100 000 .
The length of time after ureterosig­
moidostomy is more important to the 
development of carcinoma of the sig­
moid than the age of the patient. 
Probably the better understanding and 
control of complications of ureterosig­
moidostomy, such as infection and 
acidosis, leading to longer survival,
have permitted this relatively rare 
complication to occur.
Speculation concerning the etiology 
of neoplasia at the site of a ureterosig- 
moid anastomosis revolves around 
three factors: (a) the role of urine 
alone, (b) the role of urine mixed 
with fecal material and (c) the role of 
bowel-wall changes from ureteric 
prolapse into the lumen.
The possibility of a urinary car­
cinogen can be excluded, because 
carcinomas have developed near a 
“dry” anastomosis, following a ne­
phrectomy, leaving ureteral stumps 
behind. This happened in two of the 
cases after operations performed 16 
years25 and 8 years12,22 earlier. Scott 
and Boyd36 could not induce carci­
noma in the bowel of dogs using 
/J-naphthylamine during a 20- to 30- 
month period of irrigation. Although 
this time period may not be compara­
ble, the use of a known carcinogen 
as an added stimulant makes the re­
sults of this experiment more impor­
tant. In spite of the widespread dif­
fusion of urine in the colon, the 
proximity of the tumour to the 
anastomosis is notable.
The association of urine and sig­
moid fecal material may be the 
common denominator, as we are not 
aware of the development of bowel 
carcinoma in ileal or isolated sigmoid 
conduits.
As a third possibility, the ureteral
nipple may be irritative like a polyp 
in the lumen of the bowel. Repeated 
microtrauma from feces could induce 
malignant transformation.15 However, 
we could not find any scientific basis 
for this hypothesis; the true etiology 
of this cancer remains a mystery.
We believe that the paucity of re­
ports of bowel tumour after uretero­
sigmoidostomy does not reflect its true 
incidence. Better long-term follow-up 
of these patients with an awareness 
of this complication is required.
Although there are no pathognomo­
nic symptoms and signs, there are 
some clinical indications that may 
suggest the diagnosis. Most patients 
have had one or all of the following 
at an early stage: vague abdominal 
pain suggestive of a ureteral stone, 
proctorrhagia sometimes leading to 
anemia, and recent obstructive changes 
at one or both ureterosigmoid ana­
stomoses, demonstrated by intrave­
nous pyelography, rapidly interfering 
with kidney function. These symp­
toms suggest neoplasia of the sigmoid 
and must be so considered until 
proven otherwise.
Intestinal obstruction is a late stage 
that betrays irreversible damage and 
is associated with poor survival.
Increased awareness of carcinoma­
tous change after ureterosigmoidos­
tomy will result in earlier diagnosis 
if abdominal pain, proctorrhagia and 
obstructive changes are rapidly inves-
T a b le  IV — C arc in o m a  o f  th e  S ig m oid  A r is in g  a t  o r  n e a r  S ite  o f 
B ila te r a l  U re te ro s ig m o id o s to m y  fo r  M a lig n a n t C o n d itio n
A u th o r C lin ic a l in d ic a tio n Sex
A g e  a t  
o p e ra tio n ,  
y r
L a te n c y
p e rio d ,
yr
Side o f u r e te r  
in v o lv e d  by c a n c e r
R ic h e s  an d  P age, 195629 T ra n s it io n a l ce ll F 61 1 L e ft
M a s s a c h u s e tts  G e n e ra l H o s p ita l,
c a rc in o m a  o f b la d d e r  
T ra n s it io n a l ce ll M 55 8 R ig h t
19583°
S c h e in m a n ,1 9 6 1 31
c a rc in o m a  o f b lad d er  
T ra n s it io n a l ce ll M 42 9 L e ft
A m a r , 196132
c a rc in o m a  o f b la d d e r  
T ra n s it io n a l c e ll M 46 4 L e ft
c a rc in o m a  o f b la d d e r  
T ra n s it io n a l c e ll M 58 7 mo L e ft
U rd a n e ta  and a s s o c ia tes , 19669
c a rc in o m a  o f b la d d e r  
E p id erm o id  c a rc in o m a M 55 9 R ig h t
T a b le  V — B e n ig n  A d en o m a o f th e  S igm oid  A ris in g  a t  o r  n e a r  S ite  of 
U re te ro s ig m o id o s to m y  fo r  a M a lig n a n t L e s io n
A u th o r C lin ic a l in d ic a tio n Sex
A g e  a t  
o p e ra tio n ,  
y r
L a te n c y
p e rio d ,
y r
S ide o f u r e te r  
in v o lv e d  by c a n c e r
G il lm a n , 196433 T ra n s it io n a l ce ll 
c a rc in o m a  o f b la d d e r
— 75 7 L e ft
M a c G re g o r , 196834 T ra n s it io n a l ce ll 
c a rc in o m a  o f b la d d e r
M 57 5 L e ft
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tigated. The condition of patients who 
have undergone ureterosigmoidostomy 
should be monitored by proctoscopy, 
roentgenography after barium enema 
and intravenous pyelography, period­
ically for life. The longer the time 
interval after surgery, the more 
critical the assessment becomes. After 
10 years, in asymptomatic patients, 
a double contrast barium enema, done 
every other year, alternating with in­
travenous pyelography, should de­
tect early neoplastic changes.
Simple nephrectomy for a non­
functioning kidney is inadequate, as 
many examples of carcinomatous 
change around the ureteral stump 
have been reported. 4,12‘17,21,22,24,25 A 
“collarette” of colon should be in­
cluded in the excision and more radi­
cal colonic resection is necessary if 
malignant change has occurred.
It has been suggested by Carswell 
and associates22 that in view of this 
complication a reappraisal of the in­
dications for ureterosigmoidostomy 
should be made and that it should be 
restricted to patients over 50 years of 
age. We believe that ureterosigmoidos­
tomy in younger patients carries the 
risk of neoplasia but may be done 
provided that follow-up is regular 
and thorough.
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Dysfunction of the Detrusor and Urethra in 
Multiple Sclerosis: the Role of Drug Therapy
Said A. A wad, m b , b c h , f r c s [c ],* J a m e s  W.L. W il s o n , m  sc, m d , f  
J a n e t  F e n e m o r e , RNf and H. G eorge  K iru lu ta , m b , b c h , frcs[cL
Urinary tract disorders secondary 
to multiple sclerosis are common. In 
this series of 24 patients with 
multiple sclerosis, 5 had normal 
function of the detrusor, 3 had 
detrusor hypotonicity and 16 had 
detrusor hyperreflexia. The proximal 
urethra was evaluated using 
radiologic and electromyographic 
techniques. These studies showed 
that 5 patients had a normal urethra, 
15 had some degree of somatic 
dyssynergia and 3 had sympathetic 
dyssynergia. Detrusor hyperreflexia 
with somatic dyssynergia was found in 
11 patients and was the most common 
pattern. The therapeutic response 
to standard pharmacologic preparations 
was also evaluated. The regimen was 
based on the clinical and urodynamic 
findings for each patient. Dicyclomine 
hydrochloride was the drug of choice 
for detrusor hyperreflexia, bethanechol 
chloride for hypotonicity, dantrolene 
sodium for somatic dyssynergia and 
phenoxybenzamine hydrochloride for 
sympathetic dyssynergia. The authors 
found that most of their patients were 
amenable to drug therapy, the 
exception being those with advanced 
neurologic lesions.
Les problemes des voies urinaires 
secondaires a une sclerose en plaques 
sont frequents. Parmi un groupe 
de 24 patients souffrant de sclerose 
en plaques, 5 avaient un muscle
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vesical fonctionnant normalement,
3 avaient une hypotonicite de 
ce muscle et 16 avaient une 
hyperreflexie. L'uretre proximate a ete 
examinee par des moyens radiologiques 
et electromyographiques. Ces etudes 
ont revele que 5 malades avaient 
une uretre normale, 15 souffraient 
a divers degres de dyssynergie 
somatique et 3 avaient une dyssynergie 
sympathique. Une hyperreflexie 
du muscle vesical et une dyssynergie 
sympathique ont ete retrouvees 
chez 11 patients et ceci represente 
le tableau le plus frequent.
On a egalement evalue I'activite 
therapeutique des preparations 
pharmacologiques de reference.
Le regime therapeutique a ete adapte 
aux resultats des examens cliniques 
et urodynamiques chez chaque patient. 
Le chlorhydrate de dicyclomine a ete 
utilise comme medicament de choix 
pour I’hyperreflexie du muscle 
vesical, le chlorure de bethanecol pour 
I'hypotonicite, le dantrolene sodique 
pour la dyssynergie somatique et 
le chlorhydrate de phenoxybenzamine 
pour la dyssynergie sympathique. Les 
auteurs ont trouve que, a I'exception 
de ceux qui avaient des lesions 
neurologiques avancees, la plupart 
de leurs malades ont repondu a la 
medication.
The incidence of urinary tract dys 
function in patients with multiple 
sclerosis has been documented in 
previous reports.1'2 Other investiga­
tors3'8 have also reported on the ab­
normalities of detrusor and sphincter 
function in patients with this disease, 
with particular emphasis on the re­
sults of urodynamic testing. However, 
there have been fewer reports on the 
results of pharmacologic treatment in 
patients with multiple sclerosis who 
have urinary dysfunction.9 In this 
paper we evaluate the treatment of 
24 patients with urinary dysfunction 
as a result of multiple sclerosis.
Patients and Methods
Twenty-four patients (19 women, 5 
men) with multiple sclerosis have 
been referred to the urodynamic unit 
of the Kingston General Hospital 
over the past 5 years for evaluation 
and management of urinary tract dis­
orders. The mean age was 44.8 years 
(range from 23 to 62 years) and the 
mean duration of symptoms of mul­
tiple sclerosis was 8.6 years (range 
from 3 to 20 years). The symptoms 
of urinary dysfunction present in these 
patients are listed in Table I. Infec­
tion, either chronic or recurrent, was 
noted in 11 patients.
Patients were assessed on the basis 
of their history, the findings on gen­
eral physical and neurologic exami­
nations and intravenous pyelography, 
the results of frequent urine cultures 
and determination of blood urea 
nitrogen and creatinine levels. Cys­
toscopy was done only when indi­
cated, for example in those with 
hematuria or urinary lithiasis.
Usually, the urodynamic evalua­
tion was carried out when urine was 
sterile. Cystometrograms were ob­
tained with water as the filling me­
dium at a rate of 25 ml/min using a 
pump with the patient supine. Be­
cause of the lack of standardization 
in interpreting the cystometrogram, 
the criteria used in this study will be 
listed. The cystometrogram was con-
Table 1— Sym ptom s in Patients 
with M ultip le  Sclerosis
Symptom
No. of






Term inal dribbling 1 (4)
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sidered normal when bladder capacity 
was 300 to 700 ml with a minimal 
rise in intravesical pressure during 
filling until full capacity was reached.10 
In addition, patients had normal per­
ception of bladder fullness and when 
a detrusor contraction occurred, the 
patient was aware of its presence and 
was able to inhibit it rapidly. Detrusor 
hyperreflexia was diagnosed if a det­
rusor contraction occurred when the 
bladder contained less than 300 ml of 
water. On the other hand, the bladder 
was considered hypotonic if its capa­
city was greater than 700 ml, the pa­
tient was unaware of bladder fullness 
and there was no change in intra­
vesical pressure even at full capacity 
or with a detrusor contraction.
The proximal urethra was evalu­
ated simultaneously using electromyo­
graphy of the external sphincter. Nee­
dle electrodes were placed trans- 
perineally a few millimetres lateral 
to the external urinary meatus in 
women and into the bulbospongiosus
muscle in men, and the electromyo­
graphic activity was monitored by an 
audio-amplifier and an oscilloscope. 
Muscle activity was recorded using a 
“leaky integrator” (i.e., with an ex­
ponential decay) of the electromyo­
graphic signals. Normally, electro­
myographic activity should disappear 
during detrusor contraction.11 Persis­
tent muscle activity indicated somatic 
dyssynergia. No reduction in activity 
was an indication of severe dyssyner­
gia, reduced or intermittent activ­
ity signified partial dyssynergia. When 
there was obstruction of the lower 
urinary tract and somatic dyssynergia 
was either absent or very mild (seven 
patients), a voiding cystourethrogram 
was obtained before and after the in­
travenous administration of 5 mg of 
phentolamine, an a-adrenergic block­
ing agent, to rule out the presence of 
“sympathetic dyssynergia”.12 Relief of 
the obstruction after giving phen­
tolamine, as shown radiologically by 
an increase in the diameter of the
proximal urethra during voiding or a 
decrease in postvoiding residual urine, 
indicated that the patient had sym­
pathetic dyssynergia.
The results of urodynamic testing 
served as a guideline for pharma­
cologic treatment as described by 
Awad and colleagues.13 Briefly, the 
antispasmodic dicyclomine hydro­
chloride (60 to 100 mg/d) was used 
for the hyperreflexic bladder. One 
patient was unable to tolerate dicy­
clomine so propantheline bromide 
was used. Bethanechol chloride (100 
to 200 mg/d) was used for the hypo­
tonic bladder. Dantrolene sodium was 
given in divided doses increasing from 
50 mg/d to 100 mg/d (while liver 
function was monitored), often with 
diazepam (5 to 20 mg/d), in patients 
with somatic dyssynergia. Phenoxy- 
benzamine hydrochloride (Dibenzy- 
line) (10 to 20 mg/d) was given when 
sympathetic dyssynergia was consid­
ered to be an etiologic factor in ure­
thral obstruction.
T a b le  II -U ro d y n a m ic  Findings and T re a tm e n t in 24 P atien ts  w ith  M u ltip le  Sclerosis
Patient
no. Age, y r Sex D etrusor u rinae S phincter T re atm e n t
Response 
to drugs
i 55 M Normal Som atic dyssynergia D antro lene sodium Fair
2 35 F Norm al
(s e v e re )
Somatic dyssynergia D antro lene Good
3 32 M Norm al
(s e v e re )
Som atic dyssynergia None ___
4 53 F Normal
(p a r t ia l)
Som atic dyssynergia D antro lene +  diazepam Poor
5 58 F Norm al
(p a r t ia l)
Normal None _
6 49 M H yperreflexic Norm al D icyclom ine hydrochloride Good
7 62 F H yperreflexic N orm al D icyclom ine Good
8 43 F H yperreflexic Norm al D icyclom ine Poor
9 40 F H yperreflexic Norm al P ropantheline  brom ide Good
10 57 F H yperreflex ic Som atic dyssynergia Dicyclom ine Good
11 39 F H yperreflexic
(p a r t ia l)
Somatic dyssynergia Dicyclom ine Good
12 60 F H yperreflexic
(p a r t ia l)
Somatic dyssynergia Dicyclom ine Poor
13 43 F H yperreflexic
(p a r t ia l)
Somatic dyssynergia None —
14 45 M H yperreflex ic
(p a r t ia l)
Somatic dyssynergia D antro lene Poor
15 46 F H yperreflexic
(p a r t ia l)
Somatic dyssynergia In d w elling  c a th e te r —
16 44 F H yperreflexic
(p a r t ia l)
Somatic dyssynergia Dicyclom ine +  dan tro lene Good
17 56 F H yperreflexic
(s e v e re )
Somatic dyssynergia D antro lene +  diazepam Fair
18 27 F H yperreflexic
(s e v e re )
Somatic dyssynergia Dicyclom ine Poor
19 23 F H yperreflexic
(s e v e re )
Som atic dyssynergia Dicyclom ine Lost to
20 52 F H yperreflexic
(s e v e re )
Sym pathetic D ibenzyline
fo llow -up
Good
21 49 M H yperreflexic
dyssynergia  
S ym p athetic -)- somatic In d w elling  c a th e te r —
22 55 F Hypotonic
dyssynergia  (se v e re ) 
S phincter function B ethanechol chloride Poor
23 28 F Hypotonic
in determ inab le  
S phincter functio n B ethanechol + Good
24 51 F Hypotonic
indeterm inab le  
Sphincter function
dantro lene
In te rm itte n t ___
inde term inab le c a the teriza tion
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Results
The urodynamic characteristics of 
each patient and the response to 
pharmacologic treatment are set forth 
in Table II.
The cystometrogram revealed three 
patterns of detrusor function: normal 
(5 patients), hyperreflexic (16 pa­
tients) and hypotonic (3 patients). 
The commonest abnormality was 
detrusor hyperreflexia in 16 of the 
24 patients. Bladder capacities ranged 
between 50 and 300 ml (mean 130 
ml).
In three patients with detrusor 
hypotonicity, the presence of somatic 
dyssynergia could not be determined 
because detrusor contraction was ab­
sent. Eleven of the 15 patients with 
somatic dyssynergia had associated 
detrusor hyperreflexia, and of the 16 
patients who had detrusor hyperre­
flexia, 5 did not have somatic dys­
synergia (Table II). Thus, the two 
commonest abnormalities were fre­
quently, but not always, associated. 
Three patients showed evidence of 
sympathetic dyssynergia in radiologic 
studies, one as an isolated abnormal­
ity, one combined with somatic dys­
synergia and one with detrusor hypo­
tonicity. No patients had pyelographic 
evidence of hydroureter or hydrone­
phrosis secondary to outlet obstruc­
tion.
The therapeutic regimen for each 
patient (Table II) was based on the 
urodynamic findings. The antispas- 
modic dicyclomine was used to treat 
10 of 16 patients with detrusor hyper­
reflexia. Five had good results, which 
meant that urinary incontinence, if 
present, disappeared, and both ur­
gency and frequency appreciably de­
creased although none of the patients 
became asymptomatic. In three pa­
tients with minimal or no improve­
ment, treatment was considered to 
have failed. One patient had a good 
response to propantheline after she 
failed to tolerate dicyclomine. One 
patient was lost to follow-up. In gen­
eral, the best results were obtained 
when the bladder capacity was greater 
than 200 ml.
Of three patients with a hypotonic 
bladder, two were treated with betha- 
nechol and one responded well. The 
responding patient was assumed to 
have a spastic external sphincter in 
association with limb spasticity so 
dantrolene was added to the regimen, 
resulting in a decrease of postvoid- 
ing residual urine from more than 
200 ml to less than 100 ml. The third 
patient, whose urinary retention was
associated with acute exacerbation of 
multiple sclerosis, was treated by in­
termittent catheterization rather than 
by bethanechol; her bladder function 
gradually improved. The number of 
patients treated with bethanechol in 
this series was too small to warrant 
any conclusion as to its value.
Of the patients with somatic dys­
synergia, 1 refused treatment and 6 
of the remaining 15 were treated with 
dantrolene sodium; 2 of the 6 also 
received diazepam. Somatic dyssyner­
gia was not treated unless the patient 
had symptoms of obstruction and 
large volumes of residual urine. Two 
of the six treated patients had good 
results, symptoms lessened and resid­
ual urine decreased by approximately 
40%. Two patients had fair results 
with subjective improvement in symp­
toms but without a decrease in resid­
ual urine volume and two had poor 
results with no improvement.
Of the three patients with evidence 
of sympathetic dyssynergia, one had 
the isolated lesion and was treated 
with Dibenzyline with a good re­
sponse. Residual urine volume de­
creased from 250 ml to 50 ml and 
there was also symptomatic improve­
ment. The patient with associated 
detrusor hypotonicity was unable to 
tolerate the drug because of postural 
hypotension and the patient with 
combined sympathetic and somatic 
dyssynergia refused treatment and 
required placement of an indwelling 
catheter. The response to the various 
drugs is summarized in Table III. 
Overall, of the 17 patients treated 
with drugs and available for follow­
up, the response was good in 9, fair 
in 2 and poor in 6.
Discussion
The spectrum of symptoms found 
in our patients correlates with that 
presented by Bradley and colleagues.3 
However, in our series there were 
slightly more obstructive symptoms 
(hesitancy and large postvoiding re­
sidual urine volume) and fewer irri­
tative symptoms (frequency and ur­
gency) than in their series. Our results 
of urodynamic testing also agree 
closely with Bradley’s, particularly the 
cystometric findings; both showed the 
predominance of detrusor spasticity. 
This contrasts with the findings in 
Schoenberg’s series,8 in which slightly 
more than half the patients showed 
either hyporeflexic or areflexic de­
trusor muscles. Also, the combined 
lesion of spastic detrusor and somatic 
dyssynergia was encountered most 
frequently in our series (11 of 24 pa­
tients) in contrast to Schoenberg and 
colleagues8 who reported only 13 of 
58 patients in this category. Although 
detrusor hyperreflexia and somatic 
dyssynergia were commonly asso­
ciated, several patients had one ab­
normality without the other, suggest­
ing that the pathogenesis of these dys­
functions differs.
When detrusor hyperreflexia was 
associated with somatic dyssynergia, 
the abnormality that appeared to be 
the predominant cause of the patient’s 
symptoms was treated first. This was 
often the detrusor hyperreflexia. Of 
the 11 patients with the combined 
abnormality, 5 were treated with 
dicyclomine, 2 with dantrolene and 
1 with both drugs. We preferred dicy­
clomine for detrusor hyperreflexia 
because it is better tolerated than 
propantheline. However, one patient 
in this series tolerated propantheline 
better than dicyclomine. Generally, 
the results with dicyclomine were bet­
ter if bladder capacity was greater 
than 200 ml. There was no apparent 
increase in the volume of postvoiding 
residual urine following dicyclomine 
therapy even in the presence of 
somatic dyssynergia.
Two patients who had severe de­
trusor hyperreflexia (capacity less 
than 100 ml) and severe somatic 
dyssynergia required an indwelling 
Foley catheter. Both patients needed 
long-term nursing care because of 
the severity of their neurologic lesion.
Table I I I— Response to Drug Therapy
Result
Drug patients Good Fair Poor
Dicyclomine hydrochloride 9 5* — 4t
Dantrolene sodium 7 3* 2 2
Dibenzyline 2 1 — 1
Bethanechol chloride 2 1* — 1
*2 patients had combination drugs, 1 dicyclomine +  dantrolene and 1 bethanechol +  d an tro ­
lene.
f l  patient failed to tolerate dicyclomine but responded well to propantheline bromide.
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Obviously, treatment goals had to be 
adjusted to take into account the 
nature of the handicap. The minimally 
handicapped person could achieve 
near-normal bladder function but the 
severely handicapped, because of poor 
mobility, limb spasticity and de­
formities, may have great difficulty 
achieving urinary continence and nor­
mal voiding habits. In the rapidly 
deteriorating patient or one in relapse, 
re-evaluation and subsequent adjust­
ment of the therapeutic regimen was 
necessary; this occurred in two pa­
tients as symptoms changed. Recovery 
of bladder function following a re­
lapse was also seen.
In summary, bladder and urethral 
dysfunction in patients with multiple 
sclerosis is amenable to pharmacologic 
therapy. The regimen should be drawn 
up on the basis of clinical symptoms 
and the urodynamic findings. The 
majority of patients did well with this
approach but there is a small group of 
patients with advanced neurologic 
lesions whose lower urinary tract dys­
function fails to respond to pharma­
cologic therapy.
We acknowledge the assistance of 
Mr. D. Lywood and his staff in the 
biomedical engineering unit, Queen’s 
University, Kingston. This study was sup­
ported by Physicians’ Services Inc., 
Toronto, Ontario.
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Lymphadenectomy for Testicular Carcinoma
M.P. Laplante, md, frcs[c]* and B.M. Mount, m d , FRCs[c]t
Since 50%  of patients with testicular 
tumour have retroperitoneal metastases 
at the time of presentation, there 
has been little argument that the 
area of primary drainage requires fur­
ther treatment following orchiectomy. 
Patients with nonseminomatous germ 
cell tumours in stages A and B are 
candidates for retroperitoneal lym­
phadenectomy because this procedure 
is of therapeutic value and allows 
accurate staging of the disease. The 
development of extremely effective 
modern, cyclic, multidrug chemo­
therapy for extensive nonseminomatous 
testicular tumour has led to a rethinking 
of the role of lymphadenectomy in 
treating testicular cancer. Clinical 
staging is still not 100% accurate 
even with modern techniques.
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Lymphadenectomy, therefore, continues 
to be an important step in managing 
patients with nonseminomatous germ 
cell tumours. These facts are endorsed 
by the authors' review of 72 cases 
of nonseminomatous germ cell 
tumours managed at McGill University 
teaching hospitals over a 10-year 
period. The authors also discuss the 
indications for retroperitoneal 
dissection.
Comme 50%  des patients atteints de 
tumeurs testiculaires presentent 
des metastases retroperitoneales, on 
a rarement mis en doute la necessity 
d'un traitement d'appoint de la region 
de drainage primaire a la suite d’une 
orchiectomie. Les patients porteurs 
de tumeurs a cellules germinates 
non seminomateuses de stade A et 
B sont candidats pour une 
lymphadenectomie retroperitoneaie 
car cette intervention possede une 
valeur therapeutique en plus de 
permettre d'etablir de facon precise 
le stade de la maladie. Le develop- 
pement de regimes de polychimio- 
therapie cyclique extremement 
efficaces dans les cas de tumeurs 
testiculaires non seminomateuses 
etendues, a provoque une remise en 
question du role de la lymphade­
nectomie dans le traitement des 
cancers testiculaires. Le stade clinique
ne peut encore etre etabli avec 100% 
de precision, meme avec les 
techniques modernes. En consequence, 
la lymphadenectomie demeure une 
etape importante dans le traitement 
des patients souffrant de tumeurs a 
cellules germinates non seminoma­
teuses. Ces faits trouvent appui dans 
I'etude faite par les auteurs de 72 
cas de tumeurs a cellules germinales 
non seminomateuses traites dans les 
hopitaux affilies a I'Universite McGill 
au cours d'une periode de 10 ans.
Les auteurs commentent egalement 
les indications de la dissection 
retroperitoneaie.
The role of the urologic surgeon in 
the initial recognition and removal 
of a testicular tumour is not disputed. 
But subsequent surgical management 
is more controversial, particularly be­
cause the development, in recent 
years, of extremely effective chemo­
therapeutic regimens for advanced 
testicular cancer1** has led to a recon­
sideration by oncologists of the in­
dications for, and extent of, retro­
peritoneal lymphadenectomy. A re­
view of the history, rationale and re­
sults of this surgical procedure is 
timely.
At the turn of this century, Most3 
and Cuneo4 emphasized that the pri­
mary lymphatic drainage of the testis
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was to the region of its embryonic 
origin. The first successful retro­
peritoneal lymphadenectomy was per­
formed by Cuneo in 1906.5 In 1948, 
Lewis6 reported on 169 retroperi­
toneal lymphadenectomies performed 
without a single death and in the late 
1950s, Patton and Mallis7 advocated 
bilateral lymphadenectomy for testi­
cular cancer.
Ray and colleagues8 in 1974 re­
ported on the predictable primary 
lymphatic drainage from the testes. 
Drainage from the right testis is first 
to the interaortocaval nodes, then to 
the precaval, preaortic, paracaval and 
right common iliac nodes in that 
order. Subsequently, the left para-aor- 
tic and left iliac nodes may be in­
volved. Drainage from the left testis 
is, in sequence, to the upper left para­
aortic nodes (between the left renal 
artery and the superior mesenteric 
artery), the preaortic nodes and the 
left common and external iliac nodes. 
Subsequent drainage may be to the 
interaortocaval, precaval, paracaval 
and right common and external iliac 
nodes. Ray and associates also ob­
served that most, but not all, lymph 
nodes draining the testes are filled 
when bipedal lymphangiography is 
done and that lymphangiographic 
crossover from right to left is common 
and may be immediate, whereas cross­
over from left to right is rare and 
probably occurs after the left primary 
nodes are filled with tumour.
Approximately 50% of patients 
with nonseminomatous germ cell tu­
mours have retroperitoneal lymph- 
node metastases at the time of sur­
gical exploration (Table I9'13). Our ex­
perience is similar. In spite of mod­
ern, sophisticated diagnostic tech­
niques, clinical staging is still far 
from precise. Serum tumour markers 
(a-fetoprotein and //-human chorionic 
gonadotropin) give false-negative re­
sults in at least 15% of cases.14,15 
Bipedal lymphangiography is unreli­
able in demonstrating retroperitoneal
lymph-node metastases, and compu­
terized axial tomography and ultra­
sonography consistently fail to dem­
onstrate small metastatic deposits in 
the retroperitoneum.16 Since untreated 
retroperitoneal metastases result in 
the patient’s death, more accurate 
clinical staging is necessary to identify 
patients who require additional ther­
apy following orchiectomy. Retroperi­
toneal lymphadenectomy, to date, is 
the most accurate staging procedure 
available.
Currently in North America retro­
peritoneal lymphadenectomy is fav­
oured over radiotherapy for treating 
the primary lymphatic drainage area 
of nonseminomatous germ cell tu­
mours because of its value in staging 
and because of its therapeutic effi­
cacy. Although the results of numer­
ous uncontrolled studies cannot be 
used as a reliable comparison, the 
survival rates in patients subjected 
to retroperitoneal lymphadenectomy,
with or without adjuvant chemothera­
py, in stages A (tumour confined to 
scrotum) and B (metastatic disease in 
retroperitoneum only) are impressive 
(Table II17); these results are at least 
as good as those in which radiotherapy 
has been used.18'20 The strong prefer­
ence in North America for retroperi­
toneal lymphadenectomy following 
orchiectomy for nonseminomatous 
germ cell tumours is based on the 
demonstrated effectiveness with which 
regional control can be achieved 
without adjuvant chemotherapy. Local 
recurrence following meticulous lym­
phadenectomy is rare (Table III17). 
The effectiveness of combined chemo­
therapy in stage C (metastatic disease 
beyond the retroperitoneum) tumours 
has been well documented.1'2 It is also 
well recognized that because the 
maximum tolerable doses of the 
drugs must be given for optimal ef­
fect, their use may be compromised 
by permanent bone-marrow damage
Table II— Nonseminomatous Germ Cell Tumours: Tumour Free Survival 
at 24 Months* of Patients Treated Consecutively by 
Retroperitoneal Lymphadenectomy since 1974
Series17
Stage, no./total no. (% )
A B A + B
Staubitz 21/22 (95) 15/16 (94) 36/38 (95)
Donohue 57/57 (100) 54/55 (98) 111/112 (99)
Skinner 42/42 (100) 32/35 (91) 74/77 (96)
*Relapse after 24 mo is extremely rare.
Table Ill— Nonseminomatous Germ Cell Tumours: Recurrence after 
Meticulous Lymphadenectomy without Radiotherapy
Series17
Stage, no. of patients Retroperitoneal 
recurrence within 24 mo,* 
no. of patientsA B A +  B
Donohue 57 55 112 1
Staubitz 22 16 38 0
Skinner 42 35 77 0
Total 121 106 227 1 (0.44%)
*Relapse after 24 mo is extremely rare.
Table I — Incidence of Retroperitoneal Lymph-Node Metastases in Patients with Nonseminomatous 
Germ Cell Tumours of Testis Subjected to Abdominal Exploration
Primary tumour type, no./total no. (% )
Series
Embryonal
carcinoma Teratoma Teratocarcinoma Choriocarcinoma
Thompson and colleagues, 19619 
Ekman and colleagues, 196410 
Robsonand colleagues, 196511 
Whitmore, 196812 
Maier and colleagues, 196913
10/13
Z J /  o x
24/45 1/3 16/51 >
Total 4 ------------------ 211/446 (47) ---------------------------------->
VOLUME 25, NO. 3, MAY 1982 / THE CANADIAN JOURNAL OF SURGERY 263
secondary to previous radiotherapy. 
For this reason and because excellent 
results can be obtained by lympha- 
denectomy with or without adjuvant 
chemotherapy and without radio­
therapy, the majority of medical and 
surgical oncologists treating testicular 
cancer in North America omit radio­
therapy as a primary treatment in 
nonseminomatous germ cell tumours. 
The admittedly high rate of infer­
tility due to loss of ejaculation follow­
ing the procedure is a relatively small 
price to pay for such an excellent 
chance of cure. It should be empha­
sized that erectile potency is not af­
fected by the operation nor is the 
ability to experience orgasm.
Retroperitoneal Lymphadenectomy
Indications
Not all patients with testicular 
carcinoma are necessarily candidates 
for this procedure. Since localized 
seminoma (stages A and B) can be 
cured by radiotherapy, most patients 
with pure seminoma do not under­
go retroperitoneal lymphadenectomy. 
However, all patients with nonsemino­
matous germ cell tumours in stages 
A, B. (metastases to retroperitoneal 
nodes confined to four or fewer 
nodes, none of which is larger than 2 
cm) and B2 (metastases to retroperi­
toneal nodes involving more than 
four nodes or any node larger than 
2 cm) should undergo retroperitoneal 
lvmphadenectomy. Patients with 
stage B> disease (bulky, probably 
nonresectable retroperitoneal disease 
without pulmonary metastases) should 
be treated initially with intensive 
multidrug cyclic chemotherapy. If 
there is incomplete resolution of retro­
peritoneal tumour, these patients 
should be explored and the mass or 
masses resected.21 About one third 
of these patients will have fibrosis 
only, one third will have mature tera­
toma and the remainder will have 
viable residual tumour.
FIG. 1—Limits of modified unilateral 
dissection for right and left testicular 
tumours.
Only a small number of pa­
tients with seminoma are candidates 
for retroperitoneal lymphadenectomy. 
Patients with apparently pure semi­
noma in the primary specimen but 
who have an elevated serum a-feto- 
protein level are considered to have 
nonseminomatous germ cell tumours 
and should be treated as such.22
Patients with clinical stage B semi­
noma who have incomplete resolution 
or progression of metastases follow­
ing standard curative doses of radio­
therapy should probably undergo ret­
roperitoneal exploration if there is 
no evidence of pulmonary metastasis. 
This may be a relative indication and 
the role of chemotherapy in such 
cases is becoming more prominent as 
the next step in management. Many 
centres21,23'25 now treat bulky stage 
B seminoma initially with multidrug 
cyclic chemotherapy, because the 
prognosis when such patients are 
treated initially with radiotherapy 
appears to be poor, there being a 
high rate of pulmonary metastases 
subsequently. Patients with anaplastic 
seminoma frequently present with 
more advanced disease than those 
with “classic” seminoma. While 
some26,27 believe that, stage for stage, 
patients with anaplastic seminoma 
fare as well as those with the classic 
type, and respond similarly to radio­
therapy, others are of the opinion 
that anaplastic seminomas behave 
more like nonseminomatous germ cell 
tumours and should be managed dif­
ferently from patients with classic 
seminoma.28'31 The significance of 
elevated 0-human chorionic gona­
dotropin levels in patients with pure 
seminoma is uncertain. Any patient 
with seminoma, of classic or anaplas­
tic types, who persistently has an 
elevated 0-human chorionic gonado­
tropin level after standard radiothera­
py of the retroperitoneum is a reas­
onable candidate for retroperitoneal 
lymphadenectomy. Finally, in the rare 
case of sequential bilateral seminomas 
where removal of the first tumour 
has been followed by radiotherapy to 
the retroperitoneum, retroperitoneal 
lymphadenectomy may be indicated 
after removal of the second tumour, 
if it is thought that the patient mav 
not tolerate further curative doses of 
radiotherapy.
Technical A spects
In view of the pattern of primary 
lymph-node drainage from the left 
and right testes, and because the er­
ror in intraoperative clinical impres­
sion of the status of the nodes is less
than 10%, we believe that a modified 
unilateral lymphadenectomy should 
be performed (Fig. 1) if the lymph 
nodes are judged to be free of meta­
static disease at the time of explora­
tion. If, however, metastatic nodes 
are discovered, we recommend a more 
extensive bilateral dissection. Ex­
tended suprahilar dissection requiring 
thoracoabdominal exposure is not 
necessary or desirable, owing to the 
associated increase in morbidity. No 
improvement in survival has been 
demonstrated for patients who have 
undergone such a dissection. Using 
a high midline transabdominal ap­
proach, we accept as the upper limit 
of the dissection the inferior margins 
of the adrenals (i.e., about 2 cm above 
the renal arteries). Exposure for this 
part of the dissection is not especially 
difficult. The inferior mesenteric vein 
is divided with the ligament of Treitz 
and the posterior peritoneum is in­
cised along the root of the small 
bowel mesentery, carried around the 
cecum and up the right paracolic gut­
ter to the porta hepatis, thus allowing 
complete evisceration of the small 
bowel to expose the full field of dis­
section. The dissection entails com­
plete removal of all lymph-node-bear­
ing, fatty areolar tissue surrounding 
the great vessels within the boundaries 
of the dissection (Fig. 1). In a right 
sided dissection, because of the known 
possibility of right to left lymphatic 
crossover, a left hilar dissection is 
also routinely performed down to the 
level of the inferior mesenteric artery. 
An attempt is made to preserve 
one or two lumbar arteries on each 
side as well as the sympathetic trunks 
bilaterally, although the sympathetic 
fibres are unavoidably removed with 
the lymphatic tissue. The great vessels 
are stripped to the subadventitial plane 
(Fig. 2), and the psoas muscles and 
anterior longitudinal spinal ligament 
are bared. This meticulous dissection 
is time-consuming, but the liberal 
use of hemostatic clips is most useful 
in reducing the operating time. All 
lymphatic channels must be either 
clipped or ligated to prevent forma­
tion of postoperative lymphocele. An 
interiliac dissection, baring the prom­
ontory of the sacrum below the con­
fluence of the common iliac veins, is 
not routinely performed if the modi­
fied unilateral dissection is chosen. 
Much of the presacral autonomic 
plexus will thereby be preserved and 
perhaps also ejaculation.
This procedure is well tolerated by 
young patients and the complication 
rale is low. The most common post-
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operative problem is prolonged para­
lytic ileus, but this almost always 
resolves within 7 to 9 days. Careful 
attention must be paid to postoperative 
fluid balance, as there is consider­
able third space loss. Vigorous post­
operative physiotherapy and early 
mobilization probably reduce the in­
cidence of pulmonary and thrombo­
embolic complications.
Experience with Testicular Tumours 
at McGill University
In the 10-year period 1970 to 1980 
the McGill testis tumour registry 
recorded 131 testicular tumours (47 
seminomas and 84 nonseminomas). 
Although not all seminomas seen in 
the McGill-associated hospitals have 
been registered, all nonseminomatous 
germ cell tumours have been, and the 
follow-up of the patients has been 
complete. Seventy-two patients have 
undergone retroperitoneal lympbade- 
nectomy; 2 had anaplastic seminoma 
(1 with an elevated /3-human chori­
onic gonadotropin level) and 70 had 
primary nonseminomatous germ cell 
tumours. Another 10 patients have 
been registered with extragonadal 
germ cell tumours. Table IV sum-
FIG. 2— Completed modified left­
sided dissection. Anomalous left renal 
vein passes behind aorta. Right renal 
artery marks upper limit of inter- 
aortocaval dissection.
marizes the status, 2 years after op­
eration, of the 72 patients who un­
derwent retroperitoneal lymphadenec- 
tomy. Until late 1976, all patients 
who underwent retroperitoneal lym- 
phadenectomy received adjuvant (or 
prophylactic) cyclic chemotherapy 
either with actinomycin D alone or 
according to the Mendelson regimen32 
(5-fluorouracil, cyclophosphamide, 
methotrexate, and vincristine). Since 
then, patients in stages A and Bi have 
not received adjuvant chemotherapy 
but have been followed by monthly es­
timation of the a-fetoprotein and /3- 
human chorionic gonadotropin levels 
and chest roentgenography for the 
first year, then these studies every 2 
months for the subsequent year.
Pulmonary metastases developed in 
two stage A patients not receiving ad­
juvant chemotherapy. One is in com­
plete remission following 18 months 
of VAB-IV* chemotherapy2 and the 
other died following an incomplete 
response to VAB-IV.
Of the stage Bi patients, all but 
the three most recent patients received 
adjuvant chemotherapy. Of those 
who did not, pulmonary metastases 
developed within 4 months in one. 
This patient is in complete remission 
on the VAB-IV regimen. One patient 
with stage Bi tumour died. He had 
microscopic involvement of two hilar 
lymph nodes. Pulmonary metastases 
developed within 4 months of the 
lymphadenectomy even though he 
was receiving the adjuvant Mendel­
son regimen. He had a complete 
remission with the VAB-IV regimen 
but then relapsed and died 19 months 
after resection.
In the stage B2 group, the results 
were less impressive. Several of the 
nine patients who died did not com-
*The VAB-IV regimen was the fourth 
in an evolving series of multidrug cyclic 
chemotherapeutic protocols, consisting 
of bleomycin, vinblastine and high-dose 
cis-platinum, and interval maintenance 
therapy, also with multiple agents, given 
for a total of 24 months. A further 
modification (VAB-VI) using the same 
drugs in a more condensed schedule, is 
our current protocol.
ply with their chemotherapy sched­
ules and several were treated before 
the VAB protocols were introduced. 
Two others simply did not respond 
even to the most recent chemothera­
peutic regimens. In at least three of 
these cases, there was gross spillage 
of necrotic liquified tumour at the 
time of lymphadenectomy.
Five of 10 patients with stage 
C tumour are long-term survivors 
following retroperitoneal lymphade­
nectomy and cyclic chemothera­
py. Two had thoracotomy for residual 
pulmonary lesions following chemo­
therapy. Twelve other patients with 
stage C nonseminomatous germ cell 
tumours were not subjected to retro­
peritoneal lymphadenectomy. Most 
had an accelerated downhill course 
despite chemotherapy, but one is in 
complete remission. We antici­
pate a higher complete response rate 
with the chemotherapy currently in 
use.1’2 Our results compare favour­
ably with those obtained at other 
centres.
Discussion
There can be no doubt that cur­
rent, combined, cyclic chemotherapy 
using high doses of vinblastine, bleo­
mycin and cis-platinum has greatly 
improved the cure rates in nonsemi­
nomatous germ cell testicular tu­
mours. Mainly because modern 
chemotherapy is so effective in ad­
vanced disease, and because full doses 
are required for best results, most 
North American oncologists are 
now convinced that radiotherapy 
should be avoided in the primary 
treatment of these tumours. Perma­
nent bone-marrow suppression fre­
quently precludes the use of full dose 
schedules of vinblastine in patients 
who subsequently require chemothera­
py. Radiation to the mediastinum 
with scatter to the lungs may limit 
the total dose of bleomycin that can 
be tolerated in view of the known 
risk of pulmonary fibrosis when this 
drug is used. Certainly it has been 
the experience of medical oncologists 
that the use of intensive chemotherapy 
is considerably more difficult in pa­
tients who have previously received 
radiotherapy.1,23
Will the surgeon’s role change in 
the future? Certainly the high inci­
dence of infertility due to aspermia 
following retroperitoneal lymphade­
nectomy is distressing, particularly 
in young men who have not yet 
started their families. It would be 
desirable to avoid retroperitoneal 
lymphadenectomy in these patients
T ab le  IV — Status 2 Years a fte r  O peration  of 72 P atien ts
Who U nderw ent R etroperitoneal Lym phadenectom y
Tum our
stage A live , no. (N E D ,* % ) Dead, no.
A 30 (9 7 ) 1
B, 11 (9 1 ) 1
b 2 10 (5 2 ) 9
C 5 (5 0 ) 5
*N o evidence of disease.
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provided their survival was not com­
promised. Nevertheless, subsequent 
chemotherapy, should it be indicated, 
will probably have permanent effects 
on spermatogenesis. Also, there is a 
fairly high rate of impaired sper­
matogenesis in patients who harbour 
testicular tumours.33 Thus, the im­
portance of loss of ejaculation may 
have been overemphasized in the ar­
guments against the use of retroperi­
toneal lymphadenectomy for nonsemi- 
nomatous germ cell tumours.
Projected improvements in the sen­
sitivity of biochemical markers and 
other nonsurgical techniques may im­
prove the accuracy of clinical stag­
ing to the point where extensive retro­
peritoneal lymphadenectomy will no 
longer be necessary for reliable stag­
ing; a more limited sampling of the 
primary lymph nodes may become ac­
cepted as adequate and be associated 
with a lower rate of aspermia. Even 
though clinical staging is imperfect, 
it may be that a very closely moni­
tored “wait and see” policy following 
orchiectomy will spare an appreciable 
number of these patients extensive 
(and therapeutically unnecessary) op­
erations. Provided early detection of 
metastatic disease is assured, these 
patients may do as well with delayed 
chemotherapy as those whose man­
agement is based upon surgical stag­
ing. Nevertheless, we believe that, at 
present, complete, meticulous lym­
phadenectomy is the single most im­
portant factor in providing definitive 
therapy and a guideline for the ad­
juvant management of patients with 
nonseminomatous germ cell testicular 
tumours.
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Control of Postoperative Renal Hemorrhage 
by Embolization with a Gianturco Coil
G . John Ankenman, md, frcs[c]* and John B. Murray, mb, frcr, F R C P [ c ] f
A 35-year-old woman underwent a 
left pyelonephrolithotomy for removal 
of a staghorn calculus. Blood loss 
was minimal for 5 days. Then there 
was profuse bleeding from the left 
kidney that did not respond to 
conservative management. Angiographic 
examination demonstrated 
extravasation of contrast medium from 
a minor intrarenal artery in the lower 
pole of the kidney directly into 
the pelvicalyceal system. An attempt 
was made to embolize the bleeding 
vessel with Gelfoam particles but 
this failed because the Gelfoam 
passed directly into the collecting 
system. A Gianturco coil, however, 
occluded the vessel and immediately 
the hemorrhage ceased; the patient 
had no further complications.
The authors emphasize that the 
introduction of a steel coil to control 
bleeding is advocated only when 
the use of temporary occlusive agents 
is unsuccessful.
Une femme de 35 ans a subi une 
pyelonephrolithotomie gauche pour 
I’ablation d'un calcul dendritique. On 
observa pendant 5 jours un 
epanchement sanguin minime. Puis, 
il y eut alors une hemorrhagie abondan- 
te provenant du rein gauche qui ne 
repondit pas a un traitement 
conservateur. L’examen angiographique 
revela une extravasation de la 
substance de contraste a partir 
d’une petite artere intrarenale 
situee au pole inferieur du rein, 
directement dans le systeme pelvi- 
caliciel. On tenta d'obliterer le vais- 
seau hemorrhagique a I’aide de parti- 
cules de Gelfoam, mais sans succes 
puisque le Gelfoam fuit directement 
dans le systeme collecteur. Une 
spirale Gianturco permit toutefois 
d’obliterer le vaisseau et d’arreter 
immediatement I’hemorrhagie; la 
patiente n'eut pas d'autre complication.
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Les auteurs insistent sur le fait 
que I'emploi d’une spirale d'acier 
pour maitriser un saignement n’est 
recommande que lorsque les agents 
d’obliteration temporaire ont echoue.
Pyelolithotomy for removal of a 
staghorn calculus was performed suc­
cessfully on a patient who presented 
with recurrent urinary tract infec­
tions. But 5 days later persistent renal 
bleeding commenced. The patient did 
not respond to conservative manage­
ment and transcatheter segmental em ­
bolization with Gelfoam was also 
unsuccessful. However, when a steel 
(Gianturco) coil (Cook Bloomington 
Inc., Markham, Ont.) was introduced, 
the bleeding ceased immediately.
Case Report
A 35-year-old female nurse underwent 
investigation for recurrent urinary tract 
infection. The right upper tract was 
radiologically normal. On the left there 
was a large staghorn calculus (Fig. 1). 
A pyelonephrolithotomy was performed. 
The kidney was cooled by the slush tech­
nique and the renal artery clamped dur­
ing operation. The calculus was removed
FIG. 1—Plain film obtained at time 
of retrograde pyelography showing 
opaque staghorn calculus.
by an extended pyelolithotomy and smaller 
nephrotomy incision. Subsequent roent­
genograms confirmed complete removal 
of the calculus. The 1000 ml of blood 
lost during the procedure was replaced. 
At closure, bleeding from the kidney 
was minimal, so a fenestrated no. 10 
feeding tube was inserted into the ureter 
and brought out through the renal paren­
chyma. A nephrostomy was not done.
The patient had no appreciable blood 
loss for 5 days. Then the urine from 
an indwelling Foley catheter in the blad­
der became sanguineous. Blood replace­
ment was not required until 10 days af­
ter operation. Then, during the next few 
days, she received 8 units of whole 
blood, 2 units of packed cells and 6 
units of fresh frozen plasma because of 
progressive, profuse bleeding through 
the Foley catheter.
When it was apparent that she would 
not respond to conservative management, 
angiographic examination was carried 
out to identify the precise site of bleed­
ing in the hope that selective trans­
catheter embolization would stop the 
bleeding.
Renografin-76 (12 ml) was injected 
through a no. 6.5 F renal Gold catheter 
into the main renal artery; the bleeding 
site was demonstrated by focal accumu­
lation of extravasated contrast medium
FIG. 2—Selective renal arteriogram. 
There is extravasated contrast medium 
in lower pole.
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in the lower pole (Fig. 2). The catheter 
was exchanged for a no. 6.5 F cobra 
catheter which was easily passed into 
the ventral branch of the main renal 
artery close to the site of bleeding; 4 
ml of the contrast medium was injected 
and the pool of extravasated contrast 
medium was shown to communicate di­
rectly with the pelvicalyceal system, 
which contained blood clot (Fig. 3). 
With the catheter tip unaltered in its 
position, multiple fragments of gelatin 
sponge were injected in 2-ml increments 
of Gelfoam-saline and Gelfoam-contrast 
medium mixtures. Hemostasis was not 
obtained because the fragments passed 
through the vessel into the collecting 
system.
A 5-mm wide steel (Gianturco) coil was 
then introduced (Fig. 4), the catheter 
tip withdrawn to the origin of the ven­
tral branch and 8 ml of contrast medium 
injected; complete occlusion of the 
interlobar artery was achieved (Fig. 5).
There was no further bleeding. The 
patient’s postoperative course thereafter 
was smooth. Excretion urography done 
3 months after operation showed con­
traction of the lower renal pole consis­
tent with infarction but with satisfac­
tory function of the upper pole.
D iscussion
The feasibility of transcatheter 
renal infarction was initially evaluated 
experimentally in animals by Lalli 
and colleagues in 1969.1 Since then,
FIG . 3— Subselective arteriogram 
showing collecting system and proximal 
ureter opacified by extravasated con­
trast medium containing blood clot (ar­
row).
embolization of renal arteries has 
been employed in a variety of clinical 
situations,2'5 most notably as an ad­
junct to nephrectomy for renal cell 
carcinoma, but also to control hyper­
tension caused by segmental renal 
artery stenosis,6 to occlude intrarenal 
aneurysms7 and spontaneous fistulas 
associated with renal arterial disease, 
and in congenital malformations.8 
This method of control of post-trau­
matic renal hemorrhage is gaining 
acceptance with the increasing suc­
cesses of “interventional” radiology.9
A variety of embolic materials 
have been used in humans. Auto­
logous blood clot and gelatin sponge 
(Gelfoam) have proven the most 
popular temporary occlusive agents 
and with vascular hypernephromas 
are frequently used in combination 
with Gianturco steel coils for total 
obliteration of the main renal arterial 
supply.
In our case the catheter was ad­
vanced as far as possible into the in­
ferior pole vessel of the ventral 
branch of the main renal artery in 
an attempt subselectively to embolize 
the bleeding vessel. Gelfoam particles 
of increasing size were used initially, 
to provide temporary occlusion, but 
proved unsuccessful; the particles 
passed freely into the adjacent calyx,
FIG. 4— G ianturco coil in place. Cath­
eter withdrawn to more proximal posi­
tion in ventral branch.
which was in direct communication 
with the bleeding vessel. The Gian­
turco coil was then placed as close 
as possible to the bleeding site. The 
major objective of avoiding a nephrec­
tomy overshadowed the risk of seg­
mental infarction and hypertension. 
Immediate hemostasis was obtained. 
As shown on the subsequent excretion 
urogram, infarction of the lower pole 
occurred, but satisfactory excretion 
of contrast medium occurred from 
the upper pole and the patient is now 
normotensive 18 months later.
The best embolic agent would have 
been Gelfoam, which produces a clot 
that will last more than 24 hours, 
whereas autologous clot lyses more 
rapidly. A search of the literature 
did not reveal a similar case in which 
the use of Gelfoam particles was un­
successful because they passed directly 
into the renal collecting system. The 
introduction of a 5-mm wide steel 
coil was our alternative at the time 
because the 3-mm coil was not com­
mercially available. Our success in 
this case may be unprecedented, but 
we do not advocate the use of such 
a coil unless temporary occlusive 
agents are unsuccessful. Reoperation 
and increased morbidity were avoided, 
the iatrogenic infarction being the 
only apparent sequela.
FIG . 5— Postcoil embolization; selec­
tive arteriogram shows occlusion of 
lower pole branch of ventral artery.
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Renal Angiomyolipoma Not Associated 
with Tuberous Sclerosis
J.L. Chin, md and J.K. Wyatt, md, frcs[c], facs
Six cases of renal angiomyolipoma 
not associated with the tuberous 
sclerosis complex illustrate the 
common presenting clinical picture of 
this relatively rare hamartoma. The 
authors discuss the traditional and 
newer diagnostic studies used, 
particularly ultrasonography and com­
puterized axial tomography and their 
applications in the diagnosis of 
angiomyolipoma. Special emphasis is 
placed on differentiation of renal 
angiomyolipoma from renal cell 
carcinoma. Although the newer imaging 
techniques are valuable diagnostic 
aids, treatment of these renal mass 
lesions should not be based entirely 
on results of such studies.
Six cas d'angiomyolipome renal non 
relies a une sclerose tubereuse 
complexe servent a illustrer le tableau 
clinique habituel de cet hamartome 
relativement rare. Les auteurs 
commentent les techniques diagnos- 
tiques traditionnelles et plus recentes 
utilisees, particulierement I'echographie 
ultrasonique et la tomographie 
transverse axiale avec ordinateur, 
et leurs applications au diagnostic 
de I'angiomyolipome. On insiste 
specialement sur la differenciation 
entre I'angiomyolipome renal et le 
carcinome a cellules renales. Bien 
que les nouvelles techniques de 
visualisation soient des moyens
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diagnostiques utiles, le traitement de 
ces masses renales ne doit pas 
reposer entierement sur les resultats 
de telles etudes.
Renal angiomyolipoma is a benign 
hamartoma of mixed mesenchymal 
origin. About 250 cases have been 
reported. Although its association 
with the tuberous sclerosis complex 
is well known, about half the reported 
cases are not associated with tuberous 
sclerosis. Patients without signs of tu­
berous sclerosis present a diagnostic 
challenge in the differentiation of 
renal angiomyolipoma from renal cell 
carcinoma and a therapeutic chal­
lenge in preserving renal tissue.
Clinically, tumours not associated 
with tuberous sclerosis are often uni­
lateral, solitary and large. There is 
a female predominance1 and the peak 
age range is the fifth to seventh 
decade.2 The tumour involved the 
right kidney in 80% of reported 
cases.3 In contrast, patients with the 
tuberous sclerosis type of tumour are 
usually juveniles and there is no sex 
predominance. The disease is usually 
bilateral with multiple small tumours.
Patients
Over the past 10 years, six patients 
(four women, two men) with no signs 
of tuberous sclerosis presented at our 
centre with unilateral renal angiomyo­
lipoma. Their ages ranged from 39 
to 66 years (three were in their 50s). 
All had left-sided tumours. As in 
other reports, the commonest present­
ing symptoms were severe flank pain 
(five patients), hematuria (five) and a 
palpable mass (two patients). Two pa­
tients presented with the rarer pic­
tures of retroperitoneal hemorrhage 
and hypertension, respectively. All
six patients had a space-occupying 
lesion demonstrated on an excretory 
pyelogram. Renal angiography done 
in five patients showed abnormal 
tumour vessels suggestive of renal 
cell carcinoma. The sixth patient 
presented with hypovolemic shock 
from retroperitoneal hemorrhage and 
was operated upon without under­
going angiography. Renal ultrasono­
graphy showed a characteristic solid 
lesion in two patients. Radical ne­
phrectomy was performed in five pa­
tients because of the preoperative 
diagnosis of renal cell carcinoma. 
One patient with compromised renal 
function had a partial nephrectomy 
to preserve renal tissue.
Diagnosis
The diagnosis of renal angiomyo­
lipoma is mainly radiologic. Renal 
mass lesions are usually discovered 
by excretory pyelography and, if 
suspected from clinical presentation, 
should be confirmed by infusion pye­
lography with tomography. Grey-scale 
ultrasonography differentiates true 
cystic lesions from solid and partly 
solid mass lesions. The simple cyst 
can be accurately diagnosed by ultra­
sonography and further investigation 
or treatment is rarely required. For 
all other renal masses renal angio­
graphy more accurately outlines the 
vascularity of the mass and aids in 
planning the surgical procedures that 
may be necessary. Angiographic ex­
amination does not reliably differen­
tiate between the neovascularity of 
angiomyolipoma and the hypovascu- 
larity of renal cell carcinoma with 
areas of central necrosis and tumour 
infarction. The earlier attempts to dif­
ferentiate angiomyolipoma from renal 
cell carcinoma were based on sup-
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posedly characteristic angiographic 
features of angiomyolipoma, such as 
saccular aneurysmal dilatation of in­
terlobar and interlobular arteries (Fig. 
1), the “onion-skin” whorled pattern 
in the capillary phase and the absence 
of arteriovenous shunting. However, 
the current consensus is that renal 
angiography cannot be relied upon to 
differentiate angiomyolipoma from 
renal cell carcinoma, especially stage 
A carcinoma.
Renal Ultrasonography
Recent developments in ultrasono­
graphy help in establishing a more 
accurate preoperative diagnosis. Nor­
mal renal parenchyma is echo-free at
FIG. 1—Renal angiogram of angio­
myolipoma showing typical interlobar 
and interlobular artery aneurysms.
FIG. 2—Ultrasonogram showing kid­
ney (as outlined by relatively sonolucent 
perirenal fat) with dense internal echoes 
reflecting disorganization and numerous 
interphases among blood vessels, muscles, 
fat and connective tissues that constitute 
tumour.
both low and high gain settings. Renal 
cell carcinoma is usually echo-free 
at low gain, but will show some in­
ternal echoes at high settings, although 
there are some highly echogenic ex­
amples. Angiomyolipoma shows clus­
ters of internal echoes at both low 
and high gain settings,4 demonstrat­
ing the disorganization and the nu­
merous interphases among blood ves­
sels, muscles, fat and connective tis­
sues. Fig. 2 shows the typical ultra­
sonographic picture of angiomyo­
lipoma. We stress, however, that the 
diagnostic accuracy of ultrasono­
graphy is not such that the need for 
a radical cancer surgery approach can 
be dismissed, because we have en­
countered renal cell carcinomas that 
were highly echogenic at both low 
and high gain settings.
Computerized Axial Tomography
We have used computerized axial 
tomography in several cases of renal 
cell carcinoma mainly for staging, 
and there are recent reports5,6 of com­
puterized axial tomography used as 
an additional diagnostic tool for an-
FIG. 3— Fat-dominant angiomyolipo­
ma. Kenal angiogram (top) and com­
puterized tomogram (bottom) showing 
renal mass (arrow).
giomyolipoma. Fat-dominant angio- 
myolipomas are clearly seen on the 
tomogram (Fig. 3). These tumours 
have very low attenuation coefficients 
(—30) compared with other tissues be­
cause of the low density of fat.5,6 Re­
nal cell carcinoma does not contain fat 
and therefore has a much higher at­
tenuation coefficient (>0). Tumours 
with necrosis or hemorrhage have in­
termediate attenuation values (-10), 
usually quite easily distinguishable 
from angiomyolipoma.5,6 However, 
not all angiomyolipomas contain fat in 
the quantities that would display the 
characteristic low density pattern on 
the computerized axial tomogram.
Discussion
The first aim of treatment is to dis­
tinguish angiomyolipoma front a 
malignant tumour preoperatively. The 
usual work-up for renal cell carcino­
ma should be performed. Ultrasono­
graphy and computerized axial tomo­
graphy, if available, should be used 
as adjunctive tools. As emphasized 
earlier, these newer investigations can­
not be depended upon completely to 
rule out a malignant lesion. We must 
therefore bear in mind when dealing 
with certain solid and vascular renal 
mass lesions that the tumour may 
be benign. The second aim in treat­
ment is to preserve normal renal tis­
sue. However, since we have not 
absolutely resolved the diagnostic 
dilemma in patients with angiomyo­
lipoma but no signs of tuberous scle­
rosis, we cannot afford to break with 
the radical cancer surgery approach 
to justify preservation of renal tissue 
except in special circumstances.
Fig. 3 is reproduced by courtesy of 
John Wiley & Sons, Inc., New York, 
from Lee TG et al: Ultrasound findings 
of renal angiomyolipoma. JCU 1978; 6: 
150-5
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Unilateral Renal Artery Embolism 
Managed Conservatively
V. Srinivas, m d* and H.G. K iruluta , MD, FRCS[c]t
Renal artery embolism presents a 
diagnostic challenge because the 
condition is rare and it often mimics 
other more common abdominal 
problems. A conservative approach is 
favoured by most urologists but 
management is still controversial.
The authors present a case of 
unilateral renal artery embolism that 
illustrates the difficulties and delay 
in making a diagnosis. It also 
highlights the efficacy of anticoagulants 
in restoring adequate function in a 
kidney that had been totally nonfunc­
tioning and partially ischemic for 
longer than 18 hours.
Le diagnostic de I'embolie d’une 
artere renale presente un defi, du 
fait que cette affection est rare et 
qu'elle prend souvent les apparences 
d'autres problemes abdominaux plus 
frequents. La plupart des urologistes 
favorisent une approche conservatrice 
mais le traitement est toujours 
sujet a controverse.
Les auteurs decrivent un cas 
d'embolie unilateral d’une artere 
renale qui illustre les difficultes de 
diagnostic et les delais a y arriver.
II met egalement en lumiere I’efficacite 
des anticoagulants a retablir une 
fonction adequate dans un rein qui 
avait ete completement non fonc- 
tionnel et partiellement ischemique 
pendant plus de 18 heures.
Renal artery embolism is uncommon. 
Patients with the lesion are usually 
seen in the emergency department 
and have flank and abdominal pain 
that often mimics other, more com­
mon, abdominal conditions.
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Whether the embolus should be 
removed surgically1 or treated con­
servatively with systemic anticoagu­
lants2 is controversial. In a series of 
24 cases of unilateral renal artery em­
bolism, there were no deaths in pa­
tients managed nonsurgically but 18% 
of patients who were operated on 
died. The rate of kidney preservation 
in the two groups was 77% and 44% 
respectively.3 Intra-arterial infusion 
of streptokinase to dissolve the em­
bolus has also been recommended as 
an adjunct to systemic anticoagulant 
therapy.4
We recently treated a patient with 
left renal artery embolism who illus­
trates the problems associated with 
this uncommon condition.
Case Report
A 71-year-old woman was seen in the emergency department with a 6-hour history of left flank and lumbar pain of acute onset. The pain was constant and radiated to the umbilical region and left groin. Her medical history was impor­tant in that she was taking insulin for diabetes and medication for hypertension, and she had ischemic heart disease with mitral stenosis. Her blood pressure was 160/110 mm Hg, the pulse rate was 88 beats/min and was irregularly ir­regular, and the temperature was 37.5°C. The abdomen was not distended, but was tender throughout, particularly in the left costovertebral angle and left lumbar region. Peripheral pulses were present and no bruit was heard over the abdomen.The hemoglobin level was 13.4 g/dl, leukocyte count 10 X 109/1; urinalysis showed 2 to 3 erythrocytes per high- power field, trace protein and 1 to 3 leukocytes per high-power field. The blood sugar level was 263 mg/dl (14.6 mmol/1), blood urea nitrogen 14 mg/dl (5 urea, mmol/1), serum creatinine 0.8 mg/dl (70.7 pmol/1), and serum elec­trolyte and amylase levels were normal. The electrocardiogram revealed atrial fibrillation with a controlled ventricular response.Intravenous pyelography on admis­sion revealed a normally functioning right and a nonfunctioning left kidney in the early and delayed films. Both kidneys were of normal size. Cystoscopy under local anesthesia revealed a normal bladder and a left retrograde pyelogram appeared normal. There was no urine
output from the left kidney. A renal arteriogram showed that the renal vascu­lature was normal on the right; however, the left renal artery was completely oc­cluded approximately 2 cm from its origin (Fig. 1). A selective left renal arteriogram revealed a few collateral vessels and a lucency at the site of ob­struction (Fig. 2).Heparin was given intravenously (1000 U/h), and digoxin (0.125 mg/q6h, intravenously, followed by 0.125 mg, once a day, orally) was administered to control her atrial fibrillation. Warfarin therapy (5 mg once a day, then 2.5 mg once a day) was started the next day and the heparin was discontinued after 5 days. The patient did well and at the time of
FIG. 1—Flush arteriogram shows normal right renal vasculature and com­plete occlusion of left renal artery.
FIG. 2—Selective left renal arterio­gram. There are several collateral ves­sels and lucency (embolus) (arrow) oc­cluding left renal artery.
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discharge, 3 weeks later, the left kidney 
was functioning well (Fig. 3).
Discussion
Since the first case of renal artery 
embolism was reported by Traube in 
1856, a number of reports on this 
condition have appeared in the litera­
ture.2 Some of the important etiologic 
factors in the development of renal 
artery embolism are: atrial fibrilla­
tion, myocardial infarction, subacute 
bacterial endocarditis, surgery on the 
abdominal aorta, dislodgement of 
plaques during angiographic proce­
dures and blunt trauma.
The symptoms usually consist of 
acute unremitting pain localized to 
the lumbar region or spreading dif-
FIG. 3—Intravenous pyelogram after 
3 weeks (15 minute film). There is good 
function in left kidney.
ATLAS DE RADIOLOGIE DU PIED. 
J. Montagne, A. Chevrot et J.-M. 
Galmiche. 277 pp. Illust. Masson 
Paris, 1980. Prix non mentionne. ISBN 
2-225-48708-1.
This atlas on the foot, which has been 
written in French and translated into 
English, contains good-quality photo­
graphs and has an excellent bibliography. 
Each radiograph is succinctly described. 
The authors consider first the radiologic 
techniques and anatomy of the adult and 
pediatric foot. Normal variants and mul­
tiple radiologic measurements are de­
tailed. The normal and abnormal bio­
mechanics of the foot are also covered.
The chapters are divided according 
to radiologic abnormalities, so that the 
reader who is dealing with an unknown
fusely into the upper abdomen, some­
times associated with nausea or ileus. 
Invariably proteinuria and microscopic 
hematuria are present. The serum lac­
tic dehydrogenase concentration is 
usually elevated and leukocytosis may 
be present. The intravenous pyelo­
gram shows a kidney of normal size 
that is nonfunctional. Our patient 
had similar clinical findings and the 
characteristic pyelographic features, 
which made us highly suspicious of 
renal artery embolism. The lesion was 
confirmed by renal arteriography.
Recent reports suggest that the 
treatment of choice for unilateral 
renal artery embolism is the adminis­
tration of systemic anticoagulants 
possibly with percutaneous trans- 
femoral intra-arterial infusion of 
streptokinase for quick dissolution of 
the embolus.5 Anticoagulant therapy 
prevents further propagation of clot 
and occlusion of small cortical colla­
teral vessels by platelet microthrom­
bi.3 Other supportive measures are 
aimed at controlling the atrial fibril­
lation and correcting the dehydration, 
which are often present. Urinary in­
fection is treated vigorously to pre­
vent sepsis in the ischemic kidney. 
Occasionally hemodialysis is required 
for patients with acute renal failure 
due to bilateral renal artery emboliza­
tion or to an embolus in a solitary 
kidney.
Although 18 hours had passed since 
the first attack of pain and the left 
kidney was completely nonfunctional 
in our patient, she responded well to 
systemically administered anticoagu­
lants; function returned in that kidney 
within 3 weeks. Perfusion of the 
renal parenchyma via capsular and 
peripelvic collaterals has been noted 
to occur immediately after renal 
artery occlusion;6 there is also mini­
mal blood flow around the embolus. 
These two factors are important for 
preserving renal function in the pres­
ence of total renal artery occlusion 
as seen on angiography. This may also 
explain the success of conservative 
management using anticoagulants. 
Adjuvant intra-arterial streptokinase 
was not used in our patient because 
we were afraid of dislodging athero­
matous plaques.
It is essential to be aware of this 
uncommon problem so that diagnosis 
is made quickly and correct treat­
ment is instituted before irreparable 
damage occurs.
We thank Mrs. Cathy Breen for her 
secretarial assistance.
References
1. Lacombe M: Surgical versus medical treat­
ment of renal artery embolism. J Cardiovasc 
Surg (Torino) 1977; 18: 281-90
2. Parker JM, Lord JD: Renal artery em­
bolism: a case report with return of com­
plete function of the involved kidney fol­
lowing anticoagulant therapy. /  Urol 1971; 
106: 339-41
3. Moyer JD, Rao CN, W idrich WC, Olsson 
CA: Conservative management of renal ar­
tery embolus. J Urol 1973; 109: 138-43
4. F ischer CP, Konnak JW, Cho KJ, Ekhau- 
ser FE, Stanley JC: Renal artery embolism: 
therapy with intra-arterial streptokinase in­
fusion. /  Urol 1981; 125: 402-4
5. Kaufman JJ: Current Urologic Therapy,
Saunders, Philadelphia, 1980: 166
6. Love L, Bush IM: Early demonstration of 
renal collateral arterial supply. Am J Roent­
genol 1968; 104: 296-301
BOOK REVIEWS
picture can find the answer rapidly. 
Each radiologic appearance is accom­
panied by a description of the different 
diseases that can produce this picture. 
Multiple topics are covered such as local 
or diffuse increased density, periostitis, 
localized or generalized osteopenia, ex­
pansile lesions, severe loss of bone, 
osteonecrosis, arthritides and soft-tissue 
abnormalities.
This is a well-organized and didactic 
reference book which will be useful for 
rheumatologists, orthopedic surgeons 
and radiologists.
J.M. D u m a s , m d , f r c p [c]
Department of diagnostic radiology, 
Royal Victoria Hospital,
Montreal, PQ
CONGENITAL DEFORMITIES OF 
THE HAND. An Atlas of Their Sur­
gical Treatment. W. Blauth and F. 
Schneider-Sickert. 387 pp. Illust. 
Springer-Verlag New York Inc., New 
York, 1981. $230. ISBN 0-387-10084- 
9.
This impressive volume represents the 
authors’ experience in over 1000 opera­
tions for congenital hand deformity. It 
is written for all practitioners of hand 
surgery, who will find advice and an­
swers on surgical technique and timing. 
It has been translated from the original 
German but, thanks to the able transla­
tion of Ulrich Weil, one does not detect 
this during reading.
continued on page 327
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CANADIAN ASSOCIATION OF GENERAL SURGEONS
Intestinal Bypass and Gastric Partitioning 
for Morbid Obesity: a Comparison
MERVYN D eITEL, MD, FRCS[C], FACS, FICS, FACG, FACN,*
M .A. Bo jm , md , frcs[c], M.D. A tin , b s c f  and G.S. Z akhary, m dJ
The authors have compared the results 
of jejunoileal bypass and gastric 
partitioning for the treatment of morbid 
obesity in a consecutive series of 
174 patients. All patients were more 
than 45 kg overweight. There was a 
high incidence of hypertension, 
diabetes, respiratory distress, hyper­
lipemia, debilitating arthritis and 
stress incontinence, which where 
relieved by weight loss after surgery 
Thoracic epidural anesthesia was used.
In 64 patients who underwent 
jejunoileal bypass, weight loss was 
27% at 1 year and reached a plateau 
of 33% at 2 years (range from 18% 
to 53%). Liver biopsy specimens 
obtained at operation showed fat in 
the centrilobular area; postoperative 
biopsy specimens showed worsening 
of this condition at 9 months, 
improvement at 18 months and a 
normal appearance of the lobules at 
30 months. The in-continuity section 
of the bowel showed villous hyper­
trophy with cellular hyperplasia and 
the excluded bowel showed mucosal 
atrophy. Sixteen patients required
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replacement of electrolytes, 6 had 
polyarthritis, which responded to 
metronidazole therapy, and 5 had renal 
stones, which resolved after the patient 
was put on a low oxalate diet and oral 
calcium was prescribed. Diarrhea 
after 1 year was not a problem.
Gastric partitioning was carried out 
on 110 patients, forming a pouch of 
50-ml capacity. In the first 56 of these 
patients the 1.2-cm diameter outlet 
enlarged, reducing the effectiveness of 
the operation. Weight loss at 1 year 
was 21%, but at 30 months it was 
only 16% (range from 0% to 36%).
In the next 54 patients, the 1.2-cm 
outlet was reinforced about a 
calibrating bougie by a circumferential 
imbricating nonexpanding suture. In 
this group weight loss was 31% at 
1 year.
In neither series have there been 
any deaths. Jejunoileal bypass gives 
acceptable weight ioss, but patients 
require continued surveillance.
Gastric partitioning provides effective 
weight loss if enlargement of the 
outlet can be prevented.
Les auteurs ont compare parmi une 
serie de 174 patients consecutifs, 
les resultats obtenus par derivation 
jejuno-ileale et par cloisonnement 
gastrique dans le traitement de 
I'obesite pathologique. Tous les 
patients avaient plus de 45 kg en 
trop. On notait une forte incidence 
d'hypertension, de diabete, d'insuffi- 
sance respiratoire, d'hyperlipemie, 
d’arthrite debilitante et d'incontinence 
a I’effort, que la perte de poids apres 
chirurgie a ameliores. On eut recours 
a I'anesthesie thoracique epidurale.
Chez 64 patients qui avaient subi 
une derivation jejuno-ileale, la perte 
de poids etait de 27% apres 1 an 
et elle atteignit 33% apres 2 ans
(ecart de 18% a 53%). Les biopsies 
hepatiques pratiquees au moment 
de I'operation montraient du tissu 
graisseux dans la region centro- 
lobulaire; les biopsies postoperatoires 
revelerent une deterioration apres 9 
mois, une amelioration apres 18 mois 
et des lobules normaux apres 30 
mois. La section anastomosee de 
I'intestin montrait une hypertrophie 
villeuse avec hyperplasie cellulaire 
alors que la partie de I’intestin mise 
au repos presentait une atrophie de 
la muqueuse. Seize patients ont 
necessity une recharge electrolytique, 
6 ont souffert d'une polyarthrite qui 
repondit au metronidazole, et 5 ont 
eu des calculs renaux qui disparurent 
iorsque les patients recurent un 
regime alimentaire a faible teneur en 
oxalate et qu’on leur administra du 
calcium par voie orale. Apres 1 an, 
la diarrhee n’etait plus un probleme.
Un cloisonnement gastrique par 
formation d'une poche de 50 ml fut 
pratique chez 110 patients. Chez 56 
de ces patients, I'orifice de 1.2 cm de 
diametre s'elargit reduisant I'effica- 
cite de I'operation. La perte de poids 
apres 1 an etait de 21%, mais elle 
n'etait plus que de 16% apres 30 
mois (ecart de 0% a 36%). Chez les 
54 patients suivants, I’ouverture de 
1.2 cm fut renforcie autour d'une 
bougie d’etalonnage par une suture 
circonferentielle, imbriquee et non 
expansible. Dans ce groupe, la perte 
de poids etait de 31% apres 1 an.
Aucun deces n’a ete enregistre dans 
I’une ou I'autre des series. La 
derivation jejuno-ileale assure une 
perte de poids acceptable mais les 
patients necessitent une surveillance 
continue. Le cloisonnement gastrique 
entraine efficacement une perte de 
poids en autant qu’on puisse prevenir 
I'elargissement de I'ouverture.
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Diets, drugs, psychotherapy, behavi­
oral and exercise programs, injec­
tions, hypnotherapy, acupuncture and 
tooth-wiring have all been espoused 
for weight loss in morbidly obese in­
dividuals, but none has proven reli­
able over the long term. Surgical ap­
proaches have therefore evolved as a 
last resort in an attempt to provide 
effective, lasting weight loss (Fig. 1). 
We review the development of these 
procedures and compare our experi­
ence with jejunoileal bypass and gas­
tric partitioning.
FIG. 1—Patient before and after sur­
gery.
Historical Background
To allow food to bypass the major 
absorptive areas of the small bowel, 
Payne and colleagues1 and Lewis and 
colleagues2 experimented with the 
end-to-side jejunotransverse colostomy 
(Fig. 2), but the sequelae of elec­
trolyte imbalance, occasional excess 
loss of weight and liver failure were 
too hazardous. Payne then popular­
ized the end-to-side jejunoileal by­
pass3"5 (Fig. 2); his initial measure­
ments of 37.5 to 12.5 cm were asso­
ciated with late weight gain in some 
patients, so were changed to 35 to 10 
cm. These precise measurements from 
the ligament of Treitz along the me­
senteric border of the bowel were 
found to allow the weight loss to be 
maintained after adaptation of the 
functioning small bowel. The jejunal 
stump was tacked to the root of the 
transverse mesocolon to prevent in­
tussusception. Because some patients 
did not lose enough weight because of 
reflux occurring a short distance into 
the bypassed bowel,6 other procedures 
were devised.
Scott and colleagues,6"8 Salmon9 and 
Buchwald and associates10 developed 
the end-to-end jejunoileal bypass, 
draining the bypassed and isolated 
bowel into the transverse colon, sig­
moid or cecum (Fig. 3), to discourage 
reflux into and absorption by the by­
passed bowel. Palmer and Marliss11 
modified the Payne bypass by using 
a Y-shaped anastomosis (Fig. 3) to 
direct food to the cecum without re­
flux; furthermore, they simply tacked 
the jejunal stump to the adjacent 
ileum.
To avoid the undesirable sequelae 
of intestinal bypass, Mason and asso­
ciates12'13 pioneered the gastric bypass
(Fig. 4), dividing the proximal 10% 
of stomach with a Billroth II-type 
retrocolic, short-loop, gastrojejunos­
tomy, using a stoma 12 mm in diame­
ter. The limited gastric functional 
capacity and narrow outlet necessi­
tated decreased food intake. Alden11 
simplified this difficult procedure by 
a staple-line partitioning the stomach 
(which was not transected) and by an 
antecolic gastrojejunostomy to the 
proximal segment of 60-ml capacity. 
Griffen and colleagues15,16 used a 
retrocolic Roux-en-Y jejunal loop 
anastomosed to a proximal 50-ml seg­
ment of divided stomach in order to 
avoid bile reflux, lessen the hazard 
from anastomotic leakage and facili­
tate moving jejunum in a retrocolic 
fashion to a high position (Fig. 5). 
Pace and coworkers17'18 described the 
simpler technique of gastric parti­
tioning (Fig. 6), removing three cen­
tral staples before a single application 
of the TA90 stapler (United States 
Surgical Corp., Stamford, Conn.) 
leaving a 9-mm opening, but Cohn 
and associates,19 using this method, 
had a mean weight loss of only 20% 
at 10 and 16 months.
Patients and Methods
Between Sept. 26, 1973 and Sept. 
1, 1981 at the St. Joseph’s Health
FIG. 4—Original gastric bypass of 
Mason.12
FIG. 2—Left: Jejunocolic bypass after Payne and col­
leagues4 and Lewis and associates.2 Right: End-to-side jeju- 
uoileostomy (T-shaped anastomosis) popularized by Payne.3"5
FIG. 3—Left: End-to-end jejunoileal bypass; Scott and 
associates6'8 and Salmon9 drained bypassed bowel into trans­
verse (A) or sigmoid (B) colon; Buchwald and colleagues10 
chose cecum (C). Right: Modification of Payne bypass by 
Palmer and Marliss.11 Appendix is removed in all jejunoileal 
bypasses.
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Centre in Toronto, 174 consecutive 
patients underwent surgery for mor­
bid obesity, according to established 
criteria (Table I). The first 64 patients 
underwent jejunoileal bypass. From 
1973 to 1975 patients underwent the
Table I—Criteria for Operation
Presence of morbid obesity, i.e., more than 
45 kg overweight or twice the ideal 
weight for more than 5 years 
Failure of conservative treatment for more 
than 5 years 
Stable life pattern 
Absence of endocrine disorder 
Cooperative
Acceptable operative risk 
Absence of alcoholism*
‘ Because of potential hepatic complies 
tions following operation.
FIG. 5—Extension of Griffen Roux- 
en-Y gastric bypass.
FIG. 6— Gastric partitioning with
TA90 (4.8-mm staples) after Pace and 
associates.17
Scott jejunoileal procedure (Fig. 3, 
left). In the University of Toronto col­
laborative group, however, Palmer’s 
patients had a similar weight loss, so 
from 1975 on we used his simpler 
method (Figs. 3 and 7). In patients 
who underwent jejunoileal bypass, the 
mean weight was 135 kg (range from 
94 to 178 kg), the mean height was 
156 cm (range from 125 to 186 cm) 
and the mean age was 36 years
FIG. 7—Payne jejunoileal bypass 
modified by Palmer and Marliss.11 Roent­
genogram after barium meal at 2 years 
shows rapid transit to cecum. Reflux into 
bypassed ileum is negligible.
FIG. 8—Weight loss following Scott 
jejunoileal bypass. Number at each fol­
low-up point is number of patients. Ar­
rows indicate time at which two patients 
required further resection.
FIG. 9—Weight loss following Payne 
jejunoileal bypass with Y-shaped ana­
stomosis.
(range from 15 to 61 years). The 
female to male ratio was 15:1. To­
wards the end of the study period 
the Gomez-type20 of gastric partition­
ing was becoming popular as a sim­
pler and safer alternative to gastric 
bypass, so our next 110 patients 
underwent this procedure. In 
these patients the mean weight was 
127 kg (range from 90 to 207 kg), the 
mean height was 157 cm (range from 
126 to 188 cm) and the mean age 
was 33 years (range from 18 to 63 




In the nine patients who underwent 
the Scott jejunoileal bypass, the mean 
weight loss was 35% (range from 
22% to 52%) and had not risen at 
96 months postoperatively (Fig. 8). 
However, two early patients who had 
slightly excessive measurements at 
operation required a further resec­
tion, at 22 and 37 months respect­
ively, to achieve adequate weight loss.
In patients who had a modified 
Payne jejunoileal bypass with Y- 
shaped anastomosis, the weight loss 
after 72 months was 33% (range 
from 18% to 53%) and has not 
risen (Fig. 9). There has been no 
excessive weight loss.
The effects of the weight loss on 
the side-effects of morbid obesity 
are shown in Table II. Blood pressure 
fell from an average of 180/120 mm 
Hg with wide cuff to 140/90 mm Hg 
at 12 months (Fig. 10).
The early postoperative complica­
tions are shown in Table III and the 
late sequelae in Table IV. Hypoka­
lemia was treated by Slow K or Kaon 
elixir,10'21 hypomagnesemia by Mag- 
nesium-Rougier and hypocalcemia by 
Calcium-Sandoz.22 Polyarthritis was 
eliminated by metronidazole.10,23 Renal 
calcium oxalate stones were treated 
by a low oxalate diet (avoiding choco­
lates, cola drinks, tea, carrots, celery, 
spinach, gelatin, nuts, plums and 
strawberries)22 and by giving calcium 
carbonate orally.10,24 Excess “gas” re­
solved with metronidazole.
Only one jejunoileal bypass in our 
series has so far been reversed. The 
patient was a woman who weighd 123 
kg and was 156 cm tall. She suffered 
from dyspnea, diabetes, osteoarthri­
tis, urinary stress incontinence and 
recurrent varicose veins. A Payne 
jejunoileal bypass in March 1976 
reduced her weight to 58 kg and the 
associated problems subsided. How-
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ever, she had recurrent oxalate 
nephrolithiasis and would not coop­
erate with respect to diet and drug 
therapy. She underwent reversal of 
the bypass elsewhere November 1980 
and is fighting weight gain.
The adaptation of the functioning 
small bowel consisted of dilatation 
and lengthening as well as prominence 
of the valvulae conniventes, shown 
by roentgenograms after barium in 
gestion, and marked elongation of 
villi associated with cellular hyper­
plasia (but not cellular hypertrophy) 
as in Fig. 11. This figure shows the 
histologic features in the bowel of 
the patient who required further re­
section at 37 months because of in­
adequate weight loss.25 Bypassed 
bowel showed mucosal atrophy.
Of the 174 patients in the study, 
168 had liver biopsy at the time of 
operation (Table V). Patients showed 
hepatic steatosis varying from severe 
to mild. The principle area of fattv 
distribution was centrilobular (37%) 
and diffuse (34%) (Fig. 12). The nor­
mal livers (10%) tended to be present 
in the younger patients.
After jejunoileal bypass, some serial 
liver biopsy specimens appeared worse 
at 9 and 12 months, but generally 
were improved by 30 months over 
the biopsy taken before operation 
(Fig. 13). There were transient eleva­
tions of serum glutamic oxalocetic 
transaminase or alkaline phosphatase, 
or both, which generally returned 
to normal after 24 months. These 
elevations in hepatic enzyme levels 
frequently did not correlate with the
liver biopsy findings. All serum bili­
rubin levels remained normal. All 
patients were routinely given pre­
digested protein capsules (3 cap­
sules tid) containing the lipotropic 
factor L-methionine (3.9 mg/capsule), 
and larger doses were prescribed 
when the results of liver function 
tests or biopsy findings were abnor­
mal. Patients were also given multiple 
vitamins and instructed regarding a 
high-protein, low-fat diet.26,27 There 
have been no instances of liver failure.
Diarrhea after 1 year was not a 
problem. Indiscretions in dietary in­
take, such as of greasy or oily foods,
FIG. 10— Mean blood pressure ac­
companying weight loss. Circles repre­
sent systolic pressure, triangles represent 
diastolic pressure.
still caused rapid transit21 with stea­
torrhea and anal irritation in a few 
patients, and Lomotil was occasional­
ly used.20 Lomotil was also used when 
an abnormality was found in the 
electrolyte levels or results of liver 
function tests, to delay transit and 
prevent electrolyte and protein loss.
Gastric Partitioning
Fig. 14 shows the procedure we 
used. The left triangular ligament of 
these fatty livers was not divided. 
The upper portion of the Polytract 
retractor with the Gomez hand 
(Narco Pilling, Downsview, Ont.) 
placed over the padded liver facili­
tated exposure. A Penrose drain 
about the esophagus identified the 
cardia. The TA90 stapler was applied 
twice, high on the stomach, after four
T a b le  I I I — E arly  C o m p lic a tio n s
a f te r  J e ju n o ile a l B ypass
C o m p lic a tio n N o.
W ound in fe c tio n 1
S erom a 2
D eep  v e in  th ro m b o s is 2
P u lm o n a ry  em bo lism 0 *
*2 p a tie n ts  had  p re v io u s  h is to ry  o f  p u lm o -
n a ry  e m b o li.
T a b le  IV — L a te  C o m p lic a tio n s  
a f te r  J e ju n o ile a l B ypass
C o m p lic a tio n N o.
P e rs is tin g  e le c tro ly te  a b n o rm a lity 1 6 *
H yp o k a lem ia 9
H yp o m agnesem ia 4
H yp o ca lcem ia 3
P o ly a r th r it is 6
R e n a l (c a lc iu m o x a la te )  s to n es 5
E xcess f la tu s  and  b lo a tin g 11
In c is io n a l h e rn ia 6
M e c h a n ic a l o b s tru c tio n  o f bypassed  
ile u m It
In tu s s u s c e p tio n  o f je ju n a l  s tu m p It
‘ R e q u ir in g  re p la c e m e n t. 
(S a m e  p a t ie n t  (F ig .  1 1 ).
T a b le  V — S ta tu s  o f L iv e r  a t  O p e ra tio n
P rin c ip a l a re a  of % o f  p a tie n ts
fa t  d is tr ib u tio n ( n =  168)
C e n tr i lo b u la r 37.4
D iffu s e 34.4
C e n tr ilo b u la r -m id z o n a l 9.8
M id zo n a l 3.7
P e r ip o r ta l 1.2
O th e r 3.1
N o rm a l 10.4
T a b le  I I — S id e -E ffe c ts  o f M o rb id  O bes ity  in  64 P a t ie n ts  
W ho U n d e rw e n t J e ju n o ile a l B ypass
E ffe c t o f
S id e -e f fe c t B e fo re w e ig h t loss
H y p e rte n s io n 45 (s e v e re  in  1 6 ) R eso lved  in  24
D ia b e te s 36 ( f r a n k  in  8, m ild  
in  22, la te n t  in  6 )
N o  h y p e rg ly c e m ia
R e s p ira to r y  d is tress 40 (s e v e re  in  17 , 2 w ith  
P ic k w ic k ia n  s y n d ro m e )
R eso lved
H y p e r lip e m ia 15 ( ty p e  I I  in  2, 
ty p e  IV  in  1 3 )
R es o lve d
O s te o a r th r it is  (k n e e s , 46 (s e v e re  in  22, S tr ik in g  im p ro v e m e n t
a n k le s , low  back ) d e b i l i ta t in g  in  9 ) in  43
F a t ty  l iv e r 57 (m a rk e d  in  1 7 ) (S e e  te x t )
S ta s is  u lc e rs  and edem a 4 H e a le d  in  3
V a r ic o s e  ve ins 11 —
T h ro m b o p h le b it is 4 —
C h o le c y s t it is 27 (p re v io u s  ch o le c y s tec to m y  
in  19, p re s e n t c h o le c y stec to m y
U r in a r y  s tress
in  8 ) —‘
in c o n tin e n c e 35 o f 60 w o m en R eso lved  in  a ll  b u t 1
In te r t r ig o  
P s y c h o s o c ia l and
31 R e s o lv e d *
e c o n o m ic  prob lem s 33 G e n e ra l im p ro v e m e n t
*2 0  u n d e rw e n t s u b s e q u e n t lip e c to m y .
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end of the operation to decompress 
both sides of the partition.
This procedure (Fig. 14, left) was 
performed on 56 patients. The staple 
lines were secured with through-and- 
through polypropylene sutures at the 
corners. The mean weight loss (Fig. 
15) was 21% at 12 months but only 
16% (range from 0% to 36%) at 
30 months, due to stomal enlarge­
ment. Two patients weighed the same 
and two weighed more than preopera- 
tively. After many months there was 
uninhibited emptying of the proximal 
pouch and enlargement of the stoma.
The next 54 patients underwent 
a similar procedure (Fig. 14, right), 
but a circumferential, seromuscular, 
imbricating, running, polypropylene 
suture was inserted against a no. 38 F 
Maloney bougie, to produce a nonex- 
pandable outlet 1.2 cm in diameter. 
A large clip on the lesser curvature
prevented disruption of the line of 
staples. We found use of a no. 32 
F bougie (10.2 mm opening) unsatis­
factory because we had to reoperate 
4 to 6 weeks postoperatively to en­
large the outlet in five patients. The 
mean weight loss with the reinforced 
nondistensible channel (Fig. 15) at 12 
months was 31%, and there has been 
no weight gain in the five patients 
now followed up for 15 months.
Fig. 13a
Fig. l i b
Fig. 11c
FIG. 11— (a) N orm al jejunum  during 
Scott jejunoileal bypass, (b) At 24 
months after bypass, while pregnant, pa­
tient had obstruction of bypassed bowel, 
which had been drained into sigmoid 
colon; segment of ileum was resected. 
Mildly atrophic mucosa can be seen 
in bypassed bowel 25 cm from  sigmoid. 
Patient subsequently had full-term  nor­
mal delivery.25 (c) A t 37 months, she 
had resection of in-continuity bowel for 
further weight loss. Elongated villi with 
hyperplasia of cells are seen as adapta­
tion to short bowel, (d) At 47 months 
there was intussusception of jejunal 
stump, which was resected. Mucosa is 
markedly atrophic (hematoxylin and 
eosin, reduced by 49%  from X 25).
FIG . 12— Severe diffuse fatty m eta­
morphosis (> 7 5 %  of liver infiltrated). 
Some portal areas are spared (hema­
toxylin and eosin, reduced by 49% 
from  X25).
Fig. 13c
FIG . 13— (a) Liver biopsy shows dif­
fuse fatty infiltration at operation, (b) 
Same patient 12 months after jejunoileal 
bypass shows im provem ent (< 2 5 %  of 
liver occupied by fat), (c) At 36 months 
liver is norm al (hem atoxylin and eosin, 
reduced by 55%  from  x 100).
staples had been removed from the 
greater curvature side of the instru­
ment before each application, leaving 
a 50-ml pouch and a greater curvature 
channel. A no. 18 F nasogastric tube 
was placed through the outlet at the
Fig. 11a
Fig. l i d
Fig. 13b
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These patients can eat only very small 
soft meals, chewed well, slowly. Fig. 
15, right, includes three of our pa­
tients, and one from elsewhere, who 
had undergone previous gastric parti­
tioning with no control over the chan­
nel and who subsequently had the 
channel narrowed and circumfer­
entially imbricated over a bougie.
The postoperative complications in 
the 110 patients are shown in Table 
VI. The five patients requiring re­
operation had circumferential imbrica­
tion initially against a no. 32 F bougie 
and were guilty of dietary indiscre­
tion despite instructions to take tiny 
liquid meals (e.g., from a 30-ml plas­
tic medicine glass) for 8 weeks post- 
operatively.18 At reoperation, the 
through-and-through and circumferen­
tial sutures about the channel were 
removed; closure of the channel and 
gastrogastrostomy over a bougie 
would likely be the procedure in 
later cases. There was no diarrhea 
since the vagal trunks were preserved, 
but constipation occurred occasionally 
in the first 2 months, because of lack 
of dietary residue.
Fourteen patients had cholecystec­
tomy for cholelithiasis at the time 
of gastric partitioning (28 had had 
previous cholecystectomy), and 4 un­
derwent repair of a hiatal hernia using 
the Hill technique.
When excess trauma occurred in 
the stomal area during operation, a 
gastrostomy was placed in the lower 
stomach for effective decompression 
and possible later feeding. This was 
done in 19 patients. A drain was 
placed in each patient. There have 
been no leaks or subphrenic abscesses. 
There have been no metabolic com­
plications after the procedure. The 
liver has not shown the abnormalities 
that occasionally occurred after 
jejunoileal bypass, but has improved 
directly with the weight loss.
Discussion
To our knowledge all 174 patients 
who underwent surgery for morbid 
obesity are alive. Thoracic epidural 
anesthesia, supplemented by a light 
general anesthetic, was usually used, 
and the patients were awake and ex- 
tubated at the end of the operation.28 
The epidural was maintained for 
analgesia up to 3 days after operation 
Patients were able to breath and 
move with ease, and did not require 
intramuscular narcotics, which have 
a respiratory depressant effect. Fur­
ther, there is evidence that nitrogen 
balance is improved with epidural 
analgesia.29
If an epidural catheter is to be in­
serted, minidose heparin can only 
be started postoperatively, but pa­
tients went to the operating room 
wearing compression stockings. There 
were no instances of pulmonary em­
bolism.
Jejunoileal bypass produced satis­
factory weight loss, but obligates the 
patient to years of medical surveil­
lance. Scott and associates6 showed 
that as the length of bowel is short­
ened, metabolic complications in­
creased. On the other hand, increas­
ing bowel length permits future 
weight gain after bowel adaptation; 
this is anticipated because of the 
transport capability of the millions of 
intestinal absorptive cells involved.
The adaptations that maintain the 
weight as it stabilizes consist of villus 
hypertrophy in the in-continuity bow­
el and also in the immediately ad­
jacent bypassed ileum where intestinal 
contents reflux.30,31 We22 and others32 
have found mucosal atrophy in the re­
maining bypassed bowel. Friedman 
and associates33 found villus height in 
the proximal jejunum to be almost 
identical to that before jejunoileal by­
pass, but others30'32 have not found 
this.
The major cause of liver deterio­
ration after jejunoileal bypass is be­
lieved to be protein malabsorption, 
especially of methionine and choline, 
in the first 2 years.10'11,22 The lack of 
this complication in our patients may 
be due to the liberal use of pre­
digested protein capsules. It is known 
that infusions of amino acids given 
intravenously or into bypassed jeju­
num if exteriorized will rapidly re­
verse the liver changes.
In gastric partitioning, a small 
pouch to give the sensation of satiety34 
and a small calibrated outlet that will 
not expand are important.20 Double 
application of the stapler is necessary 
to prevent staple-line disruption.18
FIG. 14— Left: gastric partitioning as 
performed on first 56 patients with no 
control over outlet; this led to stomal 
enlargement. Right: gastric partitioning 
with nonexpandable outlet performed in 
last 54 patients.
Circumferential Marlex mesh about 
the outlet has been proposed, but has 
been followed by delayed progressive 
scarring and stenosis.11 Buried non- 
reactive circumferential Silastic tub­
ing may be advantageous.35 Tech­
niques have been described to leave 
a centrally located opening in the par­
tition.17 However, it is difficult to re­
inforce this central channel posteriorly 
to prevent its ultimate enlargement. 
Furthermore, with a central outlet, 
one may be unsuccessful in applying 
the stapler twice with the two open­
ings coinciding to permit a channel. 
We believe that if suture reinforce­
ment is used along the entire length 
of the partition, this can be difficult 
and hazardous. Oblique partitions 
with the outlet on the lesser curva­
ture side have been proposed,35 but 
it is known that food tends to pass 
readily down the lesser curvature 
Magenstrasse so that weight loss may 
be unsatisfactory; furthermore, a fun- 
dal pouch for distension and to give 
a sensation of fullness is helpful. 
The procedures are in a state of de­
velopment, and many improvements 
will likely be devised in the next 
decade. Comparisons of new tech­
niques are now being reported.36
Lately, in patients who are unac­
ceptable operative risks, we have used 
an intragastric balloon inserted trans-











FIG . 15— Weight loss following gas­
tric partitioning without reinforcement 
of outlet (left) and with reinforcement 
by nonexpandable imbricating Prolene 
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nasally (Fig. 16). Control over the 
volume of air in the balloon has been 
maintained by a fine nasogastric tube 
taped externally over the ear. How­
ever, the weight loss will likely be
Fig. 16b
FIG. 16—Patient with (a) intragastric 
balloon in place to provide early satiety, 
(b) This man lost 44 kg in 5 months 
with resolution of stigmata of morbid 
obesity.
limited to the period that the balloon 
is in situ.
Conclusions
Jejunoileal bypass, using critical 
measurements, has provided accepta­
ble and lasting weight loss, but the 
sequelae require prolonged surveil­
lance. Gastric partitioning with a 
pouch capacity of 50 ml is not asso­
ciated with long-term complications 
but provides unreliable weight loss 
due to the expanding outlet. The 
procedure may provide as effective 
weight loss as jejunoileal bypass if a 
secure technique is used to prevent 
subsequent enlargement of an outlet 
of 1.2 cm or less.
Addendum
After a further 6 months of follow-up, 
the mean percentage weight loss after 
gastric partitioning with the reinforced 
channel is 34% in the 14 patients who 
have passed 18 months. There continues 
to be a variation in the percentage 
weight loss in different patients, despite 
the calibrated operation. Experience with 
a further 43 patients suggests that the 
no. 36 F bougie may give optimal results 
in the procedure performed.
We thank Drs. Segundo M. Mariz 
and Frederick Harris of the department 
of pathology, the department of anes­
thesia, Dr. Douglas A. Thompson of the 
division of nephrology, and the depart­
ments of photography and medical rec­
ords for assistance.
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Because “biphasic infection” 
threatens to complicate surgery 
of the large bowel...
control sepsis with
an antibiotic to arrest primary 
gram-negative aerobic infection 
in combination with
Product Monograph available on request.
Treatment Outcome and Efficiency in Surgery
T.H. Brian Haig, md, ph d, facs, frcs[c]
Health gains for patients treated on 
the surgical service of the University 
Hospital in Saskatoon have been 
measured using an illness index 
matrix and these gains have been 
related to financial costs. Although 
many patients benefited, 46.5% did 
not, either because they suffered 
self-limiting complaints or because 
their diseases were beyond the 
surgeon's ability to help. This 60-bed 
surgical service generated costs of 
$8 million in 1979, of which about S3 
million were for services from which 
there was little or no gain for the 
patient. Since 72% of expenditures 
were for basic bed, board and nursing 
costs, more exacting use of hospital 
beds holds the greatest potential 
for increasing efficiency. There is 
evidence, too, that our use of medical 
manpower may be improvident.
S3 millions sont alles pour des services 
n'offrant que peu ou pas de benefices 
pour le patient. Comme 72% des 
depenses passent pour des couts de 
base tels que le gite, le couvert et 
le personnel infirmier, la meilleure 
facon d'ameliorer I'efficacite serait 
de faire un usage plus parcimonieux 
des lits d'hopitaux. II existe aussi des 
indices d'une utilisation abusive des 
effectifs medicaux.
Les benefices pour la sante chez les 
patients traites dans le service de 
chirurgie de I’Hopital Universitaire 
de Saskatoon ont ete mesures a 
I'aide d’une grille d’indices de maladie, 
et ces benefices ont ete rattaches 
a leurs couts financiers. Bien que 
plusieurs patients aient profite des 
traitements, il n’en a pas ete de 
meme pour 46.5%, soit parce qu’ils 
souffraient d’affections qui evoluent 
spontanement vers la guerison, soit 
que leur maladie depassait la capacite 
d intervention du chirurgien. En 1979, 
ce service chirurgical de 60 lits a 
entraine des couts de S8 millions dont
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In 1979, Canadians spent $18 579 959 
000 on health care.1 Of this sum 
90% went towards personal services 
for patients, leaving less than $2 000 
000 000 for health promotion through 
social and community interventions. 
Since, to a very large extent, the 
determinants of health lie outside the 
sphere of therapeutic medicine,25 one 
must question the disproportionate 
allocation of expenditures towards 
therapy, even in a developed country 
like Canada. Indeed, McKinlay and 
McKinlay6 contended that despite cur­
rent levels of health and longevity in 
the United States, about 92% of all 
health gains over the past 100 years 
occurred before the surge in medical 
spending began in the mid-1950s. The 
same picture emerges from Britain.7
Still, medical care has contributed 
to the health of our population over 
the past 50 years,8 as it has to com­
forting the sick for much longer than 
that. What is perhaps less apparent, 
but more disturbing, is that we seem 
to be putting more and more of our 
limited resources into interventions 
from which expectations of gain are 
least.9"18
What we lack is a good way of 
measuring the health gains that do 
accrue from medical interventions and 
of determining the cost of each in­
crement of gain. Without this knowl­
edge we cannot judge how the manv 
components of medical care compare 
with alternative ways of allocating 
resources to improve health. This 
work reports on one set of techniques 
that can be used for measuring thera­
peutic outcome and relates the out­
come to cost.
Material and Methods
Our approach was to measure the 
improvement in health experienced 
by individuals as a result of treat-
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ment in hospital and to tabulate the 
cost of that treatment; then we cal­
culated the dollar cost of each incre­
ment of benefit to give a measure of 
efficiency. We did this for a random 
sample constituting 20% of all pa­
tients treated on the adult general 
surgery service of University Hospital 
in Saskatoon during 1979, using hos­
pital charts as the sole source of 
information.
Working from concepts espoused 
by Williams14 and by Patrick and col­
leagues,15 we first defined illness as 
having three components — discom­
fort, dysfunction and prognosis. In­
dependent assessments of discomfort 
and dysfunction were made for the 
first day each patient entered the 
surgical ward in 1979. The discomfort 
component was measured using a 10- 
point ordinal scale having three 
levels of severity and three levels of 
frequency, with the absence of dis­
comfort and death, as the two ex­
tremes. For dysfunction we used the 
cardinal scale developed and tested 
by Bush and colleagues,15"17 but we 
simplified it to a 10-point scale by 
grouping entries wherever preference 
values tended to cluster. We then had 
two coordinates — one a measure of 
discomfort and the other a measure 
of dysfunction — descriptive of each 
patient s condition on the day of ad­
mission to hospital. We plotted these 
coordinates on an illness index matrix 
upon which indifference curves had 
been drawn as described by Williams14 
and by Culyer;18 each indifference 
curve was assigned the preference 
value ascribed to the corresponding 
dysfunction value. This simplification 
was considered satisfactory for an 
initial study of the method and gave 
us the desirable attribute of prefer­
ence values on a cardinal scale. Ill­
ness index measurements of like char­
acter were then made for each dav 
after the patient’s admission for 1 
year and a time profile curve was 
drawn that was descriptive of the 
patient’s course for this 1 year. A 
second curve was then drawn for 
each patient, as outlined by Williams1’ 
and by Culyer,18 descriptive of that 
patient’s probable course had treat­
ment not been undertaken. For this 
information we went to various 
sources in the medical literature,
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drawing particularly heavily upon 
Eiseman’s recent study19 o f prognosis 
in surgical disease. Using Williams’ 
technique of subtracting the area un­
der the curve depicting the course 
with treatment from that under the 
curve delineating prognosis in the 
absence o f treatment, we derived a 
value descriptive o f the gain that the 
patient achieved from therapy. We 
call this the social utility value be­
cause it describes the benefits derived 
by that person as a social being and 
not simply as a patient with a specific 
medical diagnosis.
Costs of hospital care, too, were 
tabulated individually for each pa­
tient, but no attempt was made either 
to assess social costs or to convert 
these dollar equivalents. The hospital 
business office gave us a per diem 
bed cost for each bed, including 
hostelry, dietary and nursing costs; 
this base figure was used for each 
hospital day. To it was added the 
physicians’ fees, and costs o f drugs, 
laboratory and radiologic services and 
operating room facilities; for these 
categories each patient was treated 
individually by listing, then costing 
out, all o f the services and materials 
applied to that patient while in hos­
pital.
Efficiency was defined as the dol­
lar cost of each social utility unit 
and was calculated by dividing the 
total cost of treatment by the social 
utility value derived from that treat­
ment.
Results
The distribution o f social utility
F IG . 1— Scattergram showing cost — 
benefit coordinates for each o f 316 pa­
tients.
values plotted against costs is illus­
trated in Fig. 1; it shows a skewing 
to the positive benefit side, but also 
shows a heavy clustering towards 
zero. Positive social utility values 
were attained by 53.5% of patients. 
For the 46.5% o f patients who de­
rived zero or negative benefits, 40.6% 
of the total resources were expended. 
This, projected to the whole service, 
would amount to about $3 205 855 
out of a total expenditure o f $7 895 
918 for the general surgical service 
in 1979. Thirty-six (11.4%) patients 
in the sample had. costs exceeding 
$10 000 and consumed a total of 
$566 472, which amounted to 36% 
o f the total resources for this sample. 
These patients were a decade older 
than average and their mean gain 
was about half that o f the whole 
sample, but 61% of them did benefit.
Table I shows that basic bed costs 
accounted for 72% o f the total, while 
investigative services cost about 8% 
and therapeutic materials and services 
took almost 20% . The proportion 
attributable to basic bed costs was 
somewhat greater for those who did 
not benefit, as were the investigative 
costs, while therapeutic services were 
proportionately a little higher for the 
group achieving positive health bene­
fits from their stay in hospital.
Table II records the age and sex 
distribution for the sample as it was 
divided, somewhat arbitrarily, into 
disease categories. The mean social 
utility value for the entire sample 
was +56.98, and for 16 of the 18 
disease categories the social utility 
value was positive. The magnitude 
of benefit did vary substantially be­
tween disease categories, but there 
was little constant relation between 
the degree of benefit and either age 
or sex. The proportion o f patients 
who benefited varied appreciably be­
tween disease categories as well, but
in 13 o f the 18 categories more 
people benefited than did not, with 
an average o f 75%  having a positive 
social utility value.
Few patients with benign breast 
or endocrine disease benefited, prin­
cipally because of the relatively trivial 
nature o f their illnesses. Treatment 
outcome was disappointing also for 
those with disease o f the lungs or 
thorax, exclusive of carcinoma, but 
in these cases it was usually because 
they suffered from serious diseases 
for which little could be done. While 
many patients with peripheral arterial 
disease did gain substantially from 
treatment, a relatively large propor­
tion of persons with these chronic, 
disabling diseases gained nothing.
Of all patients treated on this 
service, 45%  had complaints referable 
to the gastrointestinal system, exclu­
sive o f cancer. Most who suffered 
from the common specific diseases —  
cholelithiasis, anal and perianal 
disease, hernia, bowel obstruction 
and appendicitis —  gained substan­
tially from treatment. However, 40% 
o f this large group had a variety of 
more nebulous complaints and only 
a quarter o f these were helped as a 
result o f their hospital treatment; 
often the cause was not discovered. 
Efficiency in this group, as in almost 
all others, was substantially greater 
in those patients who were operated 
on. This reflects the fact that overall, 
more could be achieved when opera­
tion was possible.
Table III catalogues the total cost 
of treatment per patient for each dis­
ease category and shows the deriva­
tion o f these costs. Overall expendi­
tures generally reflect the complexity 
of therapeutic requirements, so ill­
nesses requiring sophisticated tech­
nology, highly skilled nursing and 
ancillary care and very specialized 




(N =  316)
Positive SUV* 
(n =  169)
Negative SUVt 
(n =  147)
Total, $ 1 579 183 938 012 641 171
Bed/board/nursing, $ (% ) 1 146 791 (72.62) (71.75) (73.89)
Investigation, $(% )
Laboratory 69 512 (4.40) (4.40) (4.40)
Radiology 43 142 (2.73) (2.55) (3.00)
Miscellaneous 10 343 (0.66) (0.64) (0.67)
Therapy, $ (%)
Physicians 168 378 (10.66) (11.17) (9.93)
Drugs 76 007 (4.81) (4.97) (4.59)
Operating room/
miscellaneous 64 961 (4.11) (4.50) (3.54)
♦Patients who derived a social utility value (SUV) greater than zero. 
(Patients who derived a social utility value of zero or less.
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categories, however, b^sic bed costs 
accounted for by far the largest ex­
penditure and investigative procedures 
the smallest. For most groups of pa­
tients the tabulations reflect quite 
well the entire dollar cost of treat­
ment for the particular illness. This
would not be true for cancer patients, 
however, as some will have received 
intensive courses of chemotherapy 
or radiotherapy after leaving hos­
pital. Similarly, expenditures for 
cardiac patients will be biased to­
wards the low side because virtually
all these patients were investigated 
on the cardiology service during an 
admission before, and distinct from, 
their admission to the surgical service. 
These services would add from 
$1000 to $2000 to the overall costs 


















%  deriving 
positive social 
utility value Efficiency/





Cholelithiasis 19 46(20) 2:17 84.14 (85.66) 68 44.12 95 44.14
Anal/perianal 15 54 (16) 9:6 68.35 (68.25) 80 41.58 93 40.34
Groin hernia 13 55(15) 13:0 101.19 (101.52) 77 20.33 85 19.54
Small bowel obstruction 13 45(22) 5:8 95.30 (94.62) 77 60.96 54 52.13
Appendicitis 12 25 (13) 8:4 167.46 (148.63) 75 12.55 100 12.55
Peptic ulcer disease 12 52 (19) 11:1 67.92 (119.72) 42 56.65 25 40.52
Other gastrointestinal/ 
abdominal§ 58 52 (24) 24:34 21.32 (61.82) 26 176.10 36 117.63
Trauma 28 41 (21) 22 :6 74.64 (90.32) 64 84.45 71 82.01
Coronary artery disease 17 51 (8) 14 :3 77.85 (72.65) 71 93.64 100 93.64
Valvularheart disease 13 57 (16) 8:5 57.92 (97.55) 54 137.00 92 133.69
Other cardiac disease 8 72 (13) 5:3 98.24 (54.23) 100 39.48 88 33.59
Peripheral artery disease 34 67 (12) 29:5 45.92 (101.84) 47 169.52 88 164.85
Venous disease 9 52 (17) 3:6 58.46 (70.97) 56 61.23 44 29.19
Carcinoma 36 65 (16) 20 :16 46.77 (60.95) 58 148.97 75 138.41
Soft tissue tumour 3 46(18) 1:2 139.70 (71.85) 100 8.26 100 8.26
Breast/eridocrine! 18 49 (11) 0:18 -22.84 (41.82) 11 N/A|| 83 N/A
Lung/thorax§ 9 57 (11) 6:3 -3 .65  (6.87) 22 N/A 44 N/A
Renal§ 3 75 (15) 1 :2 95.34 (69.17) 100 98.73 67 101.30
Total sample 316" 53 (19) 179:137 56.98 (89.38) 54 87.69 72 79.60
‘Mean ( ;t  standard deviation).
tEfficiency =  mean total co st+  mean social utility value =  the mean dollar cost for purchase of each social utility unit. 
/Efficiency calculations confined to those patients in this category who underwent operation.
^Excluding malignant neoplasms and renal transplants.
*! Total sample slightly less than total for categories because a few lesions fell neatly into more than one category.
||This calculation is meaningless when social utility value is zero or less.





Bed costs/ Investigation costs/ Therapeutic costs§
$* % V % r %
Cholelithiasis 3712 (1328) 2864 (1109) 77.16 158 (87) 4.26 690 (195) 18.58
Anal/perianal 2841 (2374) 2212 (1909) 77.8 87 (68) 3.05 541 (427) 19.04
Groin hernia 2058 (859) 1541 (632) 74.87 78 (66) 3.80 448 (230) 21.77
Small bowel obstruction 5810 (3535) 4532 (2701) 78.01 367 (447) 6.32 930 (619) 16.01
Appendicitis 2102 (1161) 1534 (898) 72.98 103 (133) 4.88 464 (139) 22.07
Peptic ulcer disease 3848 (2666) 2984 (2250) 77.55 316 (173) 8.21 548 (373) 14.24
Other gastroi ntestinal/ 
abdominalf 3721 (3221) 2996 (2638) 80.51 237 (243) 6.37 491 (468) 13.21
Trauma 6303 (5608) 4176 (3496) 66.25 652 (785) 10.35 1446 (1560) 22.94
Coronary artery disease 7290 (5807) 4593 (4993) 63.01 642 (332) 8.81 2053 (537) 28.17
Valvularheart disease 7935 (3728) 4373 (2683) 55.11 1346 (900) 16.96 2239 (805) 28.21
Other cardiac disease 3879 (1936) 2908 (1593) 74.97 216 (153) 5.59 755 (403) 19.46
Peripheral artery disease 7784 (7444) 5718 (6208) 73.45 471 (549) 6.05 1595 (1281) 20.49
Venous disease 3579 (5591) 3057 (5169) 85.41 91 (53) 2.55 431 (417) 12.04
Carcinoma 6967 (5659) 5321 (4339) 76.38 534 (633) 7.67 1109 (919) 15.92
Soft tissue tumour 1154 (183) 877 (117) 75.93 44 (31) 3.81 234 (148) 20.25
Breast/endocrine* 1866 (1265) 1259 (805) 67.47 121 (162) 6.47 486 (346) 26.06
Lung/thorax*! 5472 (5724) 4203 (4419) 76.81 403 (463) 7.37 866 (900) 15.82
Renal*! 9413 (3792) 6945 (2413) 73.78 703 (343) 7.47 1765 (1166) 18.75
Total sample 4997 (4884) 3629 (3737) 72.62 389 (312) 7.79 979 (607) 19.58
*Mean ( ±  standard deviation).
tBed, dietary, nursing and related support costs.
/Laboratory, radiologic, electrocardiographic and related costs 
^Physicians’ fees, drugs, operating room and related costs.
11 Excluding malignant neoplasms and renal transplants.
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and since they are not included in 
our figures, efficiency calculations 
for both of these groups is some­
what overstated.
Discussion
The crux of this work is the meas­
urement of treatment outcome. Over 
the past three or four decades several 
methods have become available to 
accomplish this; some are useful, 
though of restricted applicability. 
Culyer18 discussed a number of these 
in some depth and delved into the 
conceptual difficulties encountered 
with them. In addition, Sullivan20 and 
Torrance21 pointed out problems in­
herent in developing health status 
indices of the sort used in this study. 
Certainly the obstacles are real, but 
they must be overcome if we are 
to measure the benefits provided by 
our therapeutic interventions. The 
method used in this work lacks polish, 
but it has two outstanding virtues. 
First, it is applicable to all categories 
of illness and to all types of therapy, 
and second, its measurements are 
blind to medical diagnoses. This latter 
attribute has several important im­
plications. Complications and other 
unsought outcomes are accounted 
for easily and their effects weighted 
no differently from the primary com­
plaints. Moreover, when the method­
ology is refined sufficiently for pro­
spective studies, nonmedical personnel 
will be able to take the required 
measurements, thereby reducing costs 
and, perhaps more important, shield­
ing patients from medical influence in 
making their assessments of outcome.
Of greatest concern with the 
methodology is our rudimentary abil­
ity to predict the natural history of 
untreated disease. For short-term 
analyses, such as in this study, the 
medical literature supplemented by 
first-hand experience works reason­
ably well, but is less rigorous than 
one would wish. For long-term esti­
mates, the literature seems inadequate 
and personal experience unreliable. 
Some alternative tactic may be neces­
sary. The assignment of preference 
values requires more study and refine­
ment, too, for while the dysfunction 
scale of Bush and his colleagues1517 
is a tested and very good starting 
point, it is not comprehensive enough, 
and it was calibrated using healthy 
young people rather than a patient 
population. The discomfort scale we 
used is crude and has not been 
rigorously tested. The cost calcula­
tions are undoubtedly subject to some 
error as well, particularly with refer­
ence to the per diem component for 
bed, board and nursing services: 
there is bound to be some variation 
in requirements between patients. By 
sequestering and independently tabu­
lating investigative and therapeutic 
costs, however, we have fairly ac­
curately calculated the real costs en­
gendered by each patient studied.
While recognizing and accepting 
the above caveats, we can learn sev­
eral useful things from this first run 
at measuring treatment outcome and 
efficiency. First, it is evident that 
bed costs are by far the greatest of 
the cost components and investigative 
costs the smallest. So, in considering 
cost containment, keeping people who 
do not need acute care out of hos­
pital would be by far the most effec­
tive way of reducing the expense of 
medical care. Given our system of 
publicly funded personal medical 
services, however, incentives for pa­
tients, for physicians and for hos­
pitals all tend to increase rather than 
to limit hospital use. On our particu­
lar service the miscellaneous cases of 
gastrointestinal and abdominal disease 
are those for which we might improve 
our performance most in this regard 
Second, limiting laboratory and radio- 
logic investigations likely has merit in 
protecting patients from unnecessary 
discomfort and harm, but the eco­
nomic impact of these efforts will 
be modest. A third observation is 
that therapeutic services, including 
the professional component, were 
much less intensely applied to the 
usual general surgery patients than 
they were to trauma patients — now 
largely taken over by subspecialists 
— and to patients with cardiac and 
arterial disease. While it is recognized 
that a tertiary care hospital is a poor 
reflection of the larger community, 
this observation must make us won­
der whether very expensive medical 
manpower is being as well used as 
it should be or whether our general 
surgeons are being overtrained and 
underused.
Conclusions
The measurement of therapeutic 
outcome in surgery is possible and 
can be combined with cost analysis to 
evaluate efficiency. The application 
of a prototype measure of this sort 
allows us to see that we can probably 
improve the use we make of hospi­
tals and of medical personnel.
The help of Miss Emma Lew, a senior 
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Gastric Variceal Bleeding Due to 
Occlusion of Splenic Vein in Pancreatic Disease
Roger G. Keith, md, frcs, frcs[c], facs,*
Robert A. Mustard, j r „ b sc, md* and Eric A. Saibil, md, FRCP[c]f
Nine patients with gastric varices 
secondary to occlusion of the splenic 
vein, which resulted from pancreatic 
disease, were treated by the authors 
between 1973 and 1981. Profuse 
hemorrhage, recurrent bleeding and 
hypochromic anemia were investigated 
by endoscopy, gastrointestinal 
roentgenography and selective angio­
graphy. Pancreatic disease was 
defined by ultrasonography, endoscopic 
retrograde pancreatography and 
operation. There were three cases of 
chronic pancreatitis, three of 
pancreatic abscess, two of pseudocyst 
and one of carcinoma of the pancreas.
Definitive control of upper gastro­
intestinal bleeding from gastric 
varices was achieved by combining 
splenectomy with selective pancreatic 
surgical procedures. Two patients did 
not undergo operation. One death 
resulted from an unresectable carci­
noma. Bleeding did not recur in six 
patients followed for up to 8 years 
after operation.
Entre 1973 et 1981, les auteurs ont 
traite neuf patients atteints de 
varices gastriques secondaires a une 
occlusion de la veine splenique 
causee par une maladie du pancreas. 
Une hemorragie abondante, des 
saignements repetes et une anemie 
hypochrome etaient investigues par 
endoscopie, radiographie gastro- 
intestinale et angiographie selective. 
La maladie pancreatique etait precisee 
par echographie ultrasonique, 
pancreatographie endoscopique 
retrograde et a I’operation. On 
identifia trois cas de pancreatite 
chronique, trois d'abces pancreatique,
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deux de pseudo-kyste et un cancer 
du pancreas.
L’arret definitif des hemorragies 
gastro-intestinales superieures dues 
a des varices gastriques fut obtenu 
par une splenectomie associee a des 
interventions chirurgicales selectives 
du pancreas. Deux patients n’ont pas 
subi d’operation et un deceda d'un 
cancer non resecable. II n'y eut pas 
de recidives des saignements chez 
six patients suivis jusqu'a 8 ans 
apres I'operation.
Upper gastrointestinal hemorrhage is 
one of the most common reasons for 
emergency admission to a gastroin­
testinal service. Endoscopy facilitates 
early identification of the source of 
bleeding in most patients. However, 
in a minority no active bleeding site 
is identified. The cause of the hemor­
rhage is frequently attributed to gas­
tritis. Such gastric bleeding may be 
associated with pancreatic disease. 
Varices may result when splenic vein 
occlusion occurs from the extrinsic 
effects of such disease. This represents 
a form of localized, or left-sided, 
portal hypertension. The management 
of gastric variceal bleeding from this 
cause is quite different from that re­
lated to cirrhosis. In this paper we 
discuss the etiology, diagnosis and 
management of this unusual cause of 
gastrointestinal hemorrhage.
Patients and Treatment
The series comprised nine patients, 
seen between 1973 and 1981 (Table 
I). Five presented with frank upper 
gastrointestinal bleeding, three with 
hypochromic, microcytic anemia and 
one was found incidentally to have 
gastric varices at operation for chronic 
pancreatitis. All had pancreatic con­
ditions documented by ultrasono­
graphy, endoscopic retrograde pan­
creatography and operation. Disease 
included pancreatic abscess, pseudo­
cyst, chronic pancreatitis and carci­
noma of the pancreas.
Gastrointestinal roentgenography 
was not diagnostic of gastric varices 
in eight patients who underwent this 
investigation. Endoscopy similarly
was nondiagnostic (Table I). Celiac 
angiography diagnosed the condition 
in the seven patients who were 
studied, and in two cases the diagnosis 
was established at operation.
Six patients had definitive surgical 
procedures and have had no recur­
rence of their gastrointestinal bleeding 
during follow-up from 6 months to 8 
years. One patient (no. 9, Table I) 
with extensive carcinoma of the body 
of the pancreas underwent a palliative 
gastroenterostomy and died 5 months 
later.
Two patients did not have defini­
tive treatment. One patient (no. 8, 
Table I) had only hypochromic 
anemia and refused operation. The 
second (no. 5), aged 75 years, had 
moderate bleeding that ceased spon­
taneously. Because of age and asso­
ciated illnesses, she was managed 
conservatively and splenectomy will 
be performed only if bleeding recurs.
Discussion
Many disease processes may cause 
occlusion of the splenic vein with 
preservation of flow in the remaining 
portal venous system. The causes mav 
be intrinsic or extrinsic. Intrinsic 
causes, which are extremely rare, in­
clude myeloproliferative disorders and 
umbilical vein catheterization.1-2 Ex­
trinsic causes relate to structures con­
tiguous to the splenic vein — the pan­
creas anteriorly and the retroperi- 
toneum posteriorly. Rarely, retro­
peritoneal fibrosis, lymphoma or 
hematoma may produce compression 
of the splenic vein resulting in throm­
bosis.2,3 More commonly, the pan­
creatic lesion obstructs flow. Pan­
creatic diseases include chronic pan­
creatitis, congenital cyst, pseudocyst, 
abscess and carcinoma.2,4-6 Splenic 
vein thrombosis is not uncommon 
with chronic pancreatitis. Rignault and 
colleagues7 described 20 patients with 
chronic pancreatitis who underwent 
percutaneous splenic portography; 8 
were found to have isolated splenic 
vein thrombosis. Similar results have 
been reported by Salam and asso­
ciates.8
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Once the splenic vein has become 
occluded, the venous flow may take 
various routes (Fig. 1). The short gas­
tric veins may drain to the gastro­
epiploic arcade or across the fundus 
of the stomach to the left gastric vein 
(coronary vein). The fundal veins 
may drain through the esophageal 
venous plexus, producing portosys­
temic collaterals, which may also form 
between the spleen and the retroperi- 
toneum. Previous operation may have 
altered the venous anatomy, producing 
additional collateral pathways. Bur- 
bige and associates9 described a case 
of bleeding from colonic varices when 
thrombosis of the splenic vein from 
chronic pancreatitis occurred after 
previous gastrectomy had disrupted 
gastric collateral vessels.
Variceal hemorrhage secondary to 
splenic vein occlusion should be con­
sidered in any patient with pancreatic 
disease who presents with upper gas­
trointestinal bleeding (Table II). On 
physical examination, splenomegaly in 
the absence of other signs of portal 
hypertension or cirrhosis may be 
noted in about 50% of patients.10 A
pancreatic lesion may be confirmed 
promptly by abdominal ultrasono­
graphy, enhanced by grey scale and 
real time scanning. Endoscopic retro­
grade pancreatography will define any 
abnormalities of the pancreatic ducts. 
Air contrast roentgenography after 
barium ingestion will rarely confirm 
the diagnosis. Gastric fundal varices 
may assume either a localized poly­
poid configuration or produce multi­
ple rounded submucosal projections, 
which may simulate tumour or hyper­
trophic rugal folds (Fig. 2).11'13 En­
doscopy is extremely accurate in dem­
onstrating esophageal varices but 
usually cannot identify gastric varices 
because of the thickness of the gastric 
mucosa. Endoscopically, gastric var­
ices may mimic the appearance 
of hypertrophic folds. In the absence 
of ulcer, gastritis or other causes 
of upper gastrointestinal bleeding, 
the endoscopist should suspect gastric 
varices.
Celiac arteriography is the defini­
tive procedure for identifying gastric 
varices and splenic vein occlusion. 
Any patient with upper gastrointes-
FIG. 1—Collateral venous return from 
spleen may become varicose following 
thrombosis of splenic vein.
FIG. 2—Gastric barium roentgeno­
gram shows fundal varices which simu­
late polyps or hypertrophic gastric 
rugae.
Table l l— lnvestigations Recommended fo r Bleeding 
from Suspected Gastric Varices
Gastric bleeding Endoscopy
A ircontrast upper gastrointestinal roentgenography 
Pancreatic disease Ultrasonography or computerized axial tomography
Endoscopic retrograde pancreatography 
Operation
Splenic vein occlusion Selective arteriography and venography
Measurement of hepatic venous pressures
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tinal bleeding of unknown cause 
should undergo angiography.
The venous films, following selec­
tive splenic artery injection, will 
demonstrate filling of the splenic 
parenchyma but not of the main 
splenic vein (Fig. 3). Subsequently, 
the collateral venous flow will be 
seen. Usually this flow is to the portal 
vein by way of the gastroepiploic or 
coronary veins. The contributing 
varices in the gastric fundus will be 
easily identified, contrasted against 
an air-filled stomach (Fig. 4). Venous 
phase films after injection of the su­
perior mesenteric artery can be used 
to demonstrate the anatomy of the 
portal vein and rule out extrahepatic 
obstruction of the portal vein. The 
gastric and esophageal collateral veins 
will not be opacified by this injection.
Measurement of wedged and free 
hepatic venous pressures will give 
normal results, ruling out portal hy­
pertension from chronic liver disease. 
This procedure should always be 
completed at the time of angiography 
except when profuse hemorrhage 
necessitates emergency operation.
FIG. 3—Venous phase angiography 
shows complete occlusion (arrow) of 
splenic vein at hilum with collateral re­
turn through gastroepiploic veins (ar­
rows).
FIG. 4—Massive fundal varices drain 
to portal system through coronary 
(black arrow) and gastroepiploic (white 
arrow) veins.
Pancreatic disease may cause either 
gastric variceal bleeding from occlu­
sion of the splenic vein, usually at a 
nonexsanguinating rate, or brisk ar­
terial hemorrhage from rupture of a 
pseudoaneurysm. Patients with chron­
ic pancreatitis are particularly at risk, 
because splenic vein occlusion is com­
mon in this group. Moreover, 10% 
of these patients have pseudoaneu­
rysms of pancreatic arteries (splenic 
artery, gastroduodenal artery second­
ary to pseudocyst formation).14
In patients with severe upper gas­
trointestinal bleeding who undergo 
emergency surgery, the diagnosis of 
splenic vein occlusion may be estab­
lished at operation. The operative 
findings have been described by 
Salam and associates.8 The triad of 
dilatation of the gastroepiploic vein, 
enlargement of the spleen and a nor­
mal liver, associated with gastric or 
gastroesophageal varices, is highly 
suggestive (Fig. 5). The diagnosis may 
be confirmed by demonstrating pan­
creatic disease and by finding a nor­
mal portal vein pressure. Portal 
manometry and venography can be 
carried out by threading a catheter 
into a tributary of the superior 
mesenteric vein.
Once the diagnosis of bleeding 
varices secondary to splenic vein oc­
clusion is established, the definitive 
surgical procedure is splenectomy. 
There may be extensive portosystemic 
collaterals in the perisplenic liga­
ments, so it is wise to ligate the 
splenic artery before mobilizing the 
spleen. Little and Moossa15 described 
an anterior gastrotomy for oversewing 
the varices, because in their series 
active bleeding was not stopped by 
simple splenectomy. This has not 
been our experience and rebleeding 
has not been a problem in other pub­
lished series.4,8,16'18
Patients with pancreatic disease as­
sociated with occlusion of the splenic
FIG. 5—Dilated gastroepiploic veins 
coursing through gastrocolic ligament.
vein may require splenectomy com­
bined with selective pancreatic sur­
gery. Occlusion associated with a pan­
creatic pseudocyst has been reviewed 
by Salam and associates.8 Cystogas- 
trostomy should be avoided because 
of possible hemorrhage from the 
stomach. Roux-en-Y cystojejunostomy 
is the procedure of choice for drain­
ing the pseudocyst. Pseudocyst de­
compression alone will rarely relieve 
splenic vein occlusion, so splenectomy 
should also be carried out, if tech­
nically feasible. When the spleen 
forms part of the wall of the pseudo­
cyst, the surgeon should consider 
splenectomy with external drainage 
of the pseudocyst or possibly distal 
pancreatectomy including splenec­
tomy.
Management of peripancreatic ab­
scess producing splenic vein occlusion 
may present difficult technical prob­
lems. With disease limited to the body 
or tail of the gland, distal pancrea­
tectomy with splenectomy would be 
the procedure of choice. However, 
this procedure may be compromised 
by the severity of subacute and chron­
ic inflammation. Resection under such 
circumstances may contribute to post­
operative complications such as 
hemorrhage, pancreatic fistula or 
subphrenic abscess. Debridement and 
external drainage of the necrotic, 
peripancreatic tissue combined with 
splenectomy will control bleeding 
from the gastric varices and will limit 
septic complications of the pancreatic 
abscess. If the patient is not actively 
bleeding, splenectomy should be re­
served for a second operation follow­
ing control of peripancreatic sepsis.
Patients with chronic pancreatitis 
and gastric varices present a complex 
problem, combining acute gastroin­
testinal blood loss and a chronic pain 
syndrome. If bleeding is the sole prob­
lem, splenectomy alone should suf­
fice. If the pain of chronic pancrea­
titis is associated with bleeding from 
the varices, then resection including 
splenectomy should be considered, 
based on the extent of disease affect­
ing the gland. Obliteration of surgical 
planes posterior to the gland occurs 
in such cases and vascular anatomy 
can be substantially altered. Care 
should be taken to prevent injury 
to the celiac axis and hepatic artery.
Carcinoma of the pancreas pro­
ducing splenic vein occlusion and 
bleeding gastric varices presents an 
almost hopeless situation because the 
carcinoma is invariably unresectable. 
The surgeon must consider the course 
of the malignant disease and the 
severity of the bleeding when decid-
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ing whether splenectomy is indicated. 
In these patients there may be a 
place for simple ligation of the splenic 
artery or percutaneous embolization 
of the artery. The risks of splenic in­
farction with subsequent sepsis or 
revascularization with rebleeding have 
not been reported.
Conclusions
Occlusion of the splenic vein with 
gastric varices should be considered 
in any patient with gastrointestinal 
hemorrhage and proven pancreatic 
disease. If angiograms confirm the 
diagnosis, splenectomy will control 
bleeding. Most patients will also re­
quire a selective surgical procedure to 
treat the associated pancreatic disease.
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The Conduct of Cholecystectomy: Incision, Drainage, 
Bacteriology and Postoperative Complications
R.T. L ewis, mb, frcs[c], facs,* C.M. Allan , md, frcs[c], F A C s ,f  R.G. Goodall, md, frcs[c], facs,J  
B. M arien, md, FRCS[c],f M. Park, md, FRCS[c],t W. Lloyd-Sm ith , md, frcs[c], facst and
F.M. W lE G A N D , M D, F R C S[C ], FA CSt
The benefits of some ancillary 
techniques of cholecystectomy are 
exaggerated by retrospective study 
of selected patients. Therefore, the 
authors performed a prospective, 
randomized study of 100 consecutive 
patients who underwent simple 
elective cholecystectomy for chronic 
cholecystitis and cholelithiasis. No
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patient was excluded because of 
incomplete hemostasis or fear of bile 
leakage. The frequency of pulmonary 
complications and wound infections 
was independent of the type of 
incision —  vertical or subcostal. 
Peritoneal drainage was found to be 
unnecessary. Short-term drainage may 
increase the frequency of postoperative 
fever, but did not increase pulmonary 
complications or wound infections.
In these patients, intra-abdominal 
sepsis is rare; wound infections were 
uncommon and the gallbladder bile 
was usually sterile and not the cause 
of postoperative infection.
Les etudes retrospectives chez des 
patients choisis exagerent les avan- 
tages de certaines techniques 
auxiliaires de la cholecystectomie.
Les auteurs ont realise une 
etude prospective et randomisee de 
100 patients consecutifs qui ont subi 
une cholecystectomie simple non 
urgente pour cholecystite chronique 
et cholelithiase. Aucun patient ne 
fut exclu en raison d'une hemostase
incomplete ou d'une fuite de bile 
apprehendee. La frequence des 
complications puimonaires et des 
infections de plaie n’etait pas influ- 
encee par le type d'incision (verticale 
ou sous-costale). Le drainage 
peritoneal fut juge inutile. Le drainage 
de courte duree peut augmenter la 
frequence de la fievre postoperatoire 
mais il n'a pas augmente le nombre 
des complications puimonaires ou 
des infections de plaies. Chez ces 
patients, les infections intraabdo- 
minales sont rares; les infections de 
plaies furent peu frequentes et la 
bile dans la vesicule biliaire etait 
habituellement sterile et elle ne causa 
pas d'infections postoperatoires.
Although cholecystectomy is the sec­
ond commonest major operation per­
formed today,1 the ideal ancillary 
procedures have not been settled. In 
1882, Carl Langenbuch devised the 
technique of cholecystectomy by care­
ful cadaver dissection and performed 
the first such procedure on a living 
person.2 He opened the abdomen
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through a vertical lateral rectus in­
cision with a subcostal T-extension; 
after removing the gallbladder, he in­
serted a peritoneal drain before clos­
ing the abdomen. Thirty-one years 
later, a group of German surgeons 
introduced the “ideal” cholecystec­
tomy;3 it is usually performed through 
a subcostal incision, and includes 
“subserous” cholecystectomy4 and ab­
dominal closure without peritoneal 
drainage.5,6 Sporadic reports since 
then have claimed for that technique 
greater patient comfort, a shorter op­
erating time and hospital stay,7'9 
fewer wound infections and respira­
tory complications,10 and even lower 
operative mortality.11 However, since 
few careful prospective studies have 
been done, we designed a study to 
examine the effect of the type of in­
cision and the insertion or omission 
of peritoneal drains on the frequency 
of postoperative complications after 
simple elective cholecystectomy and 
to review the nature of infectious 
complications after routine cholecys­
tectomy.
Patients and Methods
Starting in December 1979, 100 
consecutive patients underwent elec­
tive cholecystectomy for chronic 
cholecystitis. Patients with acute 
cholecystitis or jaundice and those 
requiring exploration of the common 
bile duct or an additional procedure 
on the stomach or colon were not 
included. However, no other exclu­
sions, such as fear of bile leakage or 
incomplete hemostasis, were permit­
ted. The patients were randomly as­
signed by sealed envelope technique 
to one of three groups: no drain, 
Penrose drain, or closed suction 
(Hemovac drain). A subcostal or a 
vertical abdominal incision was em­
ployed depending on the usual prac­
tice of the surgeon. Forty-nine proce­
dures were performed by four sur­
geons through subcostal incisions and 
51 operations by three surgeons 
through vertical abdominal incisions.
The age, sex, weight and height 
of each patient and the duration of 
operation were noted. Ideal weight 
for height and body build values 
were obtained from standard tables.12 
A risk index of wound infection was 
calculated as suggested by Davidson 
and associates.13 This index relates 
the risk of postoperative wound in­
fection to the age of the patient, dura­
tion of operation, wound class and 
presence or absence of organisms on 
culture of the subcutaneous fat at the
end of operation. The total blood 
lymphocyte count was obtained pre- 
operatively by multiplying the total 
leukocyte count by the percentage of 
lymphocytes seen on differential 
smears. Determinations of the serum 
bilirubin, alkaline phosphatase, gluta­
mic pyruvic transaminase (SGPT) 
and lactic dehydrogenase (LDH) 
were made preoperatively and 2 and 
4 days postoperatively by standard 
methods using the Bichromatic Auto- 
analvser (Abbott Laboratories, Diag­
nostics Division, Toronto, Ont.). The 
normal values for total serum bili­
rubin are 0.3 to 1.4 mg/dl (5.13 to 
23.9 yu.mol/1), alkaline phosphatase 
90 to 280 IU/1, SGPT 4 to 25 U /l 
and LDH 52 to 142 U/l.
At operation, the degree of wound 
contamination was noted. The cystic 
duct was doubly ligated by ligature 
and metal clip, and the serosa of the 
gallbladder bed in the liver was closed 
by continuous catgut suture. A cul­
ture was obtained from the inner 
surface of the gallbladder and from 
the subcutaneous fat of the abdomi­
nal wall before skin closure.
Patients were carefully followed 
postoperatively for development of 
wound or intra-abdominal complica­
tions and for the development of non­
specific pulmonary or urinary tract 
infections. A wound infection was 
diagnosed when pus drained from the 
wound and a sample of the pus was 
then sent for culture. Wounds that 
were indurated, reddened or tender 
were followed until the condition re­
solved or there was drainage. A fur­
ther report was obtained 1 month 
after operation from the patient’s 
physician. The volume of daily drain­
age from the suction drain was re­
corded. Drains were removed on the 
second postoperative day unless the 
volume of drainage was excessive. 
Oral temperatures were recorded 
every 6 hours and a fever index was 
calculated for each patient as the 
number of postoperative days that
the temperature was higher than 
37.5°C after the first 24 hours.
Statistical evaluation was carried 
out where indicated by Student's t- 
test and y2 analysis.
Results
There were no deaths in the series 
and no patient required reoperation. 
One patient, operated upon through 
a vertical incision and closed with­
out peritoneal drainage, sustained in­
traoperative injury to the portal vein. 
This injury was identified and the 
vein repaired. Transient intra-ab­
dominal bleeding occurred postoper­
atively necessitating blood transfusion 
before vital signs were stabilized on 
the day of operation.
The 49 patients who underwent op­
eration through subcostal and 51 
through vertical abdominal incisions 
were compared with respect to mean 
age, sex, preoperative blood lympho­
cyte count, percentage of ideal weight 
for height and the Davidson risk index 
of wound infection (Table I). The 
groups were evenly matched. Post­
operative complications were equally 
frequent in patients with subcostal 
incisions and those with vertical in­
cisions. The mean postoperative fever 
indices were 2.2 ±  0.26 and 1.98 ±  
0.20 days respectively (P >  0.1, t =  
0.79); seven patients had pneumonia 
(four with subcostal and three with 
vertical incisions) and wound infec­
tions developed in one patient with a 
subcostal incision and three with ver­
tical abdominal incisions (P >  0.1, 
X2 =  0.96).
Patients with and without peri­
toneal drainage were compared with 
respect to mean age, sex, preopera­
tive blood lymphocyte counts, the 
percentage of ideal weight for height 
and the Davidson risk index of wound 
infection (Table II). These groups, 
too, were well matched. Postoperative 
complications between the groups 
are compared in Tables III and IV.
T a b le 1— C o m p a riso n  o f P a t ie n ts  A c c o rd in g  to  
T y p e  o f  In c is io n *
T y p e  o f in c is io n
S ub co s ta l V e r t ic a l
F a c to r (n  =  4 9 ) ( n =  51 ) t v a l u e !
A g e , y r 5 1 .3  ±  2.5 50.5 ± 2 . 2 0 .2 2
S e x ,m a le /fe m a le 5 /4 3 8 /4 3 —
N o . o f ly m p h o c y te s ,/m m 3 1715 ± 9 2 1782 ± 1 0 0 0 .4 9
W e ig h t, a c tu a l / id e a l  ( % ) 119 .8  ±  3 .2 140.9  ±  19.8 1 .16
R is k  in d e x ,% 15 ±  2 .6 17 ±  2.44 0 .5 3
“M e a n  v a lu e s  -+- s ta n d a rd  e r r o r  o f th e  m e a n .
t N o t  s ig n if ic a n t .
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Postoperative fever occurred more 
frequently in patients with peritoneal 
drainage, but no significant differ­
ence in fever index was observed 
between patients with (1.8 ±  0.23) 
and those without (2.3 ±  0.23) a his­
tory of chronic obstructive pulmonary 
disease and cigarette smoking; post­
operative pneumonia was equally 
common in patients with drainage 
and those without. Wound infections 
were slightly more frequent in pa­
tients with drainage than in those 
without, but the difference was not 
statistically significant. The frequen­
cy and level of increase of postoper­
ative serum bilirubin between patients 
with and those without peritoneal 
drainage, and between patients with
Penrose and those with Hemovac 
drains did not show any significant 
differences.
The striking results of cultures ob­
tained at operation from the gall­
bladder and subcutaneous fat of the 
wound and from the wounds of the 
four patients who had wound infec­
tions were the low frequency of posi­
tive cultures of the gallbladder bile 
and the lack of correlation of the 
gallbladder organisms with those 
found in the subcutaneous fat and 
in infected wounds (Fig. 1). No pa­
tient was given antibiotics prophylac- 
tically. The Davidson risk index of 
wound infection was significantly 
higher (P <  0.02) in the four patients 
who had wound infections than in
those who did not, but the factors 
constituting the index did not show 
similar differences (Fig. 2).
D iscu ss io n
Although much has been written 
on the effect of ancillary techniques 
of cholecystectomy on postoperative 
complications, few prospective studies 
have been done. Our study examines 
the problem in a prospective, con­
trolled manner. The allocation of in­
cisions was not truly random, but 
the matching of patients was.
Which Incision is Preferable?
Some surgeons14 report fewer com­
plications and others'5 more pulmo­
nary complications with subcostal in­
cisions than with vertical abdominal 
incisions. In keeping with the spiro- 
metric studies of Williams and Breno- 
witz16 we found no difference in the 
frequency of postoperative pneumonia 
or in the fever index between the 
two incisions. Haight and Ransom1' 
have reported similar results.
Is It Safe to Omit Peritoneal 
Drainage?
Our results indicate that peritoneal 
drains may be omitted safely in 
cases of uncomplicated elective 
cholecystectomy. There were no op-
F IG . 1— Bacteriology: gallb ladder, sub­
cutaneous fa t, infected wounds.
F IG . 2— Risk index: factors in w ound 
infections.
Table  II -C om parison  of P atien ts  
According to U se of D rainage
F a c to r
D ra in  
(n  =  50)
N o d ra in  
(n  =  50)
P va lu e  
( t  v a lu e )
A ge , y r 49.8 ± 2 .2 51.5 ± 2 .7 NS (0 .48 )
Sex, m a le /fe m a le 6/44 8/42 NS
N o. o f lym phocytes,/m m  ’ 1764 ± 1 0 8 1744 * 8 4 NS (0 .15 )
W e ig h t, a c tu a l/id e a l (% ) 123.3 ±  3.8 121.6 ±  3.3 NS (0 .45 )
R isk in d e x , % 13.3 ±  2.2 17.7 ±  2.5 <  0.1 (1 .3 )
NS =  not s ign ificant.
T a b le  I I I — D ra in  vs. No D ra in  
P ostoperative  C om plications
D ra in No drain
F a c to r (n  =  50) (n  =  50) P va lu e
P ostoperative  fe v e r index, d
> 3 8 .5 °C 2.5 ± 0 .2 1.7 ±  0.2 < 0 .0 1  ( t  =  2.28)
W ound in fec tion , no. 3 (2 H em ovac, 1 > 0 .3  (y -  — 1.04)
1 P en rose)
P ostoperative  pneum onia, no. 4 3 NS
Table  IV P ostoperative  B ilirub in em ia vs. D rainage
Facto rs  associated No drain P va lu e
w ith  b ilirub inem ia D rain  (n  =  50) (n  =  50) ( t  va lu e )
A b n o rm a l postoperative
11seru m  b iliru b in , no. 
P reo p era tive  serum
9 NS
< 0 .0 5  (1 .94)b iliru b in , m g/dl 0.56 ±  0.04 0.45 ±  0.03
P ostoperative  serum  
b iliru b in , m g/dl 
P ostoperative  increase
0.92 ±  0.09 0.87 ±  0.08 NS (0.56)
NS (0 .50)b iliru b in , m g/d l 0.36 ±  0.08 0.42 ±  0.08
W ith  Hemovac d ra in , m g/dl
(n  =  25)
W ith  Penrose d ra in , m g/dl
0.24 ±  0.05
(n  =  25)
C orrespond ing  hepatic
0.42 ±  0.15
110
NS (0 .30)
b ile , ml
C orresponding peritoneal
94
1100flu id , ml 940
H em ovac drainage, ml 59.2 ±  12.3
(m edian 30, range 0 450)
D ra in s  reta in ed  m ore than
2 d 5 (2 Hem ovac, 3 P en ro s e )
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erative deaths and no patients re­
quired reoperation. Glenn18 has stated 
that subhepatic accumulations occur 
after the majority of cholecystectomies 
and are of clinical importance in 
7% to 10% of cases. We should 
therefore have expected at least three 
instances of such accumulations in 
50 cholecystectomies that were not 
drained. None was suspected or diag­
nosed.
Does Any Less Obvious Morbidity 
Result from Omitting a Drain?
Edlund and associates19 found a 
transient abnormal increase in serum 
bilirubin levels after undrained chole­
cystectomy and attributed this to re­
sorption of bile that would otherwise 
have been discharged by the drain. 
Our results show that an abnormal 
postoperative bilirubin level was 
equally common in patients with and 
without drains. The extent of the 
postoperative increase in serum bili­
rubin level was also similar in the 
drained and undrained groups. Based 
on the average concentration of bili­
rubin in hepatic bile and peritoneal 
drainage fluids,20 large amounts of 
bile would have to be lost and fluid 
resorbed to produce this postoperative 
increase in serum bilirubin level. It 
is therefore unlikely that this me­
chanism alone explains the increase. 
Nor is pericholangitis21 a satisfactory 
explanation, for no significant changes 
occurred in the concentrations of 
SGPT, LDH and serum alkaline 
phosphatase.
Polk22 has recommended sump 
suction drainage of the subhepatic 
space after cholecystectomy. Sump 
drains without bacterial filters, al­
though more efficient than Penrose 
drains,23 entrain more organisms from 
the patient’s skin, dressings and en­
vironment.24 If drainage is required, 
closed suction seems preferable, but. 
surprisingly, van der Linden and asso­
ciates25 recently found that closed 
suction drains impair rather than en­
hance intraperitoneal drainage. We 
found no difference between our pa­
tients who had Penrose drains and 
those who had Hemovac drains. In­
deed, since patients without drains 
did as well as those with drains, we 
would expect little difference between 
the two types of drains.
Are There Any Advantages to 
Omitting the Drain?
We found increased frequency of 
postoperative fever in patients with 
peritoneal drains. Maull and asso­
ciates26 reported similar results, but
two other prospective studies19,27 found 
no increase.
No significant increase in wound 
infection occurred in patients with 
peritoneal drains. In contrast to the 
findings in numerous retrospective 
studies, no prospective controlled 
clinical trial has demonstrated such 
an association.
What Is the Frequency and Source 
of Postoperative Infection in 
Uncomplicated Elective 
Cholecystectomy?
In our study there were four wound 
infections, all due to Staphylococcus 
pyogenes; there was no intra-abdomi­
nal sepsis. Only 11 % of gallbladder 
cultures grew organisms and none of 
them S. pyogenes. The light growth 
of Staphylococcus epidermidis from 
the subcutaneous fat of 20% of oper­
ative wounds was probably insignifi­
cant. The lack of correlation between 
the results of cultures of the gall­
bladder, subcutaneous fat and in­
fected wounds suggests that in the 
truly “low-risk” patient28 with uncom­
plicated cholelithiasis who undergoes 
elective operation, culture of the 
gallbladder bile and subcutaneous fat 
is not useful. Since cultures obtained 
from the nasal mucosa and skin of 
two of these four patients were nega­
tive for S. pyogenes, it is unlikely 
that they were carriers of this organ­
ism. These findings are in sharp con­
trast to what occurs in “high-risk” pa­
tients.28 There, the source of post­
operative infection is endogenous, 
usually from the streptococcal or coli- 
form bacteria in the bile, and post­
operative intra-abdominal infection 
occurs more frequently. These differ­
ences have not been adequately em­
phasized, but have been noted previ­
ously by Stone and associates.29
Conclusions
In simple elective cholecystectomy 
for chronic cholecystitis and choleli­
thiasis the choice of abdominal inci­
sion, vertical or subcostal, does not 
influence the development of post­
operative pulmonary or infectious 
complications. Peritoneal drainage 
may be omitted safely without in­
creasing morbidity. Postoperative 
fever occurs less often when no drain­
age is used but the frequency of 
respiratory complications and wound 
infections is not altered. Gallbladder 
bile is usually sterile and is not the 
source of wound infection.
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Management of Duodenal Diverticula
C.H. Scudamore, md, frcs[c], R.C. Harrison, md, facs, frcs[c] and T.T. White, md, facs
Duodenal diverticula are not un­
common. Uncomplicated diverticula 
require no treatment. In the period 
1970 to 1980, 104 patients with 
symptoms presented at the Vancouver 
General Hospital and the Swedish 
Hospital in Seattle. Of these, 26% 
presented with pain and 24% with 
anemia. Malabsorption and benign 
tumours were noted infrequently. Fifteen 
patients were treated surgically for 
pain, perforation, hemorrhage, tumour, 
blind loop syndrome and obstruction 
of the duodenum, biliary tract or 
pancreatic duct. Two patients died.
The second part of the duodenum 
was involved in 82% and the third part 
in 10%. Anatomical variations are 
common in the area of the ampulla; 
these should be anticipated before 
operation. Surgical procedures in the 
area may be technically demanding and 
associated with high mortality and 
morbidity. The choice of procedure 
depends on the urgency and nature of 
the complication of the diverticulum. 
Endoscopic retrograde cholangio­
pancreatography can play a role in 
evaluating the possible significance of 
the diverticulum and the anatomy 
of the area. In some cases endoscopic 
sphincterotomy may be possible.
In some situations diverticulectomy 
is contraindicated.
II n'est pas rare de rencontrer des 
diverticules duodenaux. Lorsqu’il n’y 
a pas de complication, ils ne neces- 
sitent pas de traitement. Durant la 
periode allant de 1970 a 1980, 104 
de ces patients souffrant de symp- 
tdmes ont ete recus au Vancouver 
General Hospital et au Swedish 
Hospital de Seattle. Parmi ceux-ci, 
26% manifestaient de la douleur et 
24% etaient anemiques. De la diarrhee
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et des tumeurs benignes etaient 
rarement observees. Une intervention 
chirurgicale fut pratiquee chez 15 
patients presentant de la douleur, 
une perforation, une hemorrhagie, 
une tumeur, un syndrome de I'anse 
borgne ou une obstruction du duo­
denum, des voies biliaires ou du 
canal pancreatique. Deux patients 
sont decedes.
II y avait atteinte de la seconde 
partie du duodenum dans 82% des 
cas et de la troisieme partie dans 10%. 
Les variations anatomiques de la re­
gion ampullaire sont frequentes et elles 
devraient etre anticipees avant (’ope­
ration. Les interventions chirurgicales 
pratiquees dans cette zone peuvent 
etre techniquement difficiles et elles 
sont associees a un fort taux de 
mortality et de morbidite. Le choix 
du type d’intervention depend de 
I'urgence et de la nature des com­
plications reiiees au diverticule.
La cholangiopancreatographie 
endoscopique retrograde peut jouer 
un role quand il s'agit d’evaluer 
(’importance du diverticulum et I'ana- 
tomie de la region. Dans quelques 
cas, la sphincterotomie est possible. 
Dans certaines situations, la 
diverticulectomie est contre-indiquee.
Duodenal diverticula are found in 
2% to 5%  of all individuals who 
undergo upper gastrointestinal con­
trast studies.1’2 The duodenum is the 
second most frequent location for 
gastrointestinal diverticula after the 
colon.3 Symptoms attributed to duo­
denal diverticula are nonspecific and 
seldom severe, and it is difficult to 
identify the diverticulum as the source. 
The usual presentation of acute com­
plicated duodenal diverticular disease 
is that of a surgical emergency in an 
elderly patient, with either an acute 
abdomen or an active gastrointestinal 
hemorrhage. The diagnosis is seldom 
considered preoperatively. The condi­
tion is difficult to manage surgically 
and is associated with appreciable 
morbidity and mortality.2,4‘6
The majority of reports dealing 
with complicated duodenal diverticula 
were published before the era of mod­
ern fiberoptic endoscopy. The investi­
gation and treatment of duodenal 
diverticular disease has been altered 
by the use of the side viewing duo- 
denoscope and endoscopic retrograde
cholangiopancreatography.7’8 It now 
may be possible to investigate and 
treat some nonemergent complica­
tions of duodenal diverticula entirely 
endoscopically.7
Emergent complications must be 
recognized early and dealt with by 
a surgeon who is familiar with the 
complex anatomical relations of the 
diverticulum that may be obscured by 
inflammation or bleeding.
Patients and Method
The records of patients seen at 
the Vancouver General Hospital for 
complications arising from duodenal 
diverticular disease were reviewed for 
the 10-year period 1970 to 1980. 
Those who had treatment or surgical 
procedures for coexisting conditions 
and were found incidentally to have 
duodenal diverticular disease were ex­
cluded. Two cases from the Swedish 
Hospital in Seattle, Washington were 
also included. There were 104 pa­
tients in all.
Case Reports
The following four cases from the 
Vancouver General Hospital are 
presented to illustrate the problems 
of the behaviour, diagnosis and treat­
ment of complicated duodenal diver­
ticula.
Case 1
An 85-year-old man complained of 
generalized abdominal pain, which had 
started suddenly in the right upper 
quadrant and flank 4 hours earlier. 
Examination revealed generalized ab­
dominal tenderness, bowel sounds were 
absent and the abdominal wall was rigid. 
His temperature was 37.4°C, blood 
pressure 140/90 mm Hg, pulse rate 90 
beats/min and irregular. The leukocyte 
count was 8.9 X 10V1 with 39% poly­
morphonuclear cells and 58% lympho­
cytes, the total serum bilirubin level was 
1.4 mg/dl (23.9 umol/l), serum alkaline 
phosphatase was 122 IU/1 (normal to 
125 IU/1), serum amylase was 140 IU/1, 
(normal to 80 IU/1). The prothrombin 
time was normal. Roentgenogram of the 
abdomen showed multiple air—fluid 
levels throughout the large and small 
bowel. There was air in the retroperi­
toneal space.
A diagnosis of a ruptured viscus was 
made; supportive measures were insti­
tuted and antibiotics given. At laparo­
tomy the common bile duct was found
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to be dilated and a greenish staining 
was noted in the periduodenal tissues. 
The duodenum was kocherized. A per­
foration was noted in a duodenal diver­
ticulum that measured 3 cm. The com­
mon bile duct was explored, stones were 
removed from it and a probe was passed 
through into the duodenum. The duo­
denum was opened and the gallstones 
were removed from the diverticulum. 
The diverticulum was totally resected 
and the duodenum closed primarily. A 
T-tube was placed in the common duct. 
The patient had previously had a cho­
lecystectomy.
The postoperative course was com­
plicated by mild pancreatitis. A T-tube 
cholangiogram obtained 7 days after 
operation appeared noimal.
Case 2
An 87-year-old Caucasian woman with 
no history of abdominal complaints had 
acute epigastric pain beginning several 
hours before admission. The pain was 
steady, generalized and radiated to the 
back. She had vomited bile-stained fluid 
twice. She had had a normal bowel 
movement that morning. The blood 
pressure was 180/100 mm Hg, the 
pulse rate was 100 beats/min and regular 
and the temperature was 38°C. Bowel 
sounds were absent and her abdomen 
was distended and rigid. No abnormality 
was found on rectal examination. Ab­
normal laboratory results included a 
leukocyte count of 8.7 X 109/1, 25% 
polymorphonuclear cells, 63% lym­
phocytes and occasional metamyelocytes. 
The blood glucose level was 249 mg/dl 
(13.7 mmol/1). (The serum bilirubin, 
creatine phosphokinase, glutamic oxalo­
acetic transaminase and lactic dehydro­
genase levels were all normal.) The serum 
albumin level was 2.7 g/dl, calcium 
9.8 mg/dl (2.43 pmol/l), phosphate 2.6 
mg/dl (0.85 mmol/1) and amylase 471 
IU/1. The urine amylase level was 1624 
IU/1. The prothrombin time was 70% 
of normal. Abdominal roentgenograms 
did not reveal free air or retroperitoneal 
gas shadows. An abdominal tap pro­
duced cloudy fluid in copious quantities. 
On Gram-staining the fluid was found 
to contain Clostridium sp. and large 
numbers of leukocytes and erythrocytes 
and had an amylase concentration in 
excess of 5000 IU/1.
A diagnosis of perforated or in- 
farcted viscus was made. Supportive 
measures were instituted and antibiotics 
given. At laparotomy the periduodenal 
tissues were bile-stained and a perforated 
diverticulum of the second part of the 
duodenum was found. The biliary sys­
tem was normal to palpation.
The diverticulum was patched with 
omentum, a large T-tube was brought 
out through the lateral duodenal wall 
as a controlled fistula, and a gastro­
stomy and feeding jejunostomy were 
fashioned. A Salem sump was placed in 
the subhepatic space near the diverticu­
lum.
Postoperatively she had prolonged
bile-stained drainage from the controlled 
duodenal fistula site. This closed after 
approximately 1 month.
Case 3
An 84-year-old man complained of 
epigastric pain and weakness. His ap­
petite was diminished and he had noted 
a weight loss of 6 kg over the previous 
4 months. His pain was intermittent, 
worse between meals, most severe in the 
epigastrium and radiated to the back. 
He had noted black stools on and off 
for a few weeks. He had had his gall­
bladder removed 15 years before. He 
was a thin, pale man in no acute dis­
tress. His blood pressure was 160/90 
mm Hg supine and 140/70 mm Hg sit­
ting, accompanied by faintness and a 
pulse rate of 110 beats/min. Tenderness 
but no mass was noted in the epigas­
trium. Abnormal findings on laboratory 
studies were a hypochromic microcytic 
anemia, blood urea nitrogen value of 
50 mg/dl (18 urea, mmol/1) and serum 
creatinine value of 1.2 mg/dl (106 
umol/1). The serum amylase level was 
normal and the prothrombin time was 
90% of normal. The aspirate from the 
nasogastric tube was bile-stained. Upper 
gastrointestinal roentgenography after 
barium meal demonstrated a large duo­
denal diverticulum. Two days after ad­
mission the patient’s blood pressure 
dropped to 90/60 mm Hg and his heart 
rate climbed to 140 beats/min. Bright 
red blood appeared in a nasogastric 
aspirate. At operation a bleeding duo­
denal diverticulum was found with a 
large enterolith in its lumen. The re­
maining duodenum was normal. The 
common duct was probed and was nor­
mal. The stone was removed and the 
ulcer in the diverticulum, which was ac­
tually bleeding, was oversewn. The pa­
tient did well postoperatively.
Case 4
A 74-year-old woman presented with 
a long history of intermittent epigastric 
and right upper quadrant pain, usually 
postprandially. On occasion she would 
vomit bile-stained material which fre-
Fig. la  Fig. lb
FIG. 1—(a) Duodenal diverticulum 
obstructing common bile duct, (b) Fol­
lowing endoscopic sphincterotomy and 
stone removal.
quently brought relief of her symptoms. 
Antacids were of no help. She was 
slightly obese but in no acute distress. 
The findings on abdominal examination 
were normal. Laboratory values included 
a hemoglobin level of 13.7 g/dl, leuko­
cyte count of 6.7 X 10°/1 with 70% poly­
morphonuclear cells and 12% lympho­
cytes, serum alkaline phosphatase 120 
IU/1, prothrombin time 85% of normal, 
total serum bilirubin of 1.4 mg/dl (23.9 
pmol/l) and direct value of 0.6 mg/dl 
(10.3 umol/1). The serum glutamic oxalo­
acetic transaminase, lactic dehydro­
genase and amylase levels were normal.
Upper gastrointestinal roentgenograms 
after barium meal showed a diverticu­
lum in the medial portion of the second 
part of the duodenum and the oral 
cholecystogram, showed nonfunctioning 
gallbladder after a double dose of con­
trast material. Endoscopic retrograde 
cholangiopancreatography demonstrated 
the duodenal diverticulum with com­
pression of the bile duct. Stones were 
demonstrated in the gallbladder and 
common duct. An endoscopic sphinctero­
tomy was done and stone extraction was 
carried out with a balloon catheter (Fig. 
1). The patient remains free of symp­
toms and has not had to have her gall­
bladder removed.
Results
Our experience was essentially the 
same as that of others. The male to 
female ratio of the 104 patients was 
2:3. The average age was 71 years 
(range from 27 to 96 years). Multiple 
duodenal diverticula were found in 
22% of the patients. The first part 
of the duodenum was involved in 
6% , the second in 82% , the third 
in 10% and the fourth in 2% ; lateral­
ly projecting diverticula were found 
in 2%. Active associated diseases that 
could be responsible for presenting 
symptoms were frequently found 
(Table I). The presenting signs and 
symptoms were pain in 26% (with no 
associated disease in 4% ), hemor­
rhage in 10% (with no other source 
in 4%), anemia in 24% (with no other 
source in 6%) and diarrhea in 4%. 







Peptic ulcer disease 20
Myocardial disease 18
Diverticula elsewhere 
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ruled out as a cause for their com­
plaints, only about 25% of these pa­
tients still had unexplained symptoms.
Only 15 of the 104 patients un­
derwent operation and for varying 
indications (Table II). Two patients 
died in hospital, one of sepsis and 
pulmonary embolism and the other of 
sepsis and pancreatitis. The hospital 
stay was prolonged in two patients 




Duodenal diverticula may be true 
(full thickness) or false (mucosal). 
True diverticula may be congenital 
or be acquired traction diverticula 
secondary to chronic peptic ulcer dis­
ease. False diverticula usually occur 
on the medial or pancreatic aspect of 
the second part of the duodenum8 
(Table III). Much less frequently they 
are found in the third or fourth part 
or at multiple sites. The usual posi­
tion for second-part diverticula is 
intimately related to the entrance of 
the common bile duct into the duo­
denum. Most open within 2.5 cm of 
this point, hence the name “perva- 
terian”.1,9 These are the diverticula 
associated with most complications 
and that cause the most problems for 
both patients and surgeons.2’6 The 
commonly accepted theory explain­
ing this position is the presence of a 
congenital weakness in the duodenal 
wall allowing the entry of the pan­
creatic and common bile ducts into 
the duodenal lumen. Entrance of 
larger penetrating blood vessels may 
provide a similar weakness.10











Table I I I— Location of False Diverticula
Location %
Periampullary 85




There are two situations that give 
rise to most diverticular complications 
(Table IV): stones passing down the 
common duct may become trapped in 
the lower end of the common bile 
duct or in the diverticulum itself and 
enteroliths can form in the amuscular 
diverticular pouch from food and 
stasis.11,12 Obstructive complications 
include jaundice, pancreatitis and, 
rarely, duodenal obstruction. Stones 
in the diverticular lumen can erode 
through the thin wall causing bleed­
ing or perforation, but they need not 
be present for perforation to oc- 
cur 2,5,13 Large diverticula have a 
tenuous blood supply, and according 
to Laplace’s law the diverticulum is 
the vulnerable point if intraluminal 
duodenal pressures rise.
Perforation of the diverticulum 
usually presents as sudden pain in 
the right upper quadrant or epigas­
trium radiating to the back. This pain 
progresses rapidly and there is gen­
eralized abdominal rigidity. Accom­
panying these findings are those of 
toxicity.10,13 The important differen­
tial diagnoses include biliary tract dis­
ease, pancreatitis, a perforated viscus 
and mesenteric infarction.5'14 The pa­
tient is obviously very ill and often 
profoundly hypovolemic. Plain radio- 
logic studies may demonstrate retro­
peritoneal gas shadows but seldom 
free air.15 Contrast studies demon­
strate the presence of the diverticulum 
but may fail to show the perforation. 
The most reliable operative clue is 
that of a bile-stained periduodenal 
phlegmon.2 The perforation can be 
demonstrated after careful kocheriza- 
tion of the duodenum. Diverticulec- 
tomy with primary closure of the duo­
denal wall, followed by periduodenal 
drainage, has lowered the morbidity 
and mortality rates compared with 
drainage alone because the diverti­
culum may become necrotic or the 
source of a high enteric fistula.2 Be­
fore wide kocherization or diverticu- 






Enterolith — secondary small 
bowel obstruction (rare) 
B iliary obstruction 
Pancreatitis  
Malabsorption 
Tum our (ra re )
taken to identify the pancreatic and 
common bile ducts. Rarely, they may 
enter the diverticulum itself and thus 
would become disconnected at the 
time of resection. This would be 
disastrous.16 Lateral drainage of the 
duodenum itself as a controlled fistula 
is not usually necessary; it resulted in 
a duodenal fistula of long duration in 
our case 2.
Elective surgical treatment of 
periampullary diverticula is seldom re­
quired.17 In the past, elective diver- 
ticulectomy for nonspecific indica­
tions resulted in a mortality as high 
as 20% and persistent symptoms in 
as many as 50%.10 For patients with 
serious unexplained symptoms, such 
as those from a dilated common duct 
or recurrent pancreatitis, we advocate 
endoscopic retrograde cholangiopan­
creatography to delineate the ductal 
anatomy and to detect the presence 
of stones in the ducts or diverticulum 
once the usual contrast studies of the 
biliary tree and upper gastrointestinal 
tract have been performed.
It is important to know that the 
majority of pancreatic and common 
bile ducts come together and gain en­
trance into the duodenum at the su­
perior margin of the diverticulum. 
Although conventional contrast stud­
ies may give the impression that the 
ducts are entering the diverticular 
dome, this is exceptional but impor­
tant.1 Sphincterotomy will permit 
drainage of the common duct which 
is compressed by the diverticulum.8 
Sphincterotomy and endoscopic ret­
rograde cholangiopancreatography 
should not be done when there is 
poor patient cooperation, when there 
are medical contraindications, when 
the duct enters the dome and when 
perforation is suspected. Acute pan­
creatitis is a relative contraindica- 
tion.8,17,18
If the ampulla enters the dome of 
the diverticulum when there is com­
mon duct obstruction, diverticulec- 
tomy is contraindicated and choledo- 
choduodenostomy is much preferred. 
Reimplantation of the ducts carries 
a mortality rate of more than 30% .16 
There are three rare situations when 
the common bile duct, pancreatic 
duct or ampulla must be divided. 
The first is when there is a tumour 
in the diverticulum whose prognosis 
is worse than the expected mortality 
of duct repair. The others are when 
life-threatening hemorrhage and per­
foration are present and they cannot 
be managed by other means. If dis­
connection is essential or if the dam-
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age is done inadvertently the com­
mon duct and pancreatic duct should 
be reconstituted by separate anas­
tomoses into a Roux-en-Y loop.
Conclusions
Elective treatment of uncompli­
cated duodenal diverticula is not 
usually justified. Perforation is best 
managed by resection and primary 
closure. A diverticulum, with or with­
out common duct stones, may play 
a role in obstructing the common 
duct.
At operation a bile-stained peri­
duodenal phlegmon is the diagnos­
tic clue. The anatomy of the com­
mon duct, major pancreatic duct and 
the diverticulum may be difficult to 
determine. If the ducts enter the 
diverticulum itself choledochoduo- 
denostomy should be done and the 
diverticulum not be disturbed.
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Resection and Primary Anastomosis for 
Diverticulitis with Perforation and Peritonitis
Edward F arkouh , m b , b ch , facs, frcs[c],*  G isele H ello u , m d ,+ M ichel A llard , m d , facs, frcs[c]*
and H enri A tlas, m d , facs, frcs[c]J
Primary resection is the treatment of 
choice for diverticulitis of the colon 
with perforation and generalized 
peritonitis. Although there has been 
controversy concerning the manage­
ment of the bowel ends after 
resection, for the last 20 years 
immediate anastomosis has been 
gaining increasing support.
Between 1970 and 1981, at the 
Hopital du Sacre-Coeur in Montreal,
15 patients having diverticulitis with 
perforation and diffuse spreading
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peritonitis who fulfilled specific 
criteria were treated by primary 
resection of the perforated segment 
of bowel and immediate anastomosis. 
The criteria for operation were: (a) 
the bowel must not be distended;
(b) the bowel should be empty of 
feces; (c) edema of bowel wall at 
the resection site must be minimal; 
(d) the distal segment of colon 
should be above the peritoneal 
reflection; (e) there should be no 
fecal contamination; (f) the patient’s 
general condition should be reasonably 
good. If these criteria were met, the 
procedure was safe and gave 
satisfactory results. In the authors’ 
series, postoperative hospital stay was 
reduced considerably (it averaged 
11 days). There was one anastomotic 
leak and one death from acute 
pulmonary edema.
La resection primaire constitue le 
traitement de premier choix dans 
les cas de diverticulite du colon 
avec perforation et peritonite gene- 
ralisee. Bien que la conduite a tenir 
apres la resection avec les deux bouts 
de I'intestin ait fait I'objet d’une contro- 
verse, I'anastomose immediate s'est
gagnee de plus en plus d’appuis au 
cours des 20 dernieres annees.
Entre 1970 et 1981, a I’Hopital du 
Sacre-Coeur a Montreal, 15 patients 
qui souffraient de diverticulite avec 
perforation et peritonite diffuse en- 
vahissante, et qui rencontraient certains 
criteres specifiques ont ete traites 
par resection primaire du segment 
intestinal perfore et anastomose 
immediate. Les criteres retenus 
pour I'operation etaient les suivants:
a) absence de distension de I'intestin;
b) absence de feces dans I'intestin;
c) oedeme minime de la paroi intes- 
tinale au lieu de resection; d) le 
segment distal doit etre situe au-dessus 
de la reflexion peritoneale; e) 
absence de contamination fecale;
f) etat du patient raisonnablement 
bon. Quand chacun de ces criteres 
etait rempli, I'operation se revela 
sure et donna des resultats satisfai- 
sants. Chez la serie de patients 
traites par les auteurs, la duree du 
sejour a I’hopital fut reduite 
considerablement (une moyenne de 
11 jours apres I'operation). II y eut 
une fuite d'anastomose et un deces 
cause par un oedeme pulmonaire 
aigu.
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Perforation with diffuse peritonitis is 
a rare but serious complication of 
diverticular disease of the colon. Its 
incidence in most published reports 
is about 2% .' Although infrequent, 
this condition, once diagnosed, must 
be treated as an emergency. Hughes 
and associates2 in 1963 and Hinchey 
and associates3 in 1978 recognized 
four clinical stages of diverticular 
disease with perforation: stage I — 
pericolic abscess, confined by the 
mesentery of the colon; stage II — 
pelvic abscess, resulting from local 
perforation of a pericolic abscess; 
stage III — diffuse generalized peri­
tonitis that usually results from the 
rupture of either a pericolic or pelvic 
abscess into the peritoneal cavity; 
stage IV — fecal peritonitis, usually 
secondary to perforation of a diver­
ticulum, with feces escaping from the 
lumen of the colon into the peritoneal 
cavity. This report is concerned with 
patients belonging to stage III (those 
who had diverticulitis with perfora­
tion and diffuse spreading peritonitis). 
We intend to demonstrate the safety 
of resection and primary anastomosis 
in managing this serious complication, 
provided that the patients are carefully 
selected and certain criteria are ful­
filled.
Patients and Methods
At the Hopital du Sacre-Coeur in 
Montreal, we reviewed all patients 
with acute diverticulitis of the colon 
seen between Jan. 1, 1970 and Aug. 
31, 1981. Fifty-one had diverticular 
disease with perforation, 26 with 
generalized peritonitis (stages III and 
IV) and 25 with localized peritonitis 
(stages I and II).
Of the 26 patients with generalized 
peritonitis, 15 underwent primary re­
section of the perforated segment of 
bowel with immediate anastomosis, 4 
had primary resection and no anas­
tomosis (Hartmann procedure), while 
7 patients were treated by a three- 
stage procedure (proximal colostomy, 
resection, closure of colostomy).
Of the 15 patients treated by resec­
tion and primary anastomosis (Table 
I), 6 were men and 9 were women. 
The average age was 57 years (range 
from 33 to 77 years). In some cases, 
emergency laparotomy was indicated 
from the start, either because the 
patient was admitted with features of 
diffuse generalized peritonitis or, on 
rare occasions, because the flat plate 
of the abdomen showed a pneumo­
peritoneum (Fig. 1). However, most 
of the patients were admitted with 
clinical features suggestive of localized 
peritonitis of the left iliac fossa. They 
were initially managed by a medical 
regimen consisting of nasogastric suc­
tion, intravenous administration of 
fluids and antibiotics. Operation be­
came imperative if, despite this regi­
men, the general condition of the pa­
tient continued to deteriorate or signs 
of spreading peritonitis appeared. 
Thus, the time of observation before 
operation during which the patient 
was kept on medical treatment varied 
from a few hours to a few days 
(maximum 10 days).
In general the leukocyte count was 
elevated and only a few patients had 
a count lower than 10 X 10V1. At 
laparotomy the perforated segment 
of the colon was resected, followed 
by immediate end-to-end anastomosis 
of the bowel, using the one-layer 
technique, with 3-0 Prolene sutures.
Lavage of the peritoneal cavity with 
large amounts of isotonic saline solu­
tion was carried out before the abdo­
men was closed; Penrose and sump 
drains were inserted. We did not 
perform a proximal colostomy. All 
our patients received antibiotic thera­
py. We used a combination of clin­
damycin and gentamicin. The former 
is effective against anaerobic bac­
teria, while the latter is especially 
effective against gram-negative aero­
bes. Occasionally we added a third 
antibiotic, either penicillin or am- 
picillin, for the control of the gram- 
positive aerobes.
Results
The results of resection and primary 
anastomosis in our series were satis­
factory. There was only one com­
plication, a colocutaneous fistula, in­
dicating a small anastomotic leak. 
This healed spontaneously without 
the need for a proximal colostomy. 
Wound infection was not a problem 
since delayed wound closure was 
used. There was one death (6.6%) 
from acute pulmonary edema, which 
was confirmed by autopsy. The aver­
age period of hospital stay after oper­
ation was 11 days (range from 7 to 15 
days).
Fig. lb
FIG. 1—(a) Upright position, (b) 
lateral supine position. Arrows point to 
free air in peritoneal cavity.
Table 1— Diverticulitis of the Colon with Perforation in 
15 Patients Treated by Primary Resection and Anastomosis
Age, Leukocyte count, Time before Hospital
Sex yr X  109/1 operation, d Complication Death stay, d
M 47 17.7 1 Fistula _ 8
F 54 23.0 1 — — 12
F 73 18.0 3 — — 12
M 55 7.9 3 — — 10
F 77 7.5 10 — Acute 15
pulmonary
edema
M 56 15.5 5 — _ 14
M 69 19.2 1 — _ 9
M 55 21.7 <1 — — 14
F 68 15.9 2 — — 10
F 65 14.6 6 — _ 12
F 72 7.4 3 — _ 10
F 45 9.4 5 — — 10
F 33 18.4 1 — _ 7
F 47 9.6 3 — — 13
M 56 15.6 5 11
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Discussion
Controversy has existed for many 
years concerning the best procedure 
for the treatment of diverticulitis with 
perforation. There are two types of 
procedure: the three-stage procedure 
and primary resection with or without 
anastomosis.
Traditional teaching favoured the 
three-stage procedure. In the first 
stage proximal colostomy is done 
with drainage of the perforated seg­
ment of bowel; the diseased segment 
is resected 2 to 6 months after the 
colostomy and a third operation is 
done to close the colostomy. Although 
the three-stage procedure was the 
standard treatment for diverticulitis 
with perforation and peritonitis for a 
long time, the mortality, about 
30% ,1,4-7 is unacceptable.
We believe, as do many others,711 
that resection of the perforated seg­
ment of bowel should be the primary 
goal of therapy, since it removes 
the source of peritoneal contami­
nation. Whether to do an imme­
diate anastomosis or a colostomy with 
delayed anastomosis remains con­
troversial. Because of the high risk 
of anastomotic leak, some1214 dis­
agree with the trend to perform pri­
mary anastomosis on unprepared 
bowel in the presence of diffuse peri­
tonitis. After resection of the per­
forated segment of colon, many sur­
geons prefer either to establish a 
proximal colostomy with a mucous 
fistula, or to do the Hartmann proce­
dure —  proximal colostomy and in­
tra-abdominal closure of the rectal 
stump. In both cases anastomosis of 
the bowel ends is postponed until 
the conditions are more favour­
able.7’10,15’16
The results obtained in our series 
suggest that primary colonic resection
T a b le  I I — R e p o rte d  D e a th s  fro m  P r im a ry  
R e s e c tio n  and A n a s to m o s is  in  P a t ie n ts  
w ith  D iv e r t ic u l i t is  o f th e  C o lo n  w ith  
P e r fo ra t io n
A u th o rs
N o . o f 
p a tie n ts
N o . o f 
d e a th s
G r e g g ,1 9 5 5 17 7 0
B e ld in g , 1 9 5 7 18 3 0
L a r g e ,1 9 6 4 19 13 2
M a d d e n , 196 5 21 7 1
S m ile y , 19664 3 0
R o x b u rg h  and  
a s s o c ia te s , 196822 8 1
D a n d e k a ra n d  M cC an n , 
1 9 6 9 -1 7 1
R y a n , 197 4 20 10 0
P re s e n t  s e rie s 15 1
T o ta l 73 6 ( 8 .2 % )
with immediate anastomosis as ad­
vocated by Madden and Tan1 has its 
place in the management of diverti­
culitis with perforation and diffuse 
peritonitis. Occasionally a proximal 
colostomy may be performed if the 
integrity of the anastomosis is in 
doubt. In our series no colostomies 
were done.
Since Gregg17 in 1955 reported his 
series on diverticulitis with perfora­
tion, primary resection of the diseased 
segment of bowel with immediate 
anastomosis has gained increasing 
support. Although most of the pub­
lished series4’18-23 are small, the results 
in general are quite satisfactory. Of 
73 patients reported only 6 died, a 
mortality of 8.2% (Table II).
Although it is tempting to perform 
this procedure more often, it should 
be emphasized that it is only suitable 
for patients in whom the following 
criteria are fulfilled: (a) the bowel 
should not be distended; (b) the bowel 
should be empty of fecal material;
(c) there should be minimal edema of 
the bowel wall at the site of resection;
(d) the distal segment of the colon 
should be above the peritoneal re­
flection; (e) there should be no fecal 
contamination of the peritoneal 
cavity and (f) the patient should be 
in fairly good general condition.
If all these criteria are respected, 
primary colonic resection with im­
mediate anastomosis is a safe and 
satisfactory alternative for the man­
agement of the perforated diverticular 
colon with spreading peritonitis.
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Iatrogenic Bile-Duct Strictures
P.G. Kalm an , md, B.R. T aylor, m d , frcs[c], facs and B. L anger, md , frcs[c], facs
Management of iatrogenic stricture 
of the bile ducts is difficult and is 
associated with substantial morbidity 
and mortality. At the Toronto General 
Hospital, 61 patients with strictures 
following operative trauma underwent 
a total of 75 repairs. The overall 
success rate was 80%. End-to-end 
duct repair is preferred when feasible; 
8 of the 61 patients were treated 
this way, with success in 7. In the 
majority of patients, however, extensive 
duct scarring and shortening preclude 
its use, necessitating Roux-en-Y 
hepaticojejunostomy, done in 53 
cases. If the anastomosis is adequate, 
with good mucosal approximation, a 
stent is not essential and of 12 such 
operations, 10 were successful. Even 
when the mucosa-to-mucosa apposition 
is less than optimal, the use of a 
straight-tube stent or changeable 
U-tube stent may produce a satisfactory 
end result. Of 41 such operations, 31 
were successful.
Since iatrogenic bile-duct strictures 
lead to high morbidity and frequent 
recurrence despite seemingly adequate 
repair, continued emphasis should be 
placed on prevention of injury, 
especially during routine cholecystec­
tomy. Experience, careful dissection, 
knowledge of anatomic variations and 
good judgement concerning the 
performance of a cholecystostomy 
in difficult situations, should all 
reduce this complication to a 
minimum.
Le traitement des retrecissements 
iatrogenes des voies biliaires extra- 
hepatiques est difficile et ii est 
relie a une morbidite et une mortality 
importantes. Soixante-et-un patients du 
Toronto General Hospital qui 
souffraient de retrecissement 
secondaire a un traumatisme operatoire 
ont subi un total de 75 reparations.
Le taux global de reussite a ete de 
80%. Une reparation bout-a-bout est
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preferee chaque fois qu'elle est 
possible; 8 des 61 patients furent 
trades de cette facon, dont 7 avec 
succes. Toutefois, chez la majorite 
des patients un tissu cicatriciel 
etendu ou en raccourcissement du 
canal en empeche le recours et 
necessite une hepatico-jejunostomie 
de Roux-en-Y. Cette operation fut 
pratiquee dans 53 cas. Quand 
I'anastomose est adequate et que 
le rapprochement des muqueuses est 
bon, un gabarit n'est pas essentiel 
et sur 12 operations de ce genre, 10 
ont reussi. Meme quand I’apposition 
des muqueuses n'est pas ideal, 
I'emoloi d’un tube droit ou d'un tube 
en U variable comme gabarit peut 
donner des resultats satisfaisants. 
Sur 41 operations de ce genre, 31 ont 
ete couronnees de succes.
Comme le retrecissement iatrogene 
des voies biliaires entraine une forte 
morbidite et de frequentes recidives 
en deoit de reparations aoparamment 
adequates, I'accent doit etre mis de 
facon soutenu sur la prevention des 
lesions, particulierement durant les 
cholecystectomies ordinaires. 
L'experience, une dissection soigneuse, 
la connaissance des variations 
anatomiques et un bon jugement 
concernant la realisation des chole- 
cystostomies dans les situations 
difficiles devraient reduire cette 
complication au minimum.
A benign, extrahepatic stricture of 
the bile duct presents one of the most 
difficult management problems in 
abdominal surgerv. It is associated 
with high morbidity and appreciable 
mortality. The commonest cause is 
surgical trauma to the bile duct dur­
ing operations on the biliary tract, stomach or pancreas.
Numerous techniques of recon­struction have been described. The 
long-term results are far from satis­
factory, as many patients require mul­
tiple repairs. We review the operative 
management of iatrogenic biliary 
strictures in patients seen at the To­
ronto General Hospital over a 15- vear period.
Patients and Methods
All patients operated upon between 1966 and 1980 for benign biliary 
strictures resulting from surgical
trauma were reviewed. Sixty-one pa­tients (43 men, 18 women) were 
studied. The mean age was 49 years 
(range from 17 to 79 years). Patients 
were followed up either by the sur­
geon or, for geographic reasons, by 
the referring doctor. The follow-up 
ranged from 3 to 144 months (mean 
26.5 months, median 24 months).
The commonest procedure during 
which bile-duct injury initially oc­
curred was cholecystectomy (58 pa­
tients). Ductal operation and gastrec­
tomy were the causes in two and one 
patient respectively. In the majority 
of the original operative reports, the 
cholecystectomy was reported as 
“routine”. The injury was noted at 
the time of original operation in only 
15 patients (25% ) and all underwent 
immediate repair; 14 were operated 
on at another institution and were later referred to the Toronto General 
Hospital for further assessment and 
management. One primary repair at 
the time of injury was performed at this institution.
The sites of bile-duct injury are 
depicted diagrammatically in Fig. 1, 
which shows their relative frequency 
in the intrahepatic, common hepatic 
and common bile ducts and at the bi­furcation.
The 61 patients underwent 103 
operative reconstructions, 75 of which 
were performed at the Toronto Gen­
eral Hospital. Twenty-eight (75%) 
of the 37 patients admitted after the 
original injury were seen within the 
first 10 days, while the rest presented
FIG. 1—Location of injury; common bile duct (9), common hepatic duct (41), bifurcation (7) and right hepatic duct (4).
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from 1 month to 20 years after injury 
(mean 6 years). Jaundice (71%) and 
biliary fistula (50%) were the most 
common early signs of duct injury.
Patients whose first repair failed 
usually presented later, at a mean 
of 2 years after the previous recon­
struction. Jaundice (84%) and cholan­
gitis (67%) were found most com­
monly in this group.
Investigations
The investigative techniques used 
to diagnose the obstruction changed 
over the course of the review. At 
present, patients with a suspected 
extrahepatic biliary obstruction ini­
tially undergo ultrasonography to 
check for dilated extra- and intra- 
hepatic ducts (Fig. 2). If a bile fistula 
is present, a sinogram is carried out. 
If there is no bile fistula, percutane­
ous transhepatic cholangiography is 
performed, accurately demonstrating 
the site of obstruction and the ana­
tomy of the upper biliary tree (Fig. 
3). A catheter may be left in place 
after percutaneous transhepatic cho­
langiography to decompress the proxi­
mal ducts temporarily in preparation 
for operation, and is sometimes neces­
sary for drainage of an infected biliary 
tree. Endoscopic retrograde cholan­
giopancreatography can be useful in 
determining the distal limit of the 
obstruction (Fig. 4), as the stricture is 
often long. It is also valuable in early 
duct injuries when dilatation of the 
intrahepatic ducts has not yet oc­
curred, making percutaneous trans­
hepatic cholangiography difficult to 
perform.
These techniques have replaced 
laparotomy and operative cholangio­
graphy for diagnosis.
Reconstructive Techniques
Table I lists the types of repair used
FIG. 2— Abdominal ultrasonographic 
findings in 67-year-old woman with ob­
structive jaundice, 5 months after 
cholecystectomy for cholelithiasis. Ar­
rows indicate dilated intrahepatic bile 
ducts.
in the 75 reconstructive procedures 
performed at this institution. Axial 
(end-to-end) repair was favoured 
when early reconstruction was car­
ried out using healthy ducts with no 
dilatation or loss of tissue. It was 
possible in only nine cases.
Choledochojejunostomy or hepati- 
cojejunostomy (listed as hepatico- 
jejunostomy in Table I) using a Roux- 
en-Y loop of jejunum was used in 
53 cases; stents were placed in 41. 
Transhepatic U-tube changeable stents 
were used in 17 instances and straight 
tubes in 24 (Table II). In three 
repairs with a straight tube, the 
mucosal graft technique, to be 
described in more detail, was used. 
The U-tube stents were left in, with 
replacement, for a mean period of 9 
months. The straight-tube stents were
FIG. 3— Percutaneous transhepatic 
cholangiogram from same patient as 
in Fig. 2. Dilated intrahepatic ducts 
narrow to obstruction of common he­
patic duct at site of surgical clips 
(arrow).
left in place for a mean period of 5 
months. Simple dilatation with stent­
ing and choledochoduodenostomy 
were employed in 3 and 10 cases 
respectively.
H ep atic o  jeju n o sto m y
Unstented.—At laparotomy, proxi­
mal healthy duct is identified, cleared 
and transected. Proximal duct is then 
anastomosed, end-to-side, to a Roux- 
en-Y jejunal loop, using one layer of 
interrupted, fine, catgut sutures. We 
prefer catgut to silk because silk may 
act as a nidus for the formation of 
common bile-duct stones. If precise 
mucosa-to-mucosa apposition is ac­
complished using healthy duct, a stent 
is not necessary. However, if severe 
scarring of proximal duct prevents 
such precise anastomosis, a U-tube 
changeable stent or a straight rubber 
transhepatic stent is used.
U-tube technique (Fig. 5).—After 
the intrahepatic ducts have been dis­
sected as far as safety allows, a mal-
FIG. 4— Endoscopic retrograde cho- 
langiopancreatogram from same patient 
shows obstruction of common bile duct 
1 cm distal to surgical clips (arrow).
T a b le  1--R e s u lts  o f  75 B ile -D u c t R e c o n s tru c tio n s
O p e ra tiv e  re p a ir N o.
S uccess fu l 
o u tc o m e, no . ( % )
D ila ta t io n  a n d  s te n t 3 2 ( 6 7 )
A x ia l re p a ir 9 8 (8 9 )
C ho ledo ch o d u o d en o s to m y 10 9 (9 0 )
H e p a tic o je ju n o s to m y 53 41 (7 7 )
T o ta l 75 60 (8 0 )
T a b le  I I — R e s u lts  o f 53 H e p a tic o je ju n o s to m ie s
T e c h n iq u e N o .
S uccessfu l 
o u tc o m e , no . ( % )
U n s te n te d 12 10 (8 3 )
S ten ted 41 31 (7 6 )
S tra ig h t tu b e 24 15 (6 3 )
U -tu b e 17 16 (9 4 )
T o ta l 53 41 (7 7 )
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leable trochar is introduced into the 
left or right hepatic duct and brought 
out through the anterior surface of 
the corresponding lobe of liver. A no. 
18, long, red rubber catheter is then 
tied to the end of the trochar, re­
tracted back through the liver and 
withdrawn from the open end of the 
hepatic duct. The same procedure is 
then carried out for the other hepatic 
duct if necessary. The transhepatic 
tube is threaded into a Roux loop 
through a small incision on the anti- 
mesenteric border, and leaves the loop 
through an additional opening ap­
proximately 15 cm from its entrance. 
The lower end of the stent is brought 
through the abdominal wall to lie 
comfortably in relation to the Roux 
loop and the upper end is brought 
out through a separate stab incision 
near the exit from the liver surface. 
Side holes are cut in the tube before 
positioning so that bile can drain from 
the bile duct into the Roux-en-Y loop 
(an additional tube with identically 
located side holes is prepared at the 
same time for future exchange). The 
loop is then tacked to the undersur­
face of the liver with interrupted 
catgut sutures so that the jejunal 
mucosa abuts the intrahepatic duct 
where the rubber tube enters the 
jejunum from the liver. This proce­
dure may be repeated for the other 
intrahepatic duct and the tube se­
cured at its jejunal exit with a fine 
catgut pursestring suture.
The advantage of U-tube stenting 
in such high strictures with extensive 
scarring is that both ends of the tube 
lie outside the abdomen. If the 
tube becomes blocked with sludge it 
can easily be replaced.
Mucosal graft technique.—This op­
eration is a refinement of the U-tube 
technique. Instead of a simple open­
ing in the antimesenteric border of 
the Roux-en-Y loop, a 1-cm rim of 
seromuscular layer is removed, leav-
l7!!!- 5—U-tube technique. Single
replaceable U-tube stent is placed across 
hepaticojejunostomy at bifurcation.
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ing exposed mucosa. A no. 18 red 
rubber tube is placed transhepatically 
as described for the U-tube technique. 
The end of the tube is then brought 
through a small opening in the ex­
posed mucosa and secured there with 
a fine chromic catgut suture. With a 
combination of gentle manipulation 
of the jejunal loop from below and 
traction on the transhepatic tube 
above the liver, the exposed mucosa 
is gradually approximated to the in­
trahepatic duct. This may be secured 
in place as well, using interrupted 
fine catgut sutures between the sero­
muscular layer surrounding the mu­
cosa and the scar tissue around the 
intrahepatic duct. The distal end of 
the tube sits free in the jejunal loop 
and the proximal end is brought out 
through a stab wound near the hepatic 
exit. This technique provides mucosa- 
to-mucosa apposition under very dif­
ficult circumstances and has the ad­
vantage of requiring stenting for a 
shorter time than with the U-tube 
technique.
Results
There were no operative deaths. 
One patient died of liver failure and 
secondary biliary cirrhosis 2 months 
after his third biliary reconstruction. 
The overall complication rate follow­
ing these 75 operations was 24.3%. 
Wound infection (33.3%) and per­
sistent bile leak around the drains 
(22.2%) were encountered most fre­
quently.
A repair was considered successful 
if the patient was asymptomatic at 
follow-up or could be managed con­
servatively when mild, intermittent 
symptoms were present. The result 
was deemed unsatisfactory if reoper­
ation was necessary.
Overall, 60 of the 75 repairs 
(80%) were successful; 52 patients 
were asymptomatic and the remaining 
8 complained of only occasional mild 
symptoms. The mean follow-up in this 
group was 27 months (range from 3 
to 144 months). The overall failure 
rate was 20%. The mean period be­
tween operation and reoperation was 
11 months (range from 2 to 42 
months). Reoperation was prompted 
by frequent recurrence of jaundice 
or cholangitis, or both.
The success rate for each type of 
reconstruction performed is shown 
in Table I. Of the 22 short strictures,
3 were managed by dilatation and in­
tubation only, 9 by axial repair and 
10 by choledochoduodenostomy. The 
success rate of these procedures was 
86% overall. Most patients, however,
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had long or high strictures that re­
quired hepaticojejunostomy using a 
Roux-en-Y loop. Forty-one (77%) of 
53 patients who underwent hepatico­
jejunostomy had a successful result at 
a mean follow-up of 28 months 
(range from 3 to 144 months); 7 
(13.5%) of these patients have occa­
sional mild symptoms that have not 
necessitated reoperation. In 12 pa­
tients whose operation failed, recur­
rent jaundice or cholangitis, or both, 
necessitated reoperation within a 
mean period of 13 months (range 
from 3 to 43 months).
Hepaticojejunostomies were stented 
with straight tubes in 24 cases (Table 
II). Fifteen of these patients had 
satisfactory results. Sixteen of the 17 
patients receiving U-tube stents have 
done well, with a mean follow-up of 
38.8 months. Twelve patients had un­
stented hepaticojejunostomies and 
10 of these have had good results 
(mean follow-up of 17 months).
Discussion
The various causes of bile-duct ob­
struction were recently reviewed by 
Smith.1 He reported on 3527 patients 
presenting with biliary obstruction 
between 1946 and 1977, operative 
trauma being the cause in 44% of 
cases. The preventable aspects of in­
jury to the extrahepatic bile ducts 
have been dealt with in several re­
ports.1'5 Fundamental knowledge of 
normal anatomy and its variations as 
well as good surgical judgement are 
necessary to avoid operative bile-duct 
trauma. As Smith summarized: “The 
more common causes of bile-duct in­
jury include an inadequate incision 
and poor exposure, poor illumination, 
poor anaesthesia, poor assistance, 
ignorance of possible anatomic anom­
alies, and a failure to make certain 
identification of the anatomical 
structures.”1 The injury may be ob­
vious at the time of operation (in 
25% of our patients) or, if not recog­
nized initially, may become evident 
after a variable period.
Bile-duct reconstruction is asso­
ciated with moderate morbidity and 
mortality. Warren and lefferson5 re­
ported 1552 such operations at the 
Lahey Clinic between 1940 and 1967, 
with a 25% morbidity and 13% mor­
tality. The success of bile-duct re­
pair is often difficult to predict and 
depends on several technical factors, 
including the location of the stricture, 
the number of previous attempted re­
pairs, and the presence of surround­
ing adhesions and acute inflammation. 
Poor mucosa-to-mucosa apposition
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usually results in recurrent stenosis. 
Excess tension or overzealous mobili­
zation of the ducts may impair blood 
supply and result in stenosis. Other 
factors, such as intrahepatic bile-duct 
fibrosis, local infection, impairment 
of hepatic function and the patient’s 
overall clinical status, may also af­
fect the result.
The procedure of choice for serious 
bile-duct injury is axial repair (chole- 
dochocholedochostomy). However, 
this operation is only possible when 
duct loss is minimal, such as at the 
time of initial trauma, when both 
proximal and distal ends are healthy. 
We performed nine axial repairs and 
eight were successful. In most cir­
cumstances an end-to-end anastomosis 
cannot be performed without tension. 
In this situation, choledochoduodenos- 
tomy or hepaticojejunostomy is pre­
ferred.
In our early experience, Roux-en-Y 
hepaticojejunostomy was used only 
for high strictures, but more recently 
it has become the preferred type of 
reconstruction for all injuries except 
those amenable to primary axial re­
pair. There are distinct advantages 
with this technique: it can always be 
performed without tension regardless 
of the level of the anastomosis; an 
anastomotic leak is less hazardous 
with a Roux loop than with the duo­
denum; there is virtually complete 
protection against reflux of undi­
gested intestinal contents into the 
biliary tree and finally, if reoperation
is necessary, revision of hepatico- 
jejunal anastomosis is far easier to 
perform.
Bismuth and associates8 recently 
reported their long-term results using 
a Roux loop hepaticojejunostomy in 
117 patients with benign strictures. 
Eighty-six percent had no symptoms 
attributable to biliary disease at fol­
low-up (53.7% after 6 years). The 
operative morbidity was 17.8%, large­
ly from wound sepsis; there were no 
deaths.
The technique of transhepatic 
stenting of the biliary-intestinal anas­
tomosis in order to prevent progres­
sive stenosis was initially described 
by Smith.7’8 Saypol and Kurian9 modi­
fied this approach by bringing both 
ends of the rubber stent through the 
abdominal wall, facilitating tube re­
placement. We reported our experi­
ence with this technique in eight pa­
tients and concluded that U-tube 
stenting was particularly useful when 
extensive scarring of the proximal 
duct remnant made mucosa-to-mucosa 
anastomosis to jejunum difficult.10 
We currently have 17 patients who 
underwent transhepatic U-tube stent­
ing, and only 1 has required reopera­
tion after 1 year. These patients were 
intubated for a mean duration of 9 
months.
The importance of long-term stent­
ing is also emphasized in a number 
of reports from the Lahey Clinic.4'5'11
For high strictures with appreci­
able proximal duct scarring, an alter­
native to the U-tube stent operation 
is the jejunal-mucosal graft technique 
described by Wexler and Smith12 that 
we performed in three patients of 
this series. Smith1 leaves his trans­
hepatic tube in place for approxi­
mately 4 months. He reported success 
in 70% of patients who have under­
gone the procedure.
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SESAP III Question
626. A 20-year-old man has a painless, smooth, firm unilateral scrotal mass of six weeks known duration. 
It does not transluminate. The best management would consist of
(A) Inguinal incision with orchiectomy if a tumor is found
(B) administration of antibiotics and observation for two to four weeks
(C) needle biopsy
(D) scrotal incision to excise the mass
(E) scrotal incision and open biopsy
For the incomplete statement above select the one answer that is best of the five given.
For the critique of Item 626 see page 340 of this issue.
(Reproduced by permission from SESAP III Syllabus: Surgical Education and Self-assessment Program 
No. 3. For enrolment in the Surgical Education and Self-Assessment Program No. 3, please apply to the 
American College of Surgeons, 55 East Erie St., Chicago, IT 60611.)
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The Sugiura Procedure for Bleeding Esophageal Varices:
a Modification
R.J. Ginsberg, md, frcs[c], P.F. Waters, md, frcs[c] and S.M . Strasberg, md, frcs[c]
The Sugiura procedure is an operation 
for control of bleeding esophageal 
varices. Splenectomy, extensive 
paraesophagogastric devascularization, 
and transection and anastomosis of 
the esophagus are performed 
through two incisions. The modifica­
tions described by the authors, such 
as the single thoracoabdominal incision 
and use of a stapler, simplify and 
shorten the operation. Preliminary 
results in nine patients are 
encouraging.
L operation Sugiura sert a arreter 
le saignement des varices oesopha- 
giennes. Une splenectomie, une 
devascularisation para-oeso-gastrique 
etendue et une dissection transversale 
avec anastomose de I’oesophage sont 
pratiquees a travers deux incisions.
Les auteurs decrivent des modifications 
telles qu'une incision thoraco- 
abdominale simple et I’utilisation 
d'une agrafeuse, qui simplifient 
• operation et en racourcissent le 
temps. Les premiers resultats chez 
neuf patients sont encourageants.
The Sugiura procedure is a new tech­
nique for treating esophageal varices. 
It was developed in response to poor 
results obtained by standard porta­
caval shunts.1'3 Starting initially with 
esophageal transection as described 
by Walker,4 the procedure was modi­
fied by Sugiura in stages to include 
an extensive paraesophagogastric de­
vascularization and splenectomy. The 
results obtained by Sugiura3 have been 
outstanding, with an actuarial survival 
rate o f 83% , more than double that 
for standard shunts.
We were attracted to the operation 
not only by the results reported by 
Sugiura, but also by the fact that the 
operation approached the problem of 
varices in a manner that was in har-
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mony with our understanding of their 
pathogenesis. Portal hypertension 
should be viewed as a beneficial re­
sponse to the block in blood flow to 
the liver due to cirrhosis, since portal 
hypertension maintains liver blood 
flow. When portal pressure reaches 
about 20 cm saline, portacaval 
shunts develop. As the block in the 
liver worsens, the shunts increase in 
size, and there is probably little or 
no further increase in portal pres­
sure. This concept is in keeping 
with the observation that portal pres­
sure and the degree o f shunting are 
largely unrelated.5 Portacaval shunts 
may develop in many areas, but the 
most prominent and clinically impor­
tant one is along and through the 
esophagus. Why this should be is un­
known; however, the tendency to 
form this shunt is great. Ablation o f  
this shunt, for example by classic 
portoazygous disconnection, is not 
followed by compensatory dilatation 
o f other shunts that take over its role, 
but by a tendency for the shunt and 
for bleeding to recur. Selective de­
compression o f varices, which recog­
nizes the benefit o f portal hyperten­
sion, is also followed by a substantial 
incidence o f recurrent bleeding, 
probably because the part o f the oper­
ation that disconnects the main por­
tal system from the varices eventually 
fails.
The approach taken by Sugiura to 
deal with this situation is unique. He 
recognized that the shunt through 
the hiatus has two parts, an intra- 
esophageal component and a para­
esophageal component. The Sugiura 
operation obliterates the intraesopha- 
geal shunt, while carefully preserving 
the paraesophageal shunt. Theoreti­
cally, the paraesophageal shunt is suf­
ficient to satisfy the need for a shunt 
through the hiatus and the intraeso- 
phageal shunt does not reform. N o 
other operation incorporates this ra­
tionale.
The Sugiura operation has three 
parts: splenectomy, extensive para­
esophagogastric devascularization and 
division and suture o f the eso­
phagus. Sugiura performs the opera­
tion through separate thoracic and 
abdominal incisions, does a selective 
vagotomy as part o f the devasculari­
zation, which then requires a pyloro­
plasty, and divides and sutures the 
esophagus by hand. It is in these areas 
that we have modified the procedure. 
Sugiura’s description and diagrams of 
the method used to preserve the 
paraesophageal shunt are schematic 
and we have endeavoured to provide 
a description from our experience that 




A  thoracoabdominal incision is 
used (Fig. 1). With the patient in the 
right lateral decubitus position, the 
incision is made in the seventh or 
eighth intercostal space (i.e., that 
which, if extended, would cross just 
above the umbilicus). Posteriorly, the 
incision reaches the erector spinae, 
but anteriorly it extends only 3 to 5 
cm beyond the left costal margin and 
usually not beyond the edge o f  the 
left rectus abdominis muscle. The 
diaphragm is incised circumferentially 
at about 1.5 cm from its costal attach­
ment for a distance o f 2 to 3 cm on 
each side o f the incision, although 
extensions may be made to facilitate 
exposure in short, thick-chested per­
sons. The incision is closed in layers 
starting with the diaphragm, which is 
resutured to its costal attachment with 
no. 1 Vicryl, beginning at the ex­
tremity o f each incision and tying 
the sutures to each other and to that 
o f the internal oblique-transversus ab­
dominis muscle layers. The costal 
margin is not sutured, but the ribs are 
approximated by pericostal sutures.
Comment.— This incision provides 
superior access to the left upper qua-
FIG. 1— Incision used for modified 
Sugiura procedure.
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drant of the abdomen (Fig. 1). Re­
moval of any spleen, particularly a 
large spleen with body wall adhesions, 
is considerably easier than through 
a midline incision. The esophagogas­
tric junction and intra-abdominal eso­
phagus, which are the focal points of 
the subdiaphragmatic portion of the 
operation, are easy to see and to 
reach. Little retraction is needed, as 
the liver, even when large, sinks down 
to the right. Access to the intra- 
thoracic esophagus up to the inferior 
pulmonary vein is ample and one 
may simply and quickly inspect the 
esophagus on both sides of the dia­
phragm, an important advantage when 
completing the devascularization right 
at the hiatus. Closure of the incision 
is straightforward, preserves dia­
phragmatic function and results in 
few problems as long as the costal 
cartilages are not sutured.
Subdiaphragmatic Portion 
of the Operation
Splenectomy is performed by 
standard techniques. Sugiura does 
not state explicitly how far down the 
greater curvature the gastric devas­
cularization is carried, but it appears 
from his diagrams that only the 
short gastric vessels are taken,1,3 al­
though the omentum may be opened 
below the gastroepiploic arcade. 
Sugiura also states that the upper half 
of the stomach is stripped of venous 
collaterals.3 We have used this as 
a guide and removed gastroepiploic 
branches from the upper half of the 
greater curvature.
The remainder of the devasculariza­
tion is best viewed as if making a 
longitudinal incision on one side of 
a banana, then lifting the skin in 
front and behind, exposing and divid­
ing attachments between pulp and skin
FIG. 2— Completion of abdominal dis­
section. Esophagus has been cleared 
from left to right and highly selective 
vagotomy performed, clearing lesser 
curvature to “crow’s foot”. Large vein 
(lifted forward), usually seen posterior 
to plane of lesser omentum, is major 
portoazygous connection. It is probably 
continuation of coronary vein.
until the whole midsection of the 
pulp is free and exposed. To do this 
the left lateral portion of the eso­
phagus is exposed and the nerves, 
vessels, peritoneum and fat are lifted 
off the esophagus in front and behind 
as two flaps, and only those branches 
that directly enter the muscle of the 
esophagus or bare area of the stomach 
posteriorly are ligated and divided. 
Eventually, the right lateral border of 
the esophagus is reached and cleared, 
and the flaps of nerves, fat, perito­
neum and vessels fall away to the 
right. At this point the large paraeso­
phageal veins (now completely de­
tached from the esophagus) can be 
seen running up to the hiatus. This 
portion of the operation is completed 
by the technique used in highly selec­
tive vagotomy to clear the lesser cur­
vature down to the “crow’s foot” 
(Fig. 2). Again it is essential to stay 
on the gastric wall to avoid injur­
ing the longitudinal veins.
Comment.—Sugiura’s diagrams in 
the 1973 and 1977 papers3,3 differ 
slightly. In his latter paper it appears 
that the major paraesophageal vein 
is a continuation of the venous ar­
cade along the lesser curvature (i.e., 
right gastric and left gastric veins that 
appear to drain into the portal vein 
by way of the right gastric vein). We 
believe that the major shunt is by way 
of the coronary vein, since following 
completion of the abdominal portion 
of the operation we have been able 
to see a large vein passing through 
the hiatus on the right side of the 
esophagus in a plane posterior to the 
lesser curvature of the stomach (Fig. 
2) .
Sugiura continues the devasculari­
zation for 7 cm along the lesser cur­
vature from the esophagogastric junc­
tion. Our point of reference is the
FIG. 3—Thoracic portion of proce­
dure. Veins entering esophageal wall are 
ligated. Longitudinal veins are preserved. 
Large longitudinal vein shown is con­
tinuation of that in Fig. 2.
“crow’s foot” since we wish to pre­
serve pyloric function.
Thoracic Portion of the Operation 
(Fig. 3)
The inferior pulmonary ligament is 
divided up to the inferior pulmonary 
vein. A longitudinal incision is made 
in the mediastinal pleura over the 
esophagus. The esophagus is devas- 
cularized by the technique described 
above, first exposing the left lateral 
edge and peeling the esophagus away 
from its covering of veins, fat, nerves 
and pleura, dividing only those vessels 
that directly enter the muscle. The 
dissection of the anterior and posterior 
flaps is carried from the hiatus to the 
inferior pulmonary vein (12 to 18 
cm). This is facilitated by dissecting 
the midportion first and passing a 
Penrose drain around the first sec­
tion of cleared esophagus. Again great 
care is taken to preserve the longitu­
dinal veins. The final portion of the 
devascularization is performed at the 
hiatus. Working from both sides the 
surgeon can free the esophagus from 
all venous attachments, often without 
destroying the phrenoesophageal 
membrane. If the dissection is per­
formed from one side only, this is 
difficult to accomplish.
Comment.—Although Sugiura ob­
viously intends the paraesophageal 
venous plexus to be preserved, it is 
our impression that this is not well 
understood and that coronary and 
other longitudinal veins have been 
ligated in the course of a “Sugiura 
procedure”. It is possible that preser­
vation of the paraesophageal longi­
tudinal veins is not necessary. How­
ever, in reporting results it is im­
portant to indicate whether or not 
the longitudinal plexus was preserved, 
since the results may be different, as 
would be the rationale for the opera­
tion.
As in the abdominal part of the 
operation it is possible to see the large 
longitudinal paraesophageal vein, 
which is usually posterior and just to 
the right of the esophagus; Sugiura 
also shows a left longitudinal vein in 
the thorax, but in our experience this 
is far less prominent.
In both abdominal and thoracic 
portions of the operation, the two 
technical features that are most im­
portant are careful hemostasis and 
meticulous development of the flaps, 
otherwise longitudinal veins will be 
interrupted.
Division and Repair of the Esophagus
The circular stapler (EEA Auto
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Stapler, Auto Suture Company, Divi­
sion of United States Surgical Corp., 
Stamford, Conn.) is inserted through 
a small gastrotomy and an absorbable 
suture used to tie down the esophagus 
(Fig. 4). The point of transection is 2 
to 3 cm above the esophagogastric 
junction. After removal of the instru­
ment a D-tube is carefully guided 
through the anastomosis into the stom­
ach. The gastrotomy is closed and the 
operation is completed by a loose 
Nissen fundoplication.
Comment.—The circular stapler 
makes a difficult procedure easy and 
quick. The Nissen wrap is used to 
protect the anastomotic line and as 
an antireflux procedure. It must be 
loose.
Results
To determine the scope of this 
procedure, we decided to accept for 
operation all patients referred with 
proven varices that had bled. All pa­
tients had serious variceal hemorrhage 
requiring transfusion of several units 
of blood. The term emergency was 
applied to those patients in whom 
bleeding was active at the time of 
operation, and the term elective to all 
other patients, including those who 
had stopped bleeding only 24 hours 
before operation and who had a 
Blakemore tube still in position (two 
patients).
Five patients had alcoholic cir­
rhosis and four had cirrhosis due to 
other causes.
Seven elective procedures were per­
formed over 22 months. One patient 
had had two previous procedures, a 
Warren shunt and a splenectomy. 
Operations were performed in combi­
nation by two surgeons, a thoracic sur­
geon and an abdominal surgeon with a 
major interest in liver disease. The 
operating time was about 3 hours 
and the blood loss about 1500 ml. All 
patients had an excellent recovery,
FIG. 4— Transection and anastomosis 
with EEA circular Auto Stapler. “But­
ton” of tissue removed is shown at right.
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without postoperative encephalopathy 
and surprisingly small changes in 
liver function. At the time of writ­
ing there has been no hemorrhage, 
during a follow-up that has ranged 
from 1 to 22 months. Several patients 
have complained of dysphalgia to solid 
food at 4 to 6 weeks and have re­
quired one or two dilatations with a 
Maloney bougie. In one patient dilata­
tion resulted in a small leak at the 
anastomosis 6 weeks after operation; 
the leak was managed conservatively 
with total parenteral nutrition for 2 
weeks. Repeated dilatations (i.e., more 
than two) have not been required. One 
patient who complained of epigastric 
pain was found to have a duodenal 
ulcer 6 months after operation. This 
patient was treated with cimetidine 
for 6 months and has now been free 
of ulcer and off medication for 6 
months.
In two patients emergency opera­
tions were performed. Both were 
bleeding actively despite pressure of 
a Blakemore tube with gastric bal­
loon inflated. Both were encephalo- 
pathic, deeply jaundiced and had 
coagulopathies, one of which was 
severe. One patient had massive 
ascites and muscle wasting. Both pa­
tients died in the postoperative period, 
one on the first postoperative day of 
an uncontrollable coagulopathy, and 
the other at 14 days, of a combination 
of sepsis and liver failure.
Comment
The Sugiura procedure is a new 
and logical approach to the problem 
of bleeding varices. We have modified 
several aspects of the procedure; these 
modifications will increase the ease, 
speed and safety of the operation. The 
results in our series of nine patients 
are preliminary and permit no object­
ive statements about the efficacy of 
the procedure. However, these results 
are sufficiently encouraging that a 
controlled trial is planned.
References
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continued from page 282
The 16 chapters are systematically 
laid out in numbered subheadings and 
each chapter basically follows the same 
format. A reference and subject index 
follows at the end of each chapter.
Everything that one would want to 
know about a particular operation is 
detailed, including initial comments on 
anesthesia, positioning, exsanguination 
and skin preparation. The book con­
tains 425 figures, most in colour, all of 
which are artist’s drawings. The figures 
are clear and concise.
The basic techniques used and de­
scribed are familiar to all practising 
hand surgeons and illustrations of their 
application are numerous; for example, 
on syndactyly alone there are 58 pages 
with half of that number dedicated to 
illustrations, on right-hand pages, of all 
types and degrees of syndactyly and the 
left-hand pages related to a textual de­
scription with timely advice regarding 
the particular procedure.
This book is an atlas of the tech­
niques found most useful by the au­
thors and no time is wasted on exten­
sive discussion of alternative techniques.
Omitted are references to the role 
of microvascular surgery of free tissue 
transfers because this text is a result 
of work done before this development.
I found very little in this book to 
argue with except perhaps the use of 
the tubed pedicle in restoring or recon­
structing a web space, but even this 
was restricted to one particular situa­
tion.
This is a classic atlas and a must 
as a reference for anyone doing hand 
surgery particularly that involving con­
genital deformities.
D.J. C lassen , dds, m d , fr c s[c ]
Plastic and reconstructive surgeon, 
Assistant professor of surgery,
University of Saskatchewan,
Saskatoon, Sask.
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This book resulted from a symposium 
on gastrointestinal hemorrhage held at 
the University of Michigan. The clinical 
evaluation and investigation of gastroin­
testinal hemorrhage provides a good 
introduction. A separate chapter is de­
voted to bleeding in infants and chil­
dren. The section on chronic gastroin­
testinal blood loss features an easy-to- 
follow “diagnostic flow chart”. Diag­
nostic endoscopy and angiography are 
discussed thoroughly and the chapter 
on angiography details several typical 
radiologic findings that would be of par­
ticular interest to the non-radiologist.
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NOW IN STROKE
The Advantages of ENTROPHEN
To reduce the risk 
of stroke
Now, ENTROPHEN* is 
indicated for reducing the risk 
of recurrent transient ischemic 
attacks or stroke in men who 
have had transient ischemia 
of the brain due to fibrin 
platelet emboli. At present 
there is no evidence that 
A SA  is effective in reducing 
transient ischemic attacks 
in women, or is of j
benefit in the treatment 
of completed strokes 
in men or women.
Inhibition of platelet fl 
cyclooxygenase activity M 
by a single dose of 
ENTROPHEN*-10 
was comparable to M
that of plain ASA, 
although the effect was ||®? 
delayed, reflecting the 
delayed appearance of 
A SA  in the plasma.1
with reduced risk 
of stomach upset
When you prescribe 
ASA for long-term use, 
it is important not to create 
additional problems for 
your patients.
While they may benefit 
from the therapeutic 
effect of ASA, there is 
still a potential for 
gastric irritation and 
upset, particularly 
when the regimen calls 
for continuous daily 
dosage.
Clinical experience 
has shown that 
ENTROPHEN*, coated 
with POLYMER 37* 
reduces gastric distress 
in long-term treatment 
with high doses of ASA.
entrodheri
’ $8etylsalicylic acid taB|jfe . USP)
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C H A R L E S  E. F R O S S T  4  CO.
i. To reduce 
the risk of stroke 
with reduced risk 
of stomach upset
n, et al.: Plasma acetylsalicylate and salicylate and platelet cyclooxygenase activity following plain and enteric-coated aspirin, *°TraHpmflrk
TABLETS
entrophen
(acetylsalicylic acid tablets, USP) 
Enteric-coated with POLYMER 37* 
Anti-inflammatory—Analgesic Agent 
Platelet Aggregation Inhibitor 
DESCRIPTION
ENTROPHEN* is an enteric-coated tablet contain­
ing acetylsalicylic acid coated with POLYMER 37*. 
a partially esterified polyvinyl alcohol.
ACTION
Acetylsalicylic acid (ASA) has analgesic, anti­
pyretic and anti-inflammatory properties.
In rheumatic diseases, although the analgesic and 
antipyretic effects are useful, the major purpose 
for which ASA is used is to reduce the intensity of 
the inflammatory process. Inhibition of prosta­
glandin synthesis may be involved in the anti­
inflammatory action of ASA.
ASA also alters platelet aggregation and release 
reaction by inhibiting prostaglandin synthesis 
Thromboxane A2 is an essential step in platelet 
aggregation. ASA prevents Thromboxane A2 for­
mation by acetylation of platelet cyclooxygenase. 
This inhibition of prostaglandin synthesis is 
irreversible and affects platelet function for the 
life of the platelet.
The POLYMER 37* coating substantially resists 
disintegration in aqueous fluids having a pH lower 
than 3.5 for a period of at least 2 hours and is 
capable of disintegrating in aqueous fluids having 
a pH of at least 5.5 in from 10 to 30 minutes. Thus, 
POLYMER 37* coating effectively inhibits the 
release of ASA in the stomach, whilst allowing the 
tablet to dissolve in the upper portion of the small 
intestine for absorption from the duodenal area. 
Clinical experience has shown that POLYMER 37* 
coated acetylsalicylic acid diminishes or eliminates 
gastric distress during long-term treatment with 
high doses of ASA.
INDICATIONS
ENTROPHEN* is indicated whenever gastric 
intolerance to ASA is of concern.
ENTROPHEN* is indicated for the relief of signs 





and other forms of rheumatism
Musculoskeletal disorders
Rheumatic fever, however, penicillin and other
appropriate therapy should be administered
concomitantly.
ASA is generally considered to be the primary 
therapy for most forms of arthritis.
ENTROPHEN* is also indicated for reducing the 
risk of recurrent transient ischemic attacks or 
stroke in men who have had transient ischemia of 
the brain due to fibrin platelet emboli. At present 
there is no evidence that ASA is effective in 
reducing transient ischemic attacks in women, or 
is of benefit in the treatment of completed strokes 
in men or women.
CONTRAINDICATIONS
Sensitivity to the ingredients 
Active peptic ulcer
Patients who had a bronchospastic reaction to 
ASA or non-steroidal anti-inflammatory drugs.
WARNINGS
ASA is one of the most frequent causes of 
accidental poisoning in toddlers and infants. 
ENTROPHEN* should, therefore, be kept well out 
of the reach of all children.
PRECAUTIONS
Salicylates should be administered with caution 
to patients with asthma and other allergic condi­
tions, with a history of gastrointestinal ulcerations, 
with bleeding tendencies, with significant anemia 
or with hypoprothrombinemia.
Salicylates can produce changes in thyroid 
function tests.
Acute hepatitis has been reported rarely in 
patients with systemic lupus erythematosus and 
juvenile rheumatoid arthritis with plasma sali­
cylate concentrations above 25 mg/100 mL.
Patients have recovered upon cessation of 
therapy.
Use in Pregnancy
ASA does not appear to have any teratogenic 
effects. ASA has been found to delay parturition 
in rats. This effect has also been described with 
non-steroidal anti-inflammatory agents which 
inhibit prostaglandin synthesis.
High doses (3 g daily) of ASA during pregnancy 
may lengthen the gestation and parturition time. 
Because of possible adverse effects on the 
neonate and the potential for increased maternal 
blood loss, ASA should be avoided during the last 
three months of pregnancy.
Drug Interactions
Caution is necessary when ENTROPHEN* 
and anticoagulants are prescribed concurrently, as 
ASA may potentiate the action of anticoagulants. 
Salicylates may potentiate sulfonylurea hypo­
glycemic agents. Large doses of salicylates may 
have a hypoglycemic action, and thus, affect the 
insulin requirements of diabetics.
Although salicylates in large doses are uricosuric 
agents, smaller amounts may depress uric acid 
clearance and thus decrease the uricosuric 
effects of probenecid, sulfinpyrazone and 
phenylbutazone.
Sodium excretion produced by spironolactone 
may be decreased in the presence of salicylates. 
Salicylates also retard the renal elimination of 
methotrexate.
ADVERSE REACTIONS
Gastrointestinal reactions: nausea, vomiting, 
diarrhea, gastrointestinal bleeding and/or ulcera­
tion. Ear reactions: tinnitus, vertigo, hearing loss. 
Hematologic reactions: leukopenia, thrombo­
cytopenia, purpura. Dermatologic and Hypersen­
sitivity reactions: urticaria, angioedema, pruritus, 
various skin eruptions, asthma and anaphylaxis. 
Miscellaneous reactions: acute reversible hepato- 
toxicity, mental confusion, drowsiness, sweating 
and thirst.
SYMPTOMS AND TREATMENT 
OF OVERDOSAGE 
Symptoms
In mild overdosage these may include rapid and 
deep breathing, nausea, vomiting (leading to 
alkalosis), hyperpnea, vertigo, tinnitus, flushing, 
sweating, thirst and tachycardia. (High blood 
levels of ASA lead to acidosis.) Severe cases may 
show fever, hemorrhage, excitement, confusion, 
convulsions or coma, and respiratory failure. 
Treatment
Treatment is essentially symptomatic and sup­
portive. Administer water, universal antidote and 
remove by gastric lavage or emesis. Force fluids 
(e.g., salty broth) to replace sodium loss. If the 
patient is unable to retain fluids orally, the alkalosis 
can be treated by hypertonic saline intravenously. 
If salicylism acidosis is present, sodium bicar­
bonate intravenously is preferred because it 
increases the renal excretion of salicylates. 
Vitamin K is indicated if there is evidence of 
hemorrhage. Hemodialysis has been used with 
success.
Respiratory depression may require artificial 
ventilation with oxygen. Convulsions may best be 
treated by the administration of succinylcholine 
and artificial ventilation with oxygen. Central 
nervous system depressant agents should not 
be used.
Hyperthermia and dehydration are immediate 
threats to life and initial therapy must be directed 
to their correction and to the maintenance of 
adequate renal function. External cooling with 
cool water or alcohol should be provided quickly 
to any child who has a rectal temperature over 
104°F.
DOSAGE AND ADMINISTRATION 
Analgesic: antipyretic
Up to 2.925 g daily as necessary. 
Anti-inflammatory
Because the suppression of inflammation in­
creases with the dose of salicylate even beyond 
the point of toxicity, the therapeutic objective is 
to employ as large a dose as possible short of 
toxicity. Most patients will tolerate blood salicylate 
levels in the range of 20 to 25 mg per cent. The 
most common reason for failing to obtain a 
therapeutic response to ASA is the administration 
of inadequate doses.
The generally accepted way to achieve effective 
anti-inflammatory' salicylate blood levels of 20 to 
25 mg per cent is to titrate the dosage by starting 
with 2.6 to 3.9 g daily, according to the size, age 
and sex of the patient. If necessary, the dosage is 
then gradually adjusted by daily increments of 
0.65 g until symptoms of salicylism e.g., auditory 
symptoms, occur. Then, the dosage is decreased 
by 0.65 g daily until these symptoms disappear 
and maintained at that level as long as necessary. 
In adults the median dose at which tinnitus 
develops is 4.5 g per day, but the range extends 
from 2.6 to 6.0 g per day.
Intermittent administration is ineffective. Patients 
should be advised not to vary the dose from day 
to day depending on the level of pain because 
that often fluctuates independently of the intensity 
of the inflammation. A continuous regimen of 
0.65 g four times daily is considered to be 
minimum therapy for adults. ENTROPHEN* 
should be administered four times daily. For night­
time and early morning benefits, the last dose 
should be given at bedtime.
Once m aintenance dose is established, 
ENTROPHEN*-15 may be useful to encourage 
patient compliance.
Optimally, salicylate therapy should be monitored 
by periodic blood salicylate level determinations. 
If this is not practical, the appearance of auditory 
symptoms in the form of tinnitus or deafness are 
acceptable as an indication of the maximum 
tolerated salicylate dose.
There is an inverse relation between blood 
salicylate levels at which auditory symptoms 
appear and the age of the patient. In the young 
adult, this is usually in the range of 20 to 30 mg 
per cent. In children, however, the level may be 
much higher, or the effect apparently absent. 
Because salicylate toxicity may appear without 
such warning in children, the usual practice is to 
give ASA in a daily dose of 50 to 100 mg per 
kilogram of body weight and to follow blood levels 
aiming for a concentration of about 30 mg per cent. 
Rheumatic Fever
A total daily dosage of 100 mg per kilogram of 
body weight administered in divided doses to 
allay the pain, swelling and fever.
Cerebral ischemic attacks (men)
The recommended dosage is 1,300 mg per day 
(650 mg twice a day or 325 mg four times a day).
AVAILABILITY
No. 472—ENTROPHEN*-15 tablets containing 
975 mg of acetylsalicylic acid USP, coated with 
POLYMER 37*. Oval, pale yellow, film-coated 
tablets with the FROSST name engraved on one 
face and 472 on the other and supplied in bottles 
of 100 and 500.
No. 470—ENTROPHEN*-10 tablets containing 
650 mg of acetylsalicylic acid USP, coated with 
POLYMER 37*. Oval, orange, film-coated tablets, 
with the FROSST name engraved on one face 
and 470 on the other and supplied in bottles of 
100, 500 and 1,000.
No. 438—ENTROPHEN*-5 tablets containing 
325 mg of acetylsalicylic acid USP, coated with 
POLYMER 37*. Round, brown, film-coated tablets, 
with the FROSST name engraved on one face 
and 438 on the other and supplied in bottles of 
100, 500 and 1,000.
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VOLUNTARY CONTRIBUTIONS
Unicameral Bone Cyst
K.S. M orton, m d , c m , m  sc, frcs[c], facs
A 28-year experience with 76 
unicameral bone cysts is reviewed 
and compared to other large series 
and recommended treatments recorded 
in the English literature. Particular 
attention is paid to the importance 
of recurrence in relation to the need 
for secondary operations and in 
contrast to the disability caused 
by enforced restriction of activity. 
Evidence is presented suggesting 
that, in spite of residual radiologic 
changes, the disability is frequently 
insufficient to warrant a second 
operation. Most unicameral bone 
cysts probably run their own course, 
not always greatly affected by 
treatment, with very satisfactory 
end results.
L’experience de 28 annees portant 
sur 76 kystes osseux uniloculaires est 
analysee et comparee aux autres 
grandes series et aux traitements 
recommandes dans la litterature de 
langue anglaise. Une attention 
particuliere est accordee a I'impor- 
tance des recidives en rapport avec 
la necessity de nouvelles operations 
et en comparaison de I'incapacite 
rencontree lorsqu'une restriction des 
activites est imposee. Les constata- 
tions presentees indiquent qu'en 
depit de changements radiologiques 
residuels, I'incapacite est frequemment 
insuffisante pour justifier une 
deuxieme operation. La plupart des 
kystes osseux uniloculaires se 
resolvent probablement spontanement, 
sans etre bien souvent affectes 
par le traitement et avec un resultat 
final fort satisfaisant.
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Unicameral bone cyst has been a 
well-known but little understood en­
tity since it emerged from a conglo­
merate of cystic and fibrous lesions 
of bone discussed by authors such as 
Bloodgood1 and Elmslie.2 Jaffe and 
Lichtenstein3 established the entity 
more securely, but as recently as 1977 
Cohen,4 in an excellent summary of 
the subject, pointed out the continu­
ing gaps in the knowledge of this 
fairly common clinical problem, par­
ticularly in the areas of pathogenesis 
and treatment.
Cohen’s article prompted us to 
examine our experience of 76 cases 
of unicameral bone cyst registered 
with the University of British Colum­
bia Bone Tumour Registry over the 28- 
year period from 1951 to 1978. It was 
immediately apparent that no statis­
tical analysis could be undertaken 
because of the limitations Cohen de­
scribed: the changing patterns of
management, the relatively small 
numbers in relation to age of patient 
and bone involved and, inevitably, 
the inadequate follow-up information. 
Nevertheless, certain observations 
are valid and conclusions justified.
Patients
Our 76 patients (51 male, 25 female) 
all had solitary lesions (Fig. 1). When 
first seen they ranged in age (Table 
I) from 2 to 57 years. The common­
est age was 12 years and the majority 
were within the first two decades of 
life. The common sites were the upper 
humerus (25 patients) and upper 
femur (22 patients), but 8 cysts occur­
red in the humeral shaft and 21 were 
widely distributed in all bones but 
the skull.
Of the 76 patients, 64 were treated 
operatively; in 12 no operation was 
carried out so a pathologic diagnosis 
was not made. The type of operation 
(Table II) reflects the timing of treat­
ment rather than our current prac­
tice, for these patients were treated 
over a period of almost three decades. 
The most common procedure was 
curettage and bone grafting (45 cases), 
in earlier years with frozen bank bone 
and often accompanied by cautery.
FIG. 1— Typical radiologic appear­
ance of unicameral bone cyst of proximal 
shaft of humerus in 14-year-old girl.
Table 1— Age D istribution of 76 Cases
of Unicam eral Bone Cyst
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Later, autografts were used. The most 
recent surgical procedure has been 
subtotal, subperiosteal excision with 
or without subperiosteal bone graft­
ing (two cases).
Results
On the whole the results were satis­
factory in that we have recognized no 
disability, no loss of limb and no 
associated malignant conditions. The 
validity of this conclusion can be 
judged in part by examination of our 
follow-up figures (Table III), with on­
ly 28 patients followed up for 4 years 
or more and 37 patients followed up 
for less than 2 years.
Fracture and Refracture
Forty-four of 76 patients presented 
with a fracture through, into or near 
the cyst. The fracture ranged from 
a fine crack through thinned cortex 
to, less often, comminuted and dis­
placed fractures requiring treatment. 
Eleven patients were known to have 
suffered a second fracture; 1 of these 
had three and another four fractures.
Reoperation
Six patients underwent two opera­
tions. In all instances the initial pro­
cedure was curettage and grafting with 
banked bone. In three patients the sec­
ond operation was the same while the 
remaining three had autografts. All
T a b le  I I — T y p e  o f O p e ra tio n  P e r fo rm e d  in  
64 C ases o f U n ic a m e ra l B one  C y s t
O p e ra tio n
N o . of 
p a tie n ts
C u re tta g e 13
C u re tta g e  and b a n k e d  bone  g ra ft 29
C u re tta g e  and  a u to g e n o u s  g r a f t 16
S u b p erio s tea l re s e c tio n 2
O th e r 1
N o t described 3
T a b le  I I I — L e n g th  o f F o l lo w -u p  in  
76 C ases o f  U n ic a m e ra l B o n e  C ys t
F o llo w -u p , y r
N o . o f  
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these second operations were done in 
the 1956 to 1967 period. Another pa­
tient had two osteotomies for correc­
tion of varus deformity from a cyst in 
the trochanteric region of the femur.
Shortening and Deformity
Three patients, all with cysts of the 
upper humerus, demonstrated up to 
5.1 cm of shortening of the involved 
bone on follow-up 3 to 9 years after 
pathologic fracture and operation. 
Though angular deformity sometimes 
occurred, usually in humeral cysts, 
it did not persist and was not a com­
plaint in any patients followed up for 
4 years or longer. One patient 
with a cyst in the trochanteric region 
of the femur required osteotomy for 
varus deformity on two occasions, at 
the age of 6 and 7 years. Three years 
later the cyst had healed and the* 
result was described as satisfactory 
though there was some valgus de­
formity at the hip.
Restricted Activity
Perhaps the greatest problem in 
these patients is the sometimes lengthy 
and possibly unnecessary period of 
restricted activity because of fear of 
pathologic fracture. We are con­
vinced that any treatment that leads 
to strengthening of the bone and 
hence shortening of this period of 
relative inactivity is to be recom­
mended.
Discussion
In spite of our apparently good 
results we are aware first that de­
formity, particularly from injudicious 
surgery, is a potential problem. This 
is illustrated by the findings from one 
patient too recent to include in the 
current series. Curettings from a uni­
cameral bone cyst of the ankle show
FIG. 2—Curettings from treated uni­
cameral bone cyst showing organized 
cartilage of epiphyseal plate (hematoxyliii 
and eosin, reduced by 52% from X 125).
epiphyseal plate damage that is ex­
pected to produce progressive growth 
deformity (Fig. 2).
Neer and associates5 defined recur­
rence of unicameral bone cyst as 
“continuing expansion and thinning 
of the cortex” requiring reoperation. 
On this basis they reported failure 
rates of initial curettage and grafting 
as 30% in the upper humerus and 
17% in the upper femur.
In another large series, Spence and 
associates6,7 categorized any residual 
cystic defect as a recurrence and 
found that 64 (36%) of 177 lesions 
curetted and grafted with freeze-dried 
cancellous bone allograft recurred 
to the extent that reoperation was in­
dicated. They also reported greater 
difficulty with upper humeral lesions. 
Follow-up ranged from 7 months to 
13 years (mean 27 months). In their 
later paper, reporting 144 lesions 
curetted and grafted with freeze- 
dried crushed cortical bone allograft, 
their overall recurrence rate was 
25%; follow-up ranged from 1 to 4 
years.
A different surgical approach was 
reported by Fahey and O’Brien8 in 
a small series of 20 patients, that of 
subtotal resection and autologous or 
homologous bone grafting. Using 
strict criteria they had a recurrence 
rate of 5% at an average follow-up 
of 3.9 years. McKay and Nason9 ob­
tained a comparable recurrence rate 
(9%) in 21 patients treated by sub­
total resection without grafting and 
followed up for a similar period. In 
both series some patients had had 
previous surgical treatment.
In the 76 cases reported here, using 
the criterion of reoperation as the 
standard for recurrence, our rate was 
8%. Clearly this rate would be much 
higher if the criteria used by Spence 
and associates,6,7 and by Fahey and 
O’Brien8 were applied, but our series 
is comparable to that of Neer and 
associates.5
We believe the important feature in 
judging results of treatment of uni­
cameral bone cyst is the morbidity or 
disability the individual patient ex­
periences in relation to restriction of 
his activities, not the roentgenographic 
appearance following operative treat­
ment and therefore not the “recur­
rence rate”. If, in upper extremity or 
lower extremity cysts, there is suffi­
cient bone strength to permit unre­
stricted childhood activities, then the 
treatment has been successful whether 
or not there is radiologic recurrence 
or residual disease. If, on the other 
hand, there is insufficient confidence
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in the strength of the bone to allow 
the patient reasonable activity, then 
this may be the most valid crite­
rion of failure and the best indication 
for a second operation.
As Cohen4 pointed out, no con­
clusions are possible in a retrospective 
review such as this. Our observations, 
however, support the need for a 
greater understanding of the natural 
history of unicameral bone cyst, 
whether it be untreated, affected by 
fracture, treated surgically or, as 
more recently reported, treated by 
steroid injection.10
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Oncocytoma of the Lung
M a r c o  A. F e r n a n d e z , m d * an d  J. N y s s e n , b a , p h  D f
This report describes the clinical, 
anatomical, histologic and 
ultrastructural features of a bronchial 
oncocytoma. Histologically the 
oncocytes have granular eosinophilic 
cytoplasm. Ultrastructurally this 
corresponds to mitochondrial 
hyperplasia. Because cytoplasmic 
eosinophilia may be due to an 
abundance of cytoplasmic organelles 
other than mitochondria, it is 
emphasized that electron-microscopic 
study is an essential component in 
the diagnosis of oncocytomas.
Cette communication decrit les 
caracteristiques cliniques, anatomiques, 
histologiques et d’ultrastructure 
de I'oncocytome bronchique. Sur le 
plan histologique, les oncocytes 
possedent un cytoplasme granulaire 
eosinophile. L’ultrastructure 
correspond a celle d’une hyperplasie 
mitochondriale. Comme I'eosinophilie
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cytoplasmique peut etre due a une 
abondance d'organelles cytoplasmiques 
autres que les mitochondries, on 
souligne I’importance de considerer 
I’examen en microscopie electronique 
comme une composante essentielle 
du diagnostic des oncocytomes.
Oncocytoma is a rare variant of bron­
chial adenoma and is characterized by 
large cells in contrast to the small 
cells of the more common carcinoid. 
Seen under the electron microscope, 
the eosinophilic cells of the oncocy­
toma have cytoplasm filled with mito­
chondria. This tumour may occur in 
salivary, parathyroid and thyroid 
glands. Only a few cases diagnosed 
as bronchial oncocytoma fulfil the 
criterion of mitochondrial hyperplasia. 
We present a case of oncocytoma of 
the lung confirmed by ultrastructural 
studies.
C ase R ep o rt
Two weeks before admission to hos­
pital this previously healthy 30-year-old 
man had sudden onset of cough and 
hemoptysis. He had recently been on a 
diet and a program of strenuous exer­
cise in order to lose weight. During the 
previous 4 months he had lost 8 kg. 
He had had two episodes of pneumonia 
in the previous 2 years and had smoked 
25 cigarettes daily for 10 years.
The only abnormality found on phys­
ical examination was an enlarged 
thyroid. It felt nodular but was smooth- 
edged and enlarged, especially on the 
right. There was no lymphadenopathy.
A chest roentgenogram demonstrated 
a coin lesion, 3.5 cm in diameter, in 
the basal segment of the lower lobe of 
the right lung. Results of skin tests for 
fungus were negative. A thyroid scan 
showed many areas of reduced uptake, 
suggesting a nodular goitre. Iodine-131 
uptake indicated a euthyroid state.
Computerized axial tomography of 
the thorax confirmed the presence of 
a well-circumscribed mass in the pos­
terior basal segment of the right lower 
lobe (Fig. 1). Mediastinal nodes were 
not enlarged.
On bronchoscopic examination a 
cherry red tumour was found blocking 
the medial division of the right lower
FIG . 1— Computerized tomogram of 
thorax shows well-circumscribed mass 
(arrow) which is in posterior basal seg­
ment of right lower lobe.
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bronchus. The lesion was quite friable 
and bled easily. No biopsy specimen 
was obtained. Because of the presence 
of cold nodularity and the possibility 
of an occult carcinoma of the thyroid, 
surgical exploration of the thyroid was 
carried out and multiple biopsy speci­
mens were obtained that showed chronic 
thyroiditis. One week after the thyroid 
exploration, a right lower pulmonary 
lobectomy was performed.
The gross specimen showed an oval, 
pink tumour, 1.5 cm in maximum 
dimension, projecting into the lumen 
of the bronchus but also having an 
extrabronchial component. Distal to the 
tumour the bronchus was markedly
FIG. 2—Oval sessile tumour (small 
arrow) partially occluding bronchus, and 
diffuse dilatation (large arrow) distal to 
lesion.
FIG. 3—Polyhedral cells with granu­
lar eosinophilic cytoplasm. Nuclei are 
small with finely-distributed chromatin 
(hematoxylin and eosin, reduced by 45% 
from X400).
dilated forming a cylindrical cavity, 
6 x 5  cm, that was filled with old 
blood (Fig. 2).
Microscopically, the tumour was 
composed of polyhedral cells with abun­
dant granular eosinophilic cytoplasm. 
Their nuclei were generally small and 
vesicular but a few large pleomorphic 
forms with finely distributed chromatin 
were present. Mitoses were rare. The 
cells tended to form solid nests sur­
rounded and outlined by numerous 
thin-walled blood vessels (Fig. 3). The 
edge of the tumour was not obviously 
infiltrative.
None of the lymph nodes contained 
tumour. Some atelectasis of the paren­
chyma around the dilated, chronically 
inflamed bronchus was noted. Hemo­
siderin-filled macrophages were promi­
nent in that area. Silver stain by the 
Fontana—Masson method revealed a 
few argentaffin granules in some of the 
tumour cells. For electron microscopy 
the formalin-fixed tissue was sequentially 
postfixed in 3 % cacodylate-buffered 
glutaraldehyde and 2% osmium tetrox- 
ide and was stained with uranyl acetate 
and lead citrate. Electron-microscopic 
examination showed that the tumour 
cells contained numerous mitochondria 
and a few membrane-bound dense 
bodies. The appearance was that of an 
oncocytoma (Fig. 4).
Discussion
The term oncocyte was first used 
by Jaffe1 in 1932 to describe a tu­
mour of the salivary gland composed 
of cells containing large amounts of 
granular eosinophilic cytoplasm.
Hamperl2 described a rare variant 
of bronchial adenoma composed of 
cells with abundant strikingly eosino­
philic granular cytoplasm that he 
termed oncocytes.
Cells with granular, eosinophilic 
cytoplasm containing a variety of 
organelles have been called oncocytes 
in the past. With the use of electron 
microscopy it has become clear that
FIG. 4—Electron-microscopic appear­
ance showing marked mitochondrial hy­
perplasia. Some membrane-bound dense 
bodies (arrow) are also present (original 
magnification X8000).
very few of these cells are true 
oncocytes. For example, the eosino­
philic granularity of ovarian hilar, 
corpus luteal and testicular Leydig 
cells is due to abundant endoplasmic 
reticulum that fills the cytoplasm.3 
The cells of the granular cell myo­
blastoma contain lysosomal-like bod­
ies.4 The granularity of chemodec- 
tomas is due in large part to neuro­
secretory granules.5
Mitochondrial hyperplasia is the 
essential characteristic of oncocytes 
of the salivary6 and parathyroid 
glands,7 the H urth le ' cells of the 
thyroid gland8 and the epithelial com ­
ponent of Warthin’s tumour9 and this 
explains the deep eosinophilia of the 
cytoplasm seen with hematoxylin and 
eosin staining.
The main criterion for the diag­
nosis of the oncocytoma is mito­
chondrial hyperplasia. Fechner and 
Bentinck10 first demonstrated this in 
a bronchial oncocytoma. Our case 
of bronchial oncocytoma confirms 
this observation and re-emphasizes 
the importance of the ultrastructural 
appearance.
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Cholestatic Jaundice Caused by Sulindac
Yvon G iroux , m d , cspq , f r c p [c],* M arcel M oreau , m d , cspq , FRCs[c]f 
AND T.G. KASS, M D, M SC, CSPQ, FRCS[C]t
The authors describe a case of 
cholestatic jaundice in a 66-year-old 
woman that was caused by sulindac 
(Clinoril). The diagnosis was confirmed 
by challenging the patient with the 
drug. Abdominal pain, nausea, 
constipation, dizziness, somnolence, 
vertigo, inhibited platelet activity 
and hepatotoxicity have all been 
described in association with 
sulindac therapy, but this is the first 
time, to the authors' knowledge, 
that cholestatic jaundice has been 
reported as a side-effect.
Les auteurs decrivent un ictere 
cholestatique apparu chez une femme 
de 66 ans et cause par le sulindac 
(Clinoril). Le diagnostic fut confirme 
par provocation de la patiente avec 
le medicament. Douleurs abdominales, 
nausee, constipation, etourdissements, 
somnolence, vertige, inhibition de 
I'activite plaquettaire et hepatotoxicite 
ont tous deja ete decrits en rapport 
avec le traitement au sulindac. 
Toutefois, a la connaissance des 
auteurs, c'est la premiere fois qu’un 
ictere cholestatique est signale 
comme effet secondaire de ce 
medicament.
Sulindac, (z)-5-fTuoro-2-methyl-l-{ [p- 
(methylsulfinyl)phenyl] methylene}-lH- 
indene-3-acetic acid (Clinoril), is 
an anti-inflammatory and analgesic 
agent. Its exact mode of action is 
unknown, but it appears to inhibit the 
synthesis of prostaglandins. The max­
imal clinical effect is observed 3 
hours after intake.1 It is not a steroid, 
and is derived from indene. Its bio­
logical activity appears to be localized 
in the sulfur containing moiety.
On absorption, sulindac is metab­
olized in the liver, the reduction of 
sulfoxide to sulfur raising the plasma 
level of the active principle. Sulindac
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and its sulfur metabolite are bound to 
serum albumin and excreted princi­
pally by the kidneys, but also in the 
bile and feces.
Sulindac is used by some in the 
treatment of osteoarthritis, rheumatoid 
polyarthritis, ankylosing spondylitis, 
bursitis, tendinitis and gout (acute 
phase).
Side-effects include abdominal pain, 
nausea, constipation, dizziness, som­
nolence, vertigo and inhibition of pla­
telet activity.2 Hepatotoxicity3,4 has 
been observed.
We present in this article what is, 
to our knowledge, the first case of 
cholestatic jaundice associated with 
the use of this drug. The diagnosis 
was confirmed by challenging the pa­
tient with sulindac.
Case Report
A 66-year-old white woman under­
went acromioclavicular arthroplasty on 
May 14, 1979. When she was discharged 
from the hospital, sulindac (Clinoril) 
(200 mg bid) was prescribed for persist­
ent pain. A few days after starting 
treatment she became anorexic, nause­
ated and feverish but did not seek med­
ical advice. She was also taking isosor- 
bide dinitrate (Isordil), nitroglycerin and 
flurazepam hydrochloride (Dalmane) as 
she had been for many years. She did 
not drink alcohol.
On Sept. 1, 1979 she was admitted 
for investigation of progressive jaundice
FIG. 1— Biopsy specimen of liver 
clearly shows well-oriented columns of 
cells (hematoxylin and eosin, reduced by 
52% from X200).
and pruritus. Sulindac was discontinued 
at that time. The total serum bilirubin 
was 6.9 mg/dl (118 p.mol/1) (mainly di­
rect) (normal 0.2 to 1.4 mg/dl [3.42 
to 23.9 u.mol/1]). There were no physical 
signs of chronic liver disease. The 
serum values of amylase, lipase and 
creatine phosphokinase, and the hemo­
gram and urinalysis findings were all 
normal as were the blood urea, sugar 
and electrolyte levels, the prothrombin 
time, blood platelets, serum iron, iron­
binding capacity and serum protein, and 
the results of electrophoresis. Several 
serum levels were elevated: glutamic 
oxaloacetic transaminase was 211 U/ml 
(normal 8 to 40 U/ml), glutamic pyruvic 
transaminase was 328 U/ml (normal 9 
to 35 U/ml), lactic dehydrogenase 
was 198 U/ml (normal 109 to 193 
U/ml) and alkaline phosphatase was 
92 IU/1 (normal 9 to 35 IU/1). Ultra­
sonography was thought to show gall­
stones, so the patient was operated on. 
The gallbladder appeared to be normal 
and there were no gallstones. An intra­
operative cholangiogram was normal 
and the intrahepatic and extrahepatic bile 
duct system was well visualized, so a 
liver biopsy was done.
The biopsy specimen showed normal 
architecture with well-oriented columns, 
though some of the cells were irregu­
larly shaped. The portal spaces were 
normal. There were scattered areas of 
infiltration by lymphocytes (no plasma- 
cytes or polymorphs). No necrosis was 
found and sinusoids were normal. There 
were signs of bile stasis; biliary canals 
were widely dilated and filled with bile, 
mainly in the centrilobular area. Bile
FIG. 2— Biopsy specimen shows bile 
stasis with bile plugs (hematoxylin and 
eosin, reduced by 54% from X 1200).
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was also noted in Kupffer cells and 
some hepatocytes (Figs. 1 and 2). There 
was no cholangitis but, in some areas, 
mild fibrosis was noted in the spaces 
of Disse.
The patient was seen by a gastro­
enterologist and the diagnosis of cho­
lestatic jaundice, probably secondary to 
sulindac, was made.
Fifteen days after the operation, the 
total serum bilirubin value was 20.0 
mg/dl (342 y.mol/1) (direct 15.4 mg/dl 
[263 ij.mol/1]); the serum transaminase 
levels were normal, as were the pro­
thrombin and partial thromboplastin 
times. The serum was negative for Aus­
tralia antigen and the serum creatinine 
value was normal. The alkaline phos­
phatase value was elevated to 73 IU/1.
On Sept. 28, the patient was still 
jaundiced (total bilirubin 16.4 mg/dl 
[280 u.mol/1]; direct 12.6 mg/dl [215 
u.mol/1]). Because of the persistent 
cholestasis, she was given prednisone (20 
mg/d). The alkaline phosphatase level 
was 188 IU/1 and transaminase levels 
were normal. There had been a slow 
drop in bilirubin concentration before 
the cortisone was given. Steroids were 
discontinued on Dec. 5, 1979.
On Jan. 23, 1980, the results of liver 
function tests were normal. The total 
serum bilirubin level was 1.4 mg/dl (23.9 
u.mol/1) (half direct). Serum alkaline 
phosphatase and transaminase levels were 
also normal.
With the patient’s consent, she was 
challenged with sulindac to determine 
if that had been the cause of the chole­
static jaundice. On Mar. 5. 1980 she 
started taking sulindac (2 tabs/d) for 1 
week. On the third day she became 
anorexic, nauseated, jaundiced and suf­
fered pruritus. The total serum bilirubin 
level rose to 3.2 mg/dl (54.7 ixmol/1) 
(direct 2.2 mg/dl [37.6 u.mol/1]) and 
alkaline phosphatase to 76 IU/1. The 
serum transaminase levels were slightly 
elevated.
The medication was discontinued for 
humanitarian reasons and because it was 
clear that sulindac was the cause of 
the jaundice. The liver function test re­
sults returned to normal after challenge. 
Retrograde cholangiopancreatography 
showed that the pancreas, intrahepatic 
and extrahepatic bile ducts, cystic duct 
and gallbladder were all normal.
Discussion
We have demonstrated that sulindac 
can produce cholestasis similar to 
that produced by phenylbutazone. To 
our knowledge, this is the first case 
reported
The patient (considering the ele­
vated serum transaminase levels) may 
have presented a degree of hepato- 
toxicity following ingestion of sulindac 
but cholestasis was the primary mani­
festation. This picture of cholestasis 
persisted for 3 months. At operation
no gallstones were found. The patient 
was not drinking alcohol. Postoper- 
atively, the transaminase levels rapid­
ly returned to normal and microscopic 
examination of a liver biopsy speci­
men showed no evidence of necrosis.
The challenge with sulindac in­
duced a new elevation of serum bili­
rubin, alkaline phosphatase and trans­
aminase levels —  supporting a chole­
static more than a hepatotoxic action.
The mode of action of sulindac is 
not well understood and the mecha­
nism by which it produces cholestasis 
remains to be elucidated. We cannot 
conclude that the steroids helped in 
the recovery because that could have 
been the normal response to discon­
tinuing the sulindac.
References
1. S im o n  LS, M ills J A : N o n ste ro id a l an ti­
in flam m ato ry  d rugs (seco n d  o f  tw o parts). 
N  Engl J M ed  1980; 302; 1237-43
2. G reen  D, G iven KM, T s ’ao C, W h ippl e  
JP, Rossi EC: The effect of a new non­
steroidal anti-inflam m atory agent, sulindac, 
on platelet function. Throm b Res  1977; 
10: 283-9
3. A nderson  R J : Severe reaction with sulindac 
adm inistration (C). N  Engl J M ed  1979; 
300: 735-6
4. A hmad S, Sh eikh  A I, M eeran M K : Publicity 
about sulindac (C). Ibid: 734
NOTICES
Vascular Surgery
Vascular surgery will be the major 
topic of the 46th annual surgery 
course sponsored by the department 
of surgery of the University of Minne­
sota Medical School. The course will 
be held on June 14-16, 1982 at the 
University of Minnesota. For further 
information contact: Office of Con­
tinuing Medical Education, University 
of Minnesota Hospital Box 293, 420 




The 7th Annual Conference on the 
Clinical Application of Hyperbaric 
Oxygen is scheduled for June 9 to 11, 
1982 at the Disneyland Hotel in Ana­
heim, California. Included in the con 
ference will be plenary sessions on the 
use of hyperbaric oxygen in neuro­
logic disorders and anaerobic infec­
tions. Original papers will be pre­
sented and there will be workshops 
and exhibits. For more information, 
write: Baromedical department, Me­
morial Hospital Medical Center, 2801 
Atlantic Ave., Long Beach, CA 90801- 
1428, or call (213) 595-3613.
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Alkaline Reflux Gastritis: 
Roux-en-Y Diversion is Effective
Daniel Tasse, md, frcs[c],* Pierre Ghosn, md,* Michel Gagnon, md, F R C P [ c ] , f  Francois Martin, md, 
F R C P [ c ] , f  Stephen Morgan, md, frcs[c],* Pierre Poitras, md, F R C P [ c ] f  and D enis Bernard, md, frcs[c]*
Evert though controversy persists 
over the physiopathology of alkaline 
reflux gastritis, Roux-en-Y diversion 
is a well-accepted surgical treatment 
and was used in 23 patients over 
a 6-year period at the Hdpital St-Luc 
in Montreal. Of the 23 patients, 21 had 
complete relief of symptoms. 
Objective criteria for the selection 
of patients who would benefit from 
operation are still to be defined. The 
authors discuss the physiopathology 
through an extensive review of the 
literature.
Bien que la physiopathologie de la 
gastrite alcaline soit encore 
incompletement connue, la derivation 
sur anse de Roux-en-Y donne 
d'excellents resultats cliniques. L'objet 
de cette publication est de rapporter 
notre experience dans le traitement 
chirurgical de cette condition chez 
23 patients operes au cours des 
6 dernieres annees. Une disparition 
complete des symptomes est observee 
dans 21 des cas. Des criteres 
objectifs de selection des patients 
candidats a une intervention 
chirurgicale n'ont pas encore ete 
definis. Les mecanismes physiopatho- 
logiques de cette entite sont etudies 
a travers une revue extensive de 
la litterature.
Epigastric pain and bilious vomiting 
are distressing symptoms frequently 
encountered after gastric surgery. 
Until recently, these symptoms were 
included in the postgastrectomy syn­
dromes and were frequently attributed
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to a chronic afferent loop obstruction 
syndrome. Two decades ago, a new 
entity, “ alkaline reflux gastritis” , was 
first noted.1,2 It has been further de­
fined recently.3,4 Although its physio­
pathology is not yet clearly under­
stood, treatment by operative methods 
has gained wide acceptance in the 
literature.
The purpose o f this report is to 
describe our experience with the sur­
gical management of this syndrome in 
23 patients over the past 6 years.
Patients and Methods
From 1974 to 1980, 23 patients (14 
men, 9 women) with the diagnosis o f 
alkaline reflux gastritis were admitted 
for operation. The mean age was 45.1 
years (range from 23 to 89 years). 
The diagnosis was based on symptoms 
and radiologic, endoscopic and histo­
logic findings.
The most frequent symptom was 
burning epigastric pain, unrelated to 
meals, that was found in 95.6% o f 
the patients (Table I). The mean 
weight loss was 10 kg. Roentgeno­
grams after barium ingestion appeared
Table I—Symptoms in 23 Patients 







normal in 15 o f 16 patients. Endo­
scopy demonstrated varying degrees 
o f gastritis in all patients. Bile reflux 
o f varying severity was also observed 
in all patients; in 16 it was severe 
with intense staining o f the gastric 
mucosa.
The histologic findings in the antral 
mucosa in primary reflux gastritis 
were characterized by edema, conges­
tion and a superficial inflammatory 
infiltrate (lymphoplasmacytic). In 
some there was a marked degree o f 
diffuse interstitial fibrosis without evi­
dence o f intestinal metaplasia or 
glandular atrophy.
In secondary reflux gastritis there 
was edema, congestion, nonspecific in­
flammatory infiltration o f the lamina 
propria with or without glandular 
atrophy and intestinal metaplasia but 
no interstitial fibrosis.
Eight o f the patients had an intact 
pylorus, but only three had not had 
previous gastrointestinal surgery. F if­
teen patients had secondary bile gas­
tritis, following various surgical pro­
cedures on the stomach (Table II). 
The delay between the first operation 
and the occurrence o f symptoms 
ranged from 1 month to 14 years. 
These patients had dumping syndrome 
and one had chronic pancreatitis. All 
patients had a trial o f  medical ther­
apy with various drugs, before opera­
tion. A  little relief o f  short duration 
was experienced in seven patients. In 
most the symptoms were unchanged 
and sometimes worsened by the med­
ical regimen. The results obtained 
with different medications are shown 
in Table III.
Table I I—Previous Operations
Primary gastritis Secondary gastritis
No.(n =  8) No. (n =  15)
Cholecystectomy 3 Parietal cell vagotomy 1
Cholecystectomy and transduodenal Vagotomy and antrectomy 7
sphincteroplasty of Oddi 2 Billroth 1 5
Billroth II 2
No previous operation 3
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At surgery, 22 of the 23 patients 
had a Roux-en-Y diversion and one 
patient had a previous gastrojejunos­
tomy taken down and then a vagot­
omy and pyloroplasty done. Additional 
procedures are listed in Table IV. 
There were no operative deaths. Two 
patients were lost to follow-up, while 
21 were examined regularly for a 
mean period of 25.4 months (range 
from 4 to 62 months).
Eighteen were completely asympto­
matic. One patient was relieved of 
pain and bilious vomiting, but still 
had the preoperative manifestations 
of a dumping syndrome and early 
satiety. This was attributed to a “small 
reservoir” following a previous sub­
total gastrectomy. Two patients were 
considered as failures, not because of 
persistence of the same symptoms, but 
because of emergence of new and dif­
ferent complaints (diarrhea, parietal 
pain) after the operation. Two pa­
tients died in the follow-up period.
In the months following the opera­
tion, three patients had stenosis at the 
anastomosis; this had to be corrected 
surgically. Five patients showed signs 
of mild gastric stasis and did not re­
quire another operation.
Discussion
Alkaline reflux gastritis is a recently 
described syndrome that was previous­
ly confused with the chronic afferent 
loop syndrome. It is attributed to the 
effect of the duodenal contents, pri­
marily the biliary acids, on the gastric 
mucosa.
The damaging effect of whole bile 
on gastric mucosa was first noted by 
Smith in 1914.5 Interest in this effect 
was initiated in 1965 by Toye and 
Williams® who demonstrated that bile 
alone did not produce gastric mucosal 
injury while diversion of duodenal 
contents to the stomach produced pro­
gressive atrophic gastritis. Byers and 
Jordan7 did not find any inflamma­
tory change in isolated gastric mucosa 
explanted into the gallbladder. Men- 
guy and Max8 and Delaney and co­
workers5 noted the presence of gas­
tritis when the gastric mucosa was 
bathed in bile and kept in continuity 
with the digestive tract. These changes 
were even greater when the mucosa 
was exposed to the whole intestinal 
content.9
Delaney and colleagues10 reported 
that jejunal contents produced inflam­
matory changes in the gastric mucosa, 
but the changes were mild when pure 
bile or pure pancreatic juice was used.
Subsequently, the effect of biliary 
acids on gastric mucosa was studied 
extensively by Silen and Ritchie and 
others.1118 The theory that a mucosal 
barrier may be damaged by the biliary 
acids or other components was pro­
posed. The mucosal damage causes a 
back-diffusion of H + ions into the 
mucosa and this induces the gastritic 
changes noted. The effect is more 
severe in the presence of H + ions 
and is maximum in the ischemic mu­
cosa. Acute hemorrhagic gastritis can 
develop in these circumstances.5'19’22
In spite of these extensive studies, 
the pathophysiology of reflux gas­
tritis is not clearly understood. Or­
ganic compounds other than bile, such 
as lysolecithin, have been incrimi­
nated,23 but the responsible offending 
agent has not been positively ident­
ified.
Clinically the syndrome has been 
described by Du Plessis,1,2 van Heer- 
den and colleagues,3 Bushkin and col­
leagues24 and Miranda and asso­
ciates;25 it was clearly distinguished 
from the chronic afferent loop syn­
drome. Its characteristics are con­
tinuous burning pain not relieved by 
antacids and aggravated by meals. 
Vomiting has little or no effect on 
the pain. Vomiting occurs unpredic- 
tably and is not as projectile as in 
the chronic afferent loop syndrome; 
often the vomitus contains residuals 
of previous meals.26 Some degree of 
malnutrition is present, but is not as 
severe as in the chronic afferent loop 
syndrome. No diagnostic test is pa­
thognomonic and the diagnosis re­
mains one of exclusion. However, in 
most cases, some degree of gastric 
flaccidity exists and analysis of gastric
secretion demonstrates basal hypO- 
chlorhydria and minimal response to 
stimulation. A microcytic hypochro­
mic anemia is usually present.
Endoscopic examination shows dif­
fuse erythematous and friable mu­
cosa that bleeds easily on contact. 
Areas of superficial erosions and 
atrophy are often present. Biliary re­
flux is always noted in the stomach 
and may be severe in some cases.
Biopsy specimens reveal a decrease 
in number of the chief and parietal 
cells, superficial erosions and atrophy 
of the mucosa and an inflammatory 
cell infiltration, predominantly of 
lymphocytes, in the gastric glands. 
Although this syndrome may be seen 
in those who do not undergo opera­
tion, it is usually encountered after a 
surgical procedure on the stomach, 
especially for duodenal ulcer. Its in­
cidence is unknown, although it may 
be as high as 20%.27,28 This does not 
coincide with the incidence of gas­
tritis alone, which is encountered in 
64% to 95% of cases29 after opera­
tion for duodenal ulcer. In a recent 
study of 205 patients, 10 to 22 years 
after gastric surgery, Malchow and 
associates30 found severe chronic gas­
tritis in 40 (32%) of 125 patients 
after a Billroth I gastrectomy and in 
28 (35%) of 80 patients after a Bill­
roth II gastrectomy. Moderate changes 
were seen in 23.2% and 26%, re­
spectively, in these two groups of 
patients. Loup and associates31 ob­
served two cases (0.9%) of reflux gas­
tritis in 248 patients following va­
gotomy and pyloroplasty.
Conservative management of this 
condition has been deceiving. Anta­
cids and antisecretory drugs have no 
effect on the symptoms. Cholestyra­
mine was tried extensively, but little 
benefit was obtained32 and it soon fell 
into disuse. The effect of total paren­
teral nutrition is incomplete and the 
symptoms recur with the resumption 
of oral alimentation.33
Table IV— Surgical Procedures Associated
with Roux-en-Y Diversion
Procedure No.










•For associated severe dumping.
Table III— Results of Medical Treatment
Treatment Improved Worsened Unchanged
Antacids 7 2 10
Cholestyramine 2 0 5
Metoclopramide 4 2 9
Cimetidine 4 2 7
Diet only 3 0 4
Sucralfate 0 2 0
Propantheline 0 0 1
338 VOLUME 25, NO. 3, MAY 1982 /  THE CANADIAN JOURNAL OF SURGERY
The reported results of surgical 
treatment have been conflicting. Some 
authors found that relief was incom­
plete.34,35 However, most reports claim 
dramatic and nearly complete success 
after diversion of duodenal contents. 
Many techniques have been proposed: 
Henley loop interposition,26 The Sou- 
pault operation,26 the Tanner 19 pro­
cedure26 and simple dismantling of gas­
troenterostomy. However, Roux-en- 
Y loop interposition of a 40- to 50-cm 
segment of intestine is the most fre­
quently used procedure and the one 
that uniformly gives the best results. 
The long-term success rate with this 
operation varies between 65% and 
100%.36-11 Our own results are simi­
lar; 90.5% of our patients became 
asymptomatic.
Finally, we were particularly sur­
prised to find severe stenosis of the 
gastrojejunal anastomosis in three pa­
tients after a Roux-en-Y procedure 
for alkaline reflux gastritis. These are 
the only instances of stenotic anas­
tomosis in almost 400 gastric opera­
tions. This is due to the severe inflam­
matory changes encountered in the 
mucosa and submucosa of the stom­
ach.
In conclusion, we have found that 
diversion of duodenal contents using 
a Roux-en-Y loop is a very satisfac­
tory method of treating alkaline reflux 
gastritis.
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BOOK REVIEW S
continued from page 327
A  substantial portion of the book is 
devoted to peptic ulcer disease. There 
is an excellent discussion on the natural 
history of bleeding peptic ulcers. The 
value of gastric lavage, antacids and 
cimetidine in the management of bleed­
ing ulcers may be over emphasized. 
Surgical therapy is well discussed. The 
chapter on the pathophysiology of erosive 
gastritis and stress ulceration is infor­
mative. There is mention of therapeu­
tic endoscopy, and the principles in­
volved in laser therapy and photocoa­
gulation are well summarized. The 
chapter on therapeutic angiography is 
excellently illustrated. Portal hyperten­
sion and bleeding varices are discussed 
in detail, but the chapter on the use of 
sclerotherapy is, on account of the 
timing of this publication, not an up-to- 
date “state of the art” review. “Miscel­
laneous” causes of gastrointestinal bleed­
ing are covered in the concluding por­
tion.
This book would be an extremely 
valuable addition to any medical library.




SURGERY OF THE AORTA AND ITS 
BODY BRANCHES. Edited by John 
N. Bergan and James S.T. Yao. 632 
pp. IUust. Grune & Stratton, Inc., 
New York; Academic Press Canada 
Limited, Don Mills, 1979. $56.25. 
ISBN 0-8089-1240-2.
This volume represents the papers pre­
sented at a symposium on surgery of 
the aorta. The editors, well-known vas­
cular surgeons from Northwestern Uni­
versity Medical School in Chicago, have 
organized the book well. Although there 
are some areas of overlap because of 
multiple authorship, the text is readable 
and presents the information in an or­
derly and informative fashion.
continued on page 345
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STEMETIL®Bon Mot
J.L. Shugar, MD, FRCSfc]
The pressures of common usage 
shape and change the quality of words. 
Sometimes the changes are permanent. 
New words are born, and eventually 
their origins are forgotten or are not 
apparent. Who knows whether “gold 
bladder” or “very close veins” will 
eventually stick. Does what seems to 
be merely mispronunciation contain 
a kernel of truth, as in “minipause” — 
let it last just a short time, please — 
or does the dropping of a syllable 
really hide a forlorn hope of finding 
an “anti-inflation pill”? A group of 
patients can be “separated by sex” for 
purposes of analysis but what if the 
author of that study has them “sep­
arated for  sex”? Can investigators 
carry out “an evaluation of several 
regiments of breast cancer”? Saved 
just in time, the March issue of this 
journal almost had an article on “open 
hearth surgery” —  a cosy topic. How 
can you contradict your patient when 
she says that when she bends over, 
everything “goes out of kilt”? Perhaps 
it does. An elderly gentleman, who is
worried about atheromatous arteries, 
asks to have his “serum castor oil” 
level checked. Can you deny him? 
Watch for changes in “Gray’s. Ana­
tomy”, which will describe a new ana­
tomical entity — “the elbone” and the 
“appendic” for when only one is 
meant. In the future, broken bones 
will be fixed with “scrools”. The hurt 
will be described by a colourful word 
— “paint”. But watch out for pathol­
ogy reports that say, according to an 
O.R. nurse, “Dr. Armour, your pants 
are pressed.” That’s enough to give 
you a “migrant” headache.
Can you help me, especially you 
over-60 types, clear up a mystery? 
What is a wartime clamp?
My thanks to my mother, my pa­
tients, David Woods, Peter Morgan, 
Gillian Pancirov and Ph. d’Entremont 
for their contributions.
“Bon Mot’’ will appear in the Journal 
from time to time as material becomes 
available. We earnestly solicit your con­
tributions.
(prochlorperazine)
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monograph.
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norepinephrine may be given (not epine­
phrine as it may further depress the blood 
pressure).
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spoonful (5 ml); suppositories 5 and 10 mg. 
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The possibility that this patient has a testicular tumor must be ruled 
out. Baseline studies of chest roentgenograms, an intravenous pyelogram, 
and levels of human chorionic gonadotropin (HCG) and a-fetoprotein 
should be obtained. If the presence of a tumour is suspected, an inguinal 
incision with orchiectomy should be done. Treatment with antibiotics is 
not indicated unless pain and pyuria point to epididymitis. Needle biopsy 
and scrotal incision are contraindicated because of the risk of local 
dissemination of the tumour, which changes the route of metastases to 
include the inguinal lymph nodes. The spermatic cord should be occluded 
with a noncrushing clamp while the testis is being examined. If a tumor 
is suspected on visualization and palpation, the orchiectomy should be 
performed, but not a biopsy.
0
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centres, raising threshold for impulses1,2
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• calms activity of vomiting reflex emanating 
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sphincter (LOS) tone without affecting 
oesophageal pressure, reducing tendency to 
regurgitation*
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Maquet Osteotomy for Chondromalacia Patellae:
Avoiding the Pitfalls
A. H adjipavlou , md, m  sc , frcs[c], FACS, H. H elm y , m d , frcs[c ], P. D ubravcik, md , frcs[c], 
L. H e l ler , m d , frcs[c], facs and M. K ern er , m d , frcs[c]
The authors' modification of the 
classic Maquet procedure of anterior 
displacement of the tibial tubercle 
allows effective decompression of 
the patellofemoral joint. Strict 
adherence to the modified technique 
has prevented all major complications. 
Forty-four patients underwent this 
procedure. They were divided into a 
retrospective group of 20 and a 
prospective group of 24. Nine patients 
in the prospective group had the 
modified Maquet procedure following 
a failed Hauser operation. All had an 
excellent result due to decrease 
in the patellofemoral compression 
force. The modified Maquet procedure 
was also valuable in those who had 
an extensor lag following patellectomy 
(two patients), failed proximal 
realignment (three patients) and 
failed patellar shaving procedures 
(three patients).
Les modifications apportees par les 
auteurs a I’operation classique de 
Maquet par deplacement anterieur du 
tubercule du tibia, permettent une 
decompression efficace de I'articulation 
femoro-patellaire. En s'en tenant de 
fapon stricte a cette technique 
modifiee, on a pu prevenir toutes les 
complications majeures. Quarante- 
quatre patients ont subi cette 
intervention. Ils ont ete divises en 
groupe retrospectif de 20 sujets et 
en groupe prospectif de 24. Neuf 
patients du groupe prospectif ont eu 
I'operation modifiee de Maquet suite 
a un echec de I’operation de Hauser. 
Tous ont beneficie d'excellents 
resultats grace a la diminution de la 
force de compression de I’articulation 
femoro-patellaire. L'operation modifiee 
de Maquet s'est aussi revelee utile 
chez les sujets presentant un
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retard d'extension a la suite d’une 
patellectomie (deux patients), dans 
les cas d'echec d’un realignement 
proximal (trois patients), et lors de 
I’echec d’une operation de planage 
de la rotule (trois patients).
The treatment of patellar chondroma­
lacia is one of the most controversial 
issues in orthopedic surgery. The term 
patellar chondromalacia implies dam­
age to the articular cartilage resulting 
in softening, Assuring or fragmenta­
tion. The knee may be asymptomatic 
or transiently symptomatic with crepi­
tus and pain over its anterior aspect.1-4 
When the symptoms become clinically 
important or debilitating, conservative 
management should be used before 
surgical intervention.
Many surgical procedures have been 
considered for correcting each of the 
underlying causes of degeneration of 
the patellofemoral joint. These include 
the realignment procedures (prox­
imal5,6 and distal7'9). Soft tissue lining 
for patellar arthroplasty10 and excision 
of the damaged articular cartilage 
(shaving, chondrectomy,7,11-14 hemi- 
patellectomy [Sullivan J: personal
communication] or patellectomy11,15'17) 
have also been tried. More advanced 
cases of joint degeneration have also 
been treated by total replacement of 
the patella by a prosthesis.18,19
Patellectomy may reduce pain at 
the patellofemoral joint, but retention 
of the patella is functionally superior 
as it enhances the power and function 
of the quadriceps mechanism.20 Never­
theless, there are occasions when pa­
tellectomy is necessary because of per­
sistant pain. Maquet21 and Bandi22 
have described displacement of the 
tibial tubercle anteriorly to allow de­
compression of the patellofemoral 
joint, an attractive concept in view of 
the poor results of other procedures.
Patients
We used the Maquet21 procedure in 
44 patients between January 1976 and 
February 1981. The patients ranged 
in age from 18 to 60 years (mean 27.1 
years). There were 20 men and 24 
women divided into two groups. In 
group 1 we carried out a retrospec­
tive study of 20 consecutive pa­
tients (11 men, 9 women). Follow-up 
ranged from 27 to 54 months (mean 
35.3 months). Group 2 comprised 
24 patients (9 men and 15 wom­
en) studied prospectively. Follow-up 
ranged from 6 to 26 months (mean 
18.8 months).
The diagnosis of chondromalacia 
was made by means of arthrotomy or 
arthroscopic examination. The chon- 
dromalacic lesion in our series was 
grade 3 or 4 according to the Outer- 
bridge classification.23
Indications for Operation
The Maquet procedure was indi­
cated for the following problems: (a) 
chondromalacia due to chronic mal­
alignment (25 patients), (b) severe 
chondromalacia of the patella second­
ary to trauma (12 patients), (c) osteo­
arthritis of the patellofemoral joint 
(5 patients) and (d) extensor lag fol­
lowing patellectomy (2 patients).
Of the 25 patients with malalign­
ment, 13 knees had failed to respond 
to conservative therapy and 12 knees 
to previous surgical realignment pro­
cedures (three proximal and nine dis­
tal Hauser realignments). Of the 12 
patients with patellar chondromalacia 
due to patellar trauma, conservative 
therapy in 8 had failed, and in the 
other 4, previous surgical procedures 
(shaving in 3 patients, hemipatellec- 
tomy in 1) had failed.
Results
Criteria used to determine the re­
sults of the procedure included: (a) 
the degree of pain at the patello­
femoral joint, (b) the range of motion 
of the knee and (c) the functional 
capacity of the knee with respect to 
the activities of daily living (walking 
stairs, running, sitting and kneeling).
Four groups emerged: no improve­
ment, improvement, marked improve­
ment and asymptomatic knee.
Patients with improved knees could 
walk longer distances without pain 
than before operation. The range of 
motion was normal with mild pain on 
walking up and down stairs or when 
kneeling. There was increased pain 
only when running.













In patients rated as markedly im­
proved, there was only occasional 
pain and no disability when walking 
and only infrequent mild pain after 
long periods of fast walking, climbing 
or descending stairs or running.
Asymptomatic patients had no pain 
and could walk up and down stairs, 
kneel and run and had a normal range 
of motion of the knee.
Table I sets forth the results in the 
two groups of patients. Patients with 
extensor lag were markedly improved. 
There were no cases of infection or 
peroneal nerve palsy in the prospective 
group.
Complications (Table II)
The complications were attributed 
to certain predictable difficulties and 
compromised the overall results in 
our retrospective group of patients. 
Most of these complications arose 
within the first 2 months after opera­
tion. Of the three patients with nerve 
palsy, two had completely recovered 
at 6 months after operation and one 
had partially recovered but had resid­
ual causalgia. In one case of fracture 
of the distal end of the osteotomized 
bone, there was penetration of the 
skin and osteomyelitis, which was 
finally cured by sequestrectomy. Of 
two other cases of osteomyelitis with 
skin necrosis, one was cured, but in 
the other the site was still draining at 
the time of follow-up 32 months after 
operation.
T a b le  1 - -R e s u lts
G ro u p , no.
1 2
G ra d in g (n  =  2 0 ) (n  =  24)
N o  im p ro v e m e n t 4 0
Im p ro v e m e n t 6 1
M a rk e d  im p ro v e m e n t 5 10
A s y m p to m a tic 5 13
T a b le  I I — C o m p lic a tio n s
C o m p lic a tio n
G ro u p , no. 
1 2
F ra c tu re  a t  d is ta l e n d  o f
e le v a te d  to n g u e  o f bone 5 0
F ra c tu re  a t  u n s u p p o rte d  
p ro x im a l en d  o f e le v a te d
to n g u e  o f bone 1 0
S kin  n e c ro s is  w ith  o s te o m y e lit is 3 0
N e u ro m a  o f in f r a p a te l la r  n e rv e 2 0
C om m on p e ro n e a l n e rv e  pa lsy 3 0
P a in  a t  o s te o to m y  s ite 5 2
L a te ra l p a te l la r  t i l t 0 1
H e m ia rth ro s is 1 0
Although our technique closely re­
sembles that of Maquet and Bandi, 
strict adherence to certain minute de­
tails previously ignored reduced con­
siderably the number of complications 
and improved the results in the sub­
sequent 24 patients of the prospective 
group.
Operative Technique in Prospective 
Group
Tibial Osteotomy
The plane of the tibial osteotomy 
is critical. At the proximal end the 
osteotomy is in the coronal plane. At 
about 6 cm distal to the tibial tubercle 
the osteotomy changes its plane and 
becomes parallel to the anteromedial 
surface of the tibia (Fig. 1); it is flat 
and pliable. The original osteotomy 
resulted in a triangular cross-section 
of bone at its distal segment and 
therefore allowed a fracture to occur 
more readily (Fig. 2). The shape of 
the tongue of bone is flat and rec­
tangular measuring approximately 
10 X 1.5 X 0.5 cm (Fig. 3).
Bone Graft
The bone graft that supports the 
anteriorly displaced tibial tubercle 
(Fig. 3) is obtained from the bone 
bank or the patient’s iliac crest (Figs. 
4 and 5). It is important that the two 
longer surfaces of the bone graft be 
parallel to the two surfaces of the 
tibial osteotomy within which the 
graft is to be wedged. The shape of 
the graft, when viewed from the later-
FIG. 1—Plane of osteotomy of tibia. 
(A) Correct plane of osteotomy with 
large flat surface to prevent fracture of 
elevated tongue of bone. (B) Flat cut is 
more pliable than triangular cut.
al side, has the appearance of a trunc­
ated right triangle. The proximal end 
or short side is 1.5 cm to 2 cm thick 
and tapers distally to 0.8 cm to 1 cm. 
The longer side measures 5 cm to 
6 cm lying flat against the osteotom­
ized surface of the tibial diaphysis. 
The hypotenuse lies flat under the 
raised tongue of bone; the distal gap 
is packed with cancellous bone. We 
have maintained the anterior eleva­
tion of 1.5 cm to 2 cm since we be­
lieve, as shown by Burke (personal 
communication, 1979) that decom­
pression of the patellofemoral joint 
occurs effectively with this amount 
of displacement.
Incision
Two incisions are used (Fig. 6). 
One is a long incision over the ante­
romedial surface of the tibia, extend­
ing from the level of the tibial tu­
bercle to the middle third of the leg. 
This allows the tibial tubercle to be
FIG. 2—Plane of osteotomy of tibia.
(A) Incorrect triangular configuration.
(B) Triangular tongue of bone has no 
elastic properties.
F'lG. 3— Lateral view of osteotomized 
and anteriorly displaced tibial tubercle 
(a) before, (b) after.
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elevated. A large medial skin flap is 
created by dissecting the deep sub­
areolar space and the tibial crest is 
not denuded from the overlying soft 
tissues. A second lateral parapatellar 
incision, 5 cm long, is made for ex­
ploration of the knee joint; this allows 
good visualization of the joint and 
bypasses the infrapatellar branch of 
the saphenous nerve, thus avoiding 
damage that could result in formation 
of a neuroma. The lateral retinaculum 
is released under direct vision and the 
genicular artery is ligated. Through 
a lateral incision, the fascia of the 
anterior compartment can be released 
with a straight Smillie meniscectomy 
knife. Care must be taken not to 
denude the tibial crest.
Discussion
By strict attention to details, the re­
sults in our series of patients were 
markedly improved in those studied 
prospectively, by preventing trouble­
some technical complications.
•  Skin necrosis can be eliminated 
by using a long anteromedial inci­
sion of the subcutaneous tibial sur­
face. This contributed to better skin
FIG. 4— Bone graft. (A) Graft for 
proximal osteotomy area. (B) Cancellous 
bone for distal portion of osteotomy site.
FIG. 5— Bone graft wedged into os­
teotomy site.
closure without tension after the tibial 
tubercle was elevated, even to the 
extent of 2.5 cm.
•  Two patients in our retrospec­
tive series had a troublesome neuro­
ma of the infrapatellar branch of the 
saphenous nerve. The infrapatellar 
nerve crosses the medial aspect of the 
knee joint only slightly distal to the 
medial joint line. Damage to this nerve 
may be avoided by using a lateral 
parapatellar incision for the knee ex­
ploration and by beginning the long 
anteromedial skin incision at the level 
of the tibial tubercle.
•  Through the lateral parapatellar 
incision, the lateral retinaculum of the 
knee joint can be released, thereby 
preventing the tethering effect of the 
knee joint capsule on the patella 
(Fig. 7).
•  Postoperative hematoma and 
hemiarthrosis may be averted by tour­
niquet release before closing the 
wound and by ligating the lateral in­
ferior genicular artery if severed. He- 
movac drainage is used.
•  The three instances of peroneal 
nerve palsy in the retrospective group 
were attributed to excessive traction 
on, and displacement of, the anterior 
fascia of the leg caused by the ante­
rior displacement of the tibial tubercle 
(Fig. 8). In one case, the common
FIG. 6—Incisions. Dotted line shows 
site of lateral retinaculum release 
through lateral parapatellar incision.
peroneal nerve was found to be dis­
placed anteriorly and angulated when 
explored. One can prevent this com­
plication by releasing the lateral 
fascia; this may also prevent anterior 
compartment syndrome.14 Fig. 9 shows 
the path of the common peroneal 
nerve. The proximal cut shows the 
nerve at the posterolateral surface of 
the head of the fibula between fascia 
and bone. The middle cut shows the 
nerve anterior to the neck of the fib­
ula and the distal cut shows the nerve 
remaining anterior to the proximal 
shaft of the fibula. In the middle and 
distal cuts the nerve is not lying be­
tween fascia and bone.
The suggested shape of the bone 
graft and osteotomy of the tibia allow 
a good total contact, a snug fit and 
no pivoting of the graft when it is 
wedged between the anteriorly dis­
placed tongue and the remaining tibia. 
No transfixion screw is necessary. The 
graft should extend to the bony at­
tachment of the patellar tendon in 
order to support the tongue fully and
FIG. 7—Release of lateral retinacu­
lum prevents patellar tilt.
FIG. 8—Anterior displacement of ti­
bial tubercle exerts excessive tension on 
fascia (A) resulting in traction or com­
pression of peroneal nerve against fibula 
(B), or both.
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SO prevent it breaking when it receives 
a direct blow from a fall. In the pros­
pective study, lateral tilt of the patel­
la occurred in one case because the 
lateral release was not done at the 
time of the original Maquet proce­
dure. This was carried out later and 
corrected. Although follow-up in some 
cases in our retrospective group was 
only 6 months, even this short fol­
low-up demonstrated that there are 
difficulties that can be prevented. The 
complications in this group arose 
within 1 to 2 months after operation 
and the outcome of the procedure 
was directly related to these compli­
cations.
In the retrospective group, the use 
of banked bone eliminated the need 
for an iliac incision; there was ex­
cellent incorporation of the graft. 
All cases of distal and proximal re­
alignment fell within the markedly 
improved or asymptomatic group and 
the shaving or hemipatellectomy cases 
within the improved group.
The Maquet osteotomy is indicated 
for patients with patellofemoral ar­
thritis, chondromalacia of the patella 
secondary to direct patellar trauma 
and failed surgical intervention. We 
also use it for severe patellar chon­
dromalacia with only a mild malalign­
ment that does not require tibial tu­
bercle transplantation to correct the Q 
angle.
FIG. 9—Common peroneal nerve (ar­rows) at head of fibula (proximal cut), at neck of fibula (middle cut) and at shaft of fibula (distal cut).
We thank Mr. David Saxe, depart­ment of photography, Jewish General Hospital and Miss Christine Lalonde, Lady Davis Institute, for their work on the illustrations and Carmela Iuculano and Barbara Dubravcik for preparing the manuscript.
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continued from page 339
This book is divided into six sections. The first section deals with evaluation and investigation of patients being con­sidered for aortic surgery. It includes a discussion on physiologic changes that occur during aortic cross-clamping.The second section deals with prin­ciples of surgery of the thoracic and abdominal aorta, including some special chapters on the types of bypass sys­tems used during thoracic aortic cross­clamping, “the small aorta syndrome” and the problem of colonic ischemia following surgery on the abdominal aorta. There is excellent discussion on the abdominal aortic aneurysm, from the standpoint of elective and emergency surgery of ruptured aneurysms.Aortoiliac occlusive disease forms the basis for the third section, which in­cludes a discussion on importance, extra- anatomic bypasses and management of aortocaval problems.There follow sections on renal vas­cular hypertension and mesenteric ischemia, and discussions of the roles of percutaneous and iliac occlusive 
disease.The last section deals with special problems in aortic surgery and con­siders such topics as splanchnic artery aneurysms, surgery for infected aortic grafts, spinal cord ischemia after aortic surgery and aortoenteric fistulas.This book provides an exhaustive out­line of the aorta and its surgical prob­lems. One would have hoped that some of these areas would have been dealt with in greater detail, but overall, this book serves as a good guide to current thoughts in the management of aortic diseases and will be of value to students of aortic disease, be they housestaff or 
vascular surgeons.
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Solu-Medrol, like other corticosteroids, exerts its action 
by its anti-inflammatory effect.
Indications and Clinical Uses:
Intravenous administration of Solu-Medrol is indicated 
in situations in which a rapid and intense hormonal 
effect is required.
Shock:
In severe shock adjunctive use of intravenous methyl­
prednisolone sodium succinate (Solu-Medrol) may aid 
in achieving hemodynamic restoration. Corticoid 
therapy should not replace standard methods of 
combating shock, but present evidence indicates that 
concurrent use of large doses of corticoids with other 
measures may improve survival rates. In particular, 
large pharmacological doses of Solu-Medrol have been 
proven useful in bacteremic or endotoxin shock, 
hemorrhagic shock, traumatic shock, and cardiogenic 
shock.
Contraindications:
Except when used for short-term or emergency therapy 
as in acute sensitivity reactions, Solu-Medrol is 
contraindicated in patients with arrested tuberculosis, 
herpes simplex keratitis, acute psychoses, Cushing’s 
syndrome, peptic ulcer, vaccinia and varicella.
Precautions:
Existence of diabetes, osteoporosis, chronic psychoses, 
active tuberculosis, renal insufficiency or predisposition 
to thrombophlebitis requires that Solu-Medrol be 
administered with extreme caution. In the presence of 
infection, the causative organism must be brought 
under control with appropriate anti-bacterials, or 
therapy with Solu-Medrol should be discontinued. 
While therapy with corticoids does not appear to be 
contraindicated in pregnancy, caution is recommended, 
particularly during the first trimester. Also, newborn 
infants of mothers who received such therapy during 
pregnancy should be observed for signs of hypo- 
adrenalism and appropriate measures instituted if such 
signs are present. Since Medrol, like prednisolone, sup­
presses endogenous adrenocortical activity, it is highly 
important that the patient receiving Solu-Medrol be 
under careful observation, not only during the course 
of treatment but for some time after treatment is 
terminated. Adequate adrenocortical supportive 
therapy including ACTH, must be employed promptly 
if the patient is subjected to any unusual stress such as 
surgery, trauma, or severe infection. Patients should be 
advised to inform subsequent physicians of the prior 
use of Solu-Medrol.
There have been a few reports of cardiovascular 
collapse associated with the rapid intravenous admini­
stration of large doses of Solu-Medrol (greater than
0.5 grams) in organ transplant recipients. The cause 
and relation to other medications (i.e., diuretics) is not 
known at this time, but physicians should be alert to 
this possibility.
Adverse Reactions:
Adverse reactions are not likely to result from short­
term intravenous administration of Solu-Medrol, but 
may be anticipated if continued therapy with oral or 
intra-muscular corticosteroid preparations is to follow. 
Medrol has less tendency than prednisolone to induce 
retention of sodium and water, and in some cases has 
been observed to produce diuresis and an increased 
excretion of sodium. Likewise, therapy with Medrol 
appears to produce less nervousness and psychic 
stimulation than that produced by prednisolone. While 
epigastric distress has not been totally lacking in 
patients receiving Medrol, the incidence and severity of 
this side reaction to date suggest that although Medrol 
has an enhanced anti-inflammatory potency when com­
pared with prednisolone on a weight basis, the so- 
called ulcerogenic potential of this corticosteroid is no 
greater, and may even be less, than that of 
prednisolone.
With the exception of the differences noted in the 
preceding paragraph, Medrol is similar to hydro­
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cortisone and prednisolone in regard to the kinds of 
adverse reactions and metabolic alterations to be 
anticipated when treatment is intensive or prolonged. 
Negative nitrogen balance is usually counteracted by a 
high protein intake. In patients with diabetes mellitus, 
Solu-Medrol may increase insulin requirements during 
the period of administration. Ecchymotic manifesta­
tions, while noted only rarely during the clinical 
evaluation of Medrol, may occur. Excessive loss of 
potassium is not likely to be induced by effective 
maintenance doses of Medrol. If such reactions are 
serious or distressing to the patient, reduction in 
dosage or discontinuance of corticoid therapy may be 
indicated. While a retardant effect on wound healing is 
seldom encountered, except in high doses, it should be 
a matter of consideration when Solu-Medrol is admin­
istered in conjunction with surgery.
Symptoms and Treatment of Overdosage:
Single large doses of Solu-Medrol do not have any 
apparent toxic effect and require no specific therapy. 
Continuous overdosage would require careful gradual 
reduction of dosage in order to prevent the occurrence 
of acute adrenal insufficiency.
Dosage and Administration:
In treating severe shock there is a tendency in current 
medical practice to use massive (pharmacological) 
doses of corticosteroids. The following are Solu-Medrol 
doses suggested by various authors:
Author Dose Repeat
Oaks 100 mg Every 2-6 hours
Weil 200 mg 100 mg. every 4-6 hours
Melby 250 mg Every 4-6 hours
Cavanagh 15 mg/kg Every 24 hours
Dietzman 30 mg/kg In 4 hours if needed
Therapy is initiated by administering Solu-Medrol 
intravenously over a period of at least 10 minutes. In 
general high dose corticosteroid therapy should be 
continued only until the patient’s condition has 
stabilized; usually not beyond 48 to 72 hours.
Although adverse effects associated with high dose 
short term corticoid therapy are uncommon, peptic 
ulceration may occur.
In other indications initial dosage will vary from 10 to 
500 mg depending on the clinical problem being 
treated. The larger doses may be required for short­
term management of severe, acute conditions. The 
initial dose usually should be given intravenously over 
a period of at least 10 minutes. Subsequent doses may 
be given intravenously or intramuscularly at intervals 
dictated by the patient’s response and clinical 
condition.
Availability:
As Solu-Medrol (methylprednisolone sodium succinate) 
in 40 mg and 125 mg Mix-O-Vial; 500 mg and 1 g vials 
with water for injection.
Product monograph is available on request.
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Surgery for Morbid Obesity
To the editors.— The “editorial” of Free­
man and Burchett on page 247 of this 
issue requires comment. It does not ac­
tually tell “where we are going” in the 
surgery for morbid obesity. Indeed our 
follow-up is comprehensive, with charts 
of patients who undergo jejunoileal by­
pass and gastric partitioning each having 
separate drawers in our filing-cabinets, 
and summarized in loose-leaf books. Pre- 
operatively we explain to the patient that 
lifelong medical surveillance is manda­
tory. If patients do not keep appoint­
ments, a letter is sent, followed by a 
telephone call; some of the patients who 
had to be thus retrieved had the best 
results.
One patient who had a jejunoileal by­
pass has moved and is now under the 
care of another surgeon well known in 
this field. One underwent reversal else­
where as stated in our paper and the 
remaining 62 (not 61) jejunoileal bypass 
patients are well and being followed up 
by us. One patient who had gastric parti­
tioning will not return for follow-up, 
and we are only aware of her state 
through her friends who have undergone 
the procedure.
Our graphs are intended as a simple 
means of displaying the data: weight loss 
is shown on the left, mean percent loss 
in body weight on the right, with the im­
portant standard deviation from the mean 
and number of patients at each point of 
follow-up being included. The follow-up 
(in months), to the time the manuscript 
was submitted, is shown on the bottom 
of the graphs, and is obviously not long 
term in the gastric partitioning group. In 
the jejunoileal bypass groups, with the 
measurements and technique outlined in 
the paper, more than 80% of patients 
maintain a weight loss greater than 25% 
of body weight, but 100% have weight 
loss of more than 15% of body weight.
Surgeons who have never performed 
jejunoileal bypass tend to decry this 
procedure, and we have emphasized its 
hazards, but Payne of Los Angeles with 
more than 20 years’ experience,1 Gourlay 
of Vancouver with 535 intestinal bypass 
patients over 9 years,1 and Buchwald2 
after operating on 800 patients have all 
found this to be an acceptable procedure. 
Because the post-bypass course demands 
the surgeon’s availability, many have 
switched to gastric procedures. Serious 
liver problems have been rare in non­
alcoholics. One of us (M.A.), together 
with the two pathologists acknowledged 
at the end of our paper, has continued 
to follow-up the condition of the livers 
in these patients and this is the topic of 
another paper. We have found the de­
crease in stool frequency to agree with 
that noted by MacLean in his review;3 
diarrhea is rare in our patients after 18
continued on page 351
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Fate of Omental Graft after Revascularization
of the Heart
T om as A. Sa l e r n o , m d , f r c s [c ],* R.O. W e s t , MD,f R. B e v e r l y  L y n n , m d , f c c p , f r c s , f r c s ( e d in ) ,
FRCS[C], FACS* AND EDWARD J.P. CHARRETTE, MD, FCCP, FACS, FACA, FRCS[C]*
Three patients who had had 
epicardiectomy, and internal mammary 
artery and omental grafts implanted 
as part of myocardial revascularization, 
recently underwent a second 
operation for coronary artery bypass 
grafting. All internal mammary 
artery implants were patent and 
appeared to revascularize the myo­
cardium distal to the occluded 
segment of the coronary artery, as 
determined by angiography. Although 
adhesions were present at operation, 
there was no evidence of the free 
omental graft in two patients. The 
pedicled omental graft was present 
and viable in the remaining patient, 
but did not appear to have vascular 
communication with the epicardiec- 
tomized myocardium.
Trois patients qui avaient eu une 
epicardiectomie, avec une greffe 
d'artere thoracique interne et greffe 
epiploi'que comme moyen de revascu­
larisation du myocarde, ont du subir 
recemment une seconde operation, 
soit un pontage aorto-coronarien. Les 
greffes d'arteres thoraciques 
internes etaient toutes permeables 
et paraissaient, a i'angiographie, avoir 
revascularise la partie du myocarde 
distale au segment oblitere de I’artere 
coronaire. Bien que des adherences 
aient ete visibles a I’operation, chez 
deux patients il n'y avait aucun indice 
de permeabilite des greffes epiploiques. 
Chez le troisieme patient le pedicule 
de la greffe epiploi'que etait present 
et viable, mais ne semblait pas avoir 
de communication vasculaire avec le 
myocarde epicardiectomise.
The objective of this paper is to re­
port the findings at reoperation of 
the fate of the omental graft
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placed in patients who had had in­
ternal mammary artery implantation, 
epicardiectomy and omental grafting 
and who underwent coronary artery 




A 60-year-old man had undergone 
left internal mammary artery implanta­
tion, epicardiectomy and free omental 
grafting 8 years before admission. He 
presented with incapacitating angina. 
Coronary angiography revealed severe 
triple-vessel coronary artery disease and 
a patent internal mammary artery im­
plant without the formation of colla­
teral vessels via the free omental graft 
(Fig. 1). At operation, adhesions were 
found between the pericardium and the 
epicardium without visual and micro­
scopic evidence of the presence of the 
omental graft. Triple-vessel coronary 
artery bypass grafting was performed; 
recovery was smooth.
Case 2
A 64-year-old man had had right and 
left internal mammary artery implants, 
epicardiectomy and free omental graft­
ing 9 Vi years previously. On admis­
sion he was suffering from unstable 
angina. Cardiac catheterization re­
vealed triple-vessel coronary artery dis­
ease. Both internal mammary artery im­
plants were patent but there was no 
evidence of collateral circulation through 
the free omental graft (Fig. 2). The
FIG. 1—Case 1. Coronary angio­
gram gives no evidence of collateral 
circulation between heart and omental 
grafts.
operative findings were similar to those 
in case 1.
Case 3
Ten years before admission, a 63- 
year-old farmer had undergone left in­
ternal mammary artery implantation, 
epicardiectomy and pedicled omental 
grafting. He presented with angina re­
fractory to medical therapy. Coronary 
angiographic examination revealed triple- 
vessel coronary artery disease and a 
patent internal mammary artery implant. 
There was no evidence of collateral 
circulation by way of the omental graft 
(Fig. 3). At operation, the pedicled 
omental graft was found to be viable. 
It occupied a large space in the postero­
lateral and inferior pericardial sac. The 
graft was easily peeled away from the 
epicardium. Through-and-through left 
ventricular myocardial biopsy was per­
formed in an area where the omental
FIG. 2— Case 2. Coronary angiogram 
shows no evidence of collateral circula­
tion between heart and omental grafts.
FIG. 3—Case 3. Coronary angiogram 
gives no evidence of collateral circula­
tion between heart and omental grafts.
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graft was intact and appeared to com­
municate with the epicardium. Micro­
scopic examination revealed no evidence 
of increased collateral circulation or 
communication with the omental graft. 
After triple-vessel coronary artery by­
pass grafting the patient made an uncom­
plicated recovery.
Discussion
O’Shaugnessy1 in 1936 first used 
the greater omentum attached to its 
abdominal blood supply to revascu­
larize the ischemic myocardium. This 
was followed by extensive work by 
Vineberg and associates2-4 on the free 
omental graft as an adjunct to myo­
cardial revascularization with the in­
ternal mammary artery implant. Using 
the dog as the model, Vineberg and 
his coworkers5’6 demonstrated that in
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the ameroid constricted coronary ar­
tery, collaterals developed between 
the ischemic epicardiectomized heart, 
the free omental graft and the sur­
rounding tissues. Free omental strips 
were successfully implanted into the 
walls of both ventricles in animals.' 
Vineberg and associates,5 in an adden­
dum to their manuscript, reported 
that the implanted omentum would 
fill with dye when either coronary 
artery was injected in a patient who 
died 18 months after operation.
For whatever reasons, coronary ar­
tery bypass grafting has recently 
gained popularity in the treatment of 
ischemic heart disease, whereas the 
free and pedicled omental grafting, 
epicardiectomy and the internal mam­
mary artery implantation are infre­
quently used. Yet several clinical 
reports8'10 attest to the efficacy of in­
ternal mammary artery implantation 
in revascularizing the human heart. 
Similarly, epicardiectomy and free 
omental grafting have been shown to 
increase collateral flow in the ischemic 
hearts of dogs; collateral channels and 
viable omental grafts have been dem­
onstrated at 6 months after opera­
tion."
Little is known about the fate of 
the omental graft in the human heart, 
the degree of vascularity created by 
epicardiectomy and omental grafting, 
and the technical difficulties that 
might be encountered if coronary ar­
tery bypass grafting is contemplated 
in such patients. The omentum was 
not apparent in both patients who had 
received a free omental graft, as de­
termined by lack of collateral flow 
at angiography, lack of bleeding dur­
ing operation and by light microscopy 
of the myocardial biopsy specimen. 
The pedicled omental graft, on the 
other hand, was found to be present 
and viable at time of operation, oc­
cupying a large space in the opened 
pericardium. It was peeled away from 
the epicardium without difficulty and 
the myocardial biopsy specimen did 
not show invasion of the epicardium 
by omental vessels, nor was there 
evidence of increased vascularity. By 
light microscopic examination the 
epicardial layer of these three hearts 
could not be distinguished from an­
other heart that did not have epicar­
diectomy or omental grafting. In all 
three patients the internal mammary 
artery implants were carefully pre­
served.12 The bypass surgery was per­
formed without technical difficulties.
One should be cautious in drawing 
conclusions based on three patients, 
when animal work would appear to
support the concept of omental graft­
ing in addition to internal mammary 
artery implantation and epicardiec­
tomy. The difference between our 
patients and the animal model could 
be due to species differences or tech­
niques of surgery, or both. That these 
patients had internal mammary ar­
tery implantation, epicardiectomy and 
omental grafting did not preclude 
subsequent coronary artery bypass 
grafting. The technical aspects of the 
procedure did not differ from routine 
bypass grafting reoperations, except 
that the internal mammary artery had 
to be snared during cardioplegic 
arrest12 in order to prevent noncoro­
nary collateral flow from washing off 
the cardioplegic solution. Also, the in­
ternal mammary artery is a valuable 
source of blood in these ischemic 
hearts and care must be taken to 
preserve it.
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continued from page 348
months; then it occurs only after exces­
sively greasy meals. Freeman and Bur­
chett do not give the reference for diar­
rhea persisting after 1 year in 20% and 
being the main cause for reversal. They 
give no references for any of their state­
ments.
For gastric partitioning we did not use 
the technique of Pace, but chose our 
outlet on the greater curvature side, 
where future procedures would be more 
accessible. The first 56 patients who did 
not have reinforcement of the outlet are 
not all failures; the data and standard 
deviations indicate that adequate weight 
loss occurred in a proportion. The “non- 
reinforced” group of 56 patients continue 
to show weight loss that is greater than 
25% in 18 patients, with a maximum loss 
in body weight at 36 months of 36%; 
weight loss is greater than 20% in 25 
of the 56 patients and greater than 15% 
in 28, which we regard as unacceptable. 
As noted in the paper, four patients 
returned to their preoperative weight. 
However, we are suspicious that many 
of the “non-reinforced” patients who 
have lost significant amounts of weight 
have been able to maintain this through 
their own effort after an initial substan­
tial weight loss. The reoperation to re­
inforce the outlet is usually not a major 
undertaking.
We agree that the circumferential im­
bricating suture “does not guarantee per­
fect results”. However, in the recent 
report by Gomez,4 published 2 months 
after we submitted our manuscript, using 
the identical technique, there was a mean 
weight loss of 32% at 12 and 18 months, 
and 33 % at 24 months. He had only one 
postoperative death in approximately 200 
patients (0.5%), from cardiac cause.4 The 
patients with outlet reinforcement con­
tinue to vomit if they attempt to overeat. 
Patient compliance is directly related to 
the time in explanation that anyone who 
undertakes this surgery must spend with 
the patient.
Freeman and Burchett do not give a 
reference for the 4% mortality with re­
operation, and do not indicate if this is 
a personal experience.
A properly reinforced stoma should 
not enlarge, unless the suture is broken. 
We do not concur that a patient spitting 
up saliva and feeding via a jejunostomy 
for 6 months or longer is acceptable; 
moreover, a stricture may become tight­
er. We suggest that dilatation by a Grunt- 
zig balloon catheter inserted through a 
pediatric gastroscope be attempted. Re­
operation in our experience may be 
simple or arduous. We disagree that fail­
ures are those who have lost more than 
15% of their initial weight. We believe 
that loss of less than 25% of body 
weight should be regarded as a failure. 
If Freeman and Burchett’s 15% is used, 
50% of our patients with “unreinforced” 
partitions and 100% of those with “re­
inforced” partitions have lost adequate 
weight.
In markedly obese patients who pre­
sent at weight-loss clinics, sustained 
weight loss has been reported in 2% at 
2 years,5 and there is a high rate of 
recidivism on long-term follow-up, with 
an ultimate weight loss of less than 1%.6
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P. L. Heilpern, MD, FRCP(C) 
Director of Professional Services 
SIR MORTIMER B. DAVIS 
JEWISH GENERAL 
3755 Cote Ste. Catherine Road 
Montreal, Quebec H3T 1E2
— S82-007
stapling fo r m orbid obesity. A m  J Surg  1981; 
142: 67-72
2. Buchwald H. Rucker R D : The history  of 
m etabolic surgery for m orbid obesity and 
a com m entary. W orld  J  Surg  1981; 5: 781-7
3. M acL ean L D : In testinal bypass operations 
for obesity: a review . Can J  Surg  1976; 19: 
387-99
4. G om ez C A : G astroplasty  in m orbid obesity: 
a progress report. W orld  J  Surg  1981; 5: 
823-8
5. Stunkard A, M cL aren-H um e  M : The results 
o f trea tm en t fo r obesity: a review o f the  
litera tu re  and  repo rt o f a  series. A M  A  A rch  
Intern M ed  1959; 103: 79-85
6. W illcutts H D : C om prehensive weight con­
tro l program s. Presen ted  at the A m erican  
Society fo r Paren tera l and E nteral N utrition  
Regional Sem inar, Chicago, June 22, 1979 
(tape no . 11-74-79).
ROYAL COLLEGE FELLOWSHIP SURGEON —
wanted to join a busy, challenging long estab­
lished family practice. Vanderhoof is situated in 
the centre of British Columbia, Canada, a fast 
growing logging and farming community located 
in prime recreational area where all outdoor 
activities are available; skiing, hiking, fishing, 
hunting, etc. We have a 65-bed hospital with a 
well equipped operating room. The clin ic is 
within three minutes walk of the hospital. Please 
contact: Dr. G.C. Joly, Dr. C.H. Stephen or Mrs. 
J. Philips at RR#2, Vanderhoof, BC V0J 3A0. 
Tel. (604) 567-2201. — S82-009
THE THREE TEACHING HOSPITALS — of the
University of Western Ontario, London, Canada, 
offer one to two year positions for Senior Fellows 
in Critical Care Medicine. The units in all three 
hospitals are multidisciplinary in nature and 
hence offer a broad experience in critical care. 
Clinical and basic research experience is pro­
vided. The training program may be tailored to 
the applicant’s future needs. Prerequisites for 
application for 1983-1984 include completion of 
training in a primary specialty. Applications for 
any of the positions at the three University of 
Western Ontario teaching hospitals should be 
received by July 1, 1982 and may be obtained 
from: William J. Sibbald, MD, FRCP(C), FACP. 
Coordinator, Critical Care/Trauma Unit, Victoria 
Hospital. London, Ont., Canada N6A 4G5.
—S82-010
THE UNIVERSITY OF BRITISH COLUMBIA —
Faculty of Medicine, Department of Surgery. A 
Director of General Thoracic Surgery is required 
by the University of British Columbia, with an 
expected appointment date of July, 1982. Appli­
cants should have obtained their fellowship in 
The Royal College of Physicians and Surgeons of 
Canada in cardiovascular and thoracic surge^ 
or their Certificate of Competence in thoracic 
surgery or equivalent, and be eligible for regis­
tration by the College of Physicians and Surgeons 
of British Columbia. The applicant should have 
a proven record in thoracic research and a major 
interest in teaching residents, planning to take 
both the Fellowship and the Certificate of Com­
petence. Rank and salary negotiable depending 
upon experience and qualifications. Applications 
accompanied by a curriculum vitae and request 
for further information to: The Division of Cardio­
vascular, and Thoracic Surgery, c/o Department of 
Surgery, Faculty of Medicine, 700 West 10th 
Avenue, Vancouver, BC, Canada V5Z 1L5.
—S82-013
VASCULAR SURGEON: PQ — Applications are 
invited for a full-tim e clinical surgeon in a large 
bilingual teaching hospital. The successful appli­
cant w ill have responsibility for directing an 
active non-invasive vascular laboratory. Excellent 
opportunities for basic and clinical research. 
Reply to: Dr. N.M. Sheiner, Surgeon-in-Chief, The 
Sir Mortimer B. Davis-Jewish General Hospital, 
3755 Cote St. Catherine Road, Montreal, Quebec 
H3T 1E2. —S82-014
classified advertising
As a further service to its readers the Canadian Journal o f Surgery is pleased 
to accept suitable classified advertisements. The deadline is 1 month before 
issue date. Regular classified rates (for each insertion): $31.00 for the first 
40 words or less, additional words 300 each, to maximum of 150 words 
(additional $12.00 for frame). Special Display under 75 words, 2(4" X2", 
$75.00. $5.00 charge (first insertion only) for CJS box numbers. Display 
rates available on request.
Copy should be mailed to the Canadian Journal o f Surgery, PO Box 
8650, Ottawa, Ontario K1G 0G8.





In vitro studies indicate that the bacterial action of CLAFORAN (cefotaxime sodium), a 
semisynthetic cephalosporin antibiotic, results from inhibition o f cell wall synthesis.
INDICATIONS AND CLINICAL USES
CLAFORAN (cefotaxime sodium) may be indicated for the treatment of infections 
caused by susceptible strains of the designated micro-organisms in the diseases listed 
below:
USUAL ADULT DOSAGE OF CLAFORAN (CEFOTAXIME SODIUM)
Type of Infection
Daily Dost 
(grams) Frequency end Route
Uncomplicated Gonorrhea 1 1 gram IM (single dose)
Uncomplicated infections 
such as pneumococcal 
pneumonia or acute urinary 
tract infection




3-4 1 gram every 6-8 hours 
IMor IV
a
Lower respiratory tract infections: pneumonia and lung abscess caused by 
Streptococcus pneumoniae (formerly Diplococcus pneumoniae), other Streptococci 
(excluding[Enterococci, e.g.,S. faecalis), Staphylococcus aureus (penicillinase and 
non-penicillinase producing), Escherichia coli. Hemophilus influenzae, (including 
ampicillin-resistant strains), and unspecified Klebsiella species.
Urinary tract infections: caused by Escherichia coli, unspecified Klebsiella species 
(including K. pneumoniae), Proteus mirabilis, indole-positive Proteus, Serratia 
marcescens and Staphylococcus epidermidis. Also, uncomplicated gonorrhea caused 
by N. gonorrhoeae including penicillin-resistant strains.
Bacteremia/Septicemia: caused by Escherichia coli, unspecified Klebsiella strains and 
Serratia marcescens.
Skin infections: caused by Staphylococcus aureus (penicillinase and non-penicillinase 
producing), S. epidermidis. Group k. Streptococci, Escherichia coli, Proteus mirabilis 
and indole-positive Proteus.
Intra-abdominal infections: caused by Escherichia coli, and unspecified Klebsiella 
species.
Gynecological infections: including pelvic inflammatory disease, endometritis and 
pelvic cellulitis caused by E. coli. Group A Streptococci and Staphylococcus 
epidermidis, anaerobic bacteria including unspecified Peptococcus and 
Peptostreptococcus strains and some strains of Bacteroides frag His. In several cases, 
although clinical cures were achieved, bacteriological follow-up was not available. 
Clinical experience with CLAFORAN in anaerobic infections is limited. CLAFORAN has 
been used w ith some success in wound and intra-abdominal infections against some 
strains of unidentified Bacteroides and anaerobic cocci.
CLAFORAN has been shown to be active against some strains of Pseudomonas.
In the treatment o f infections encountered in immunosuppressed and granulocytopenic 
patients, results of therapy with cefotaxime have not been impressive.
CLAFORAN should not be considered in the treatment of enterococcal infections, i.e. 
Strep, faecalis.
Specimens for bacteriologic culture should be obtained prior to therapy in order to 
isolate and identify the causative organisms and to determine their susceptibilities to 
CLAFORAN. Therapy may be instituted before results of susceptibility studies are 
known; antibiotic treatment should be re-evaluated once these results become 
available.
CONTRAINDICATIONS
CLAFORAN is contraindicated in patients who have shown hypersensitivity to 
cefotaxime sodium, the cephalosporin, or the penicillin groups of antibiotics.
WARNINGS
Before therapy with CLAFORAN is instituted, it must be determined whether the patient 
has had previous hypersensitivity reactions to cefotaxime, cephalosporins, penicillins 
or other drugs. CLAFORAN should be given with caution to patients with Type 1 
hypersensitivity reactions to penicillin. Antibiotics, including CLAFORAN should be 
administered w ith caution to patients who have demonstrated some form of allergy, 
particularly to drugs. If an allergic reaction to CLAFORAN occurs, the drug should be 
discontinued and the patient treated with the usual agents (e.g. epinephrine, 
antihistamine, pressor amines or corticosteroids).
PRECAUTIONS
Pregnancy: The safety of CLAFORAN (cefotaxime sodium) in pregnancy has not been 
established. Consequently, use of the drug in pregnant women requires that the likely 
benefit from the drug be weighed against the possible risk to the mother and fetus. 
Nursing Mothers: CLAFORAN is excreted in human milk in low concentrations. Caution 
should be exercised when the drug is administered to nursing mothers.
Pediatric Use: The safety and effectiveness of CLAFORAN in infants and children have 
not yet been established. It has, however, been used in children at a dosage range of 
100-150 m g/kg/day in 2-4 divided doses.
Kidney : Although CLAFORAN rarely produces alterations in kidney function, evaluation 
of renal status is recommended, especially in severely ill patients receiving high doses. 
Patients with markedly impaired renal function should be placed on the special dosage 
schedule recommended under DOSAGE AND ADMINISTRATION, because normal 
doses in these individuals are likely to produce excessive serum concentration of the 
metabolites.
Prolonged use o f CLAFORAN may result in the overgrowth of nonsusceptible 
organisms. Constant observation of the patient's condition is essential. If superinfection 
occurs, therapy should be discontinued and appropriate measures taken.
Positive direct Coomb's test is known to develop in individuals during treatment with 
the cephalosporin group of antibiotics, including cefotaxime sodium.
In laboratory tests a false positive reaction to glucose may occur with reducing 
substances but not with the use of specific glucose oxydase methods.
ADVERSE REACTIONS
The most frequent adverse reactions encountered are:
Local (5%) -  injection site inflammation with intravenous administration. Pain, 
induration and tenderness after intramuscular injection.
Hypersensitivity (1.8%) -  Rash, pruritus, fever.
Gastrointestinal (1.7%) -  Colitis (not pseudomembranous), diarrhea, nausea, and 
vomiting. A few cases of pseudomembranous colitis have been reported.
Hemic and Lymphatic System -  Mild reversible leukopenia, granulocytopenia and 
thrombocytopenia have been reported. Some patients developed positive direct 
Coomb's test during treatment with CLAFORAN (cefotaxime sodium).
Genitourinary System -  Moniliasis, vaginitis.
Central Nervous System (0.2%) -  Headache.
Liver -  Transient elevations in SGOT, SGPT, serum LDH, and serum alkaline 
phosphatase levels have been reported.
Kidney -  Increased serum creatinine and BUN have occasionally been observed.
SYMPTOMS AND TREATMENT OF OVERDOSAGE
Since no case of overdosage has been reported to date with CLAFORAN, no specific 
information on symptoms or treatment is available. Treatment o f overdosage should be 
symptomatic.
DOSAGE AND ADMINISTRATION
CLAFORAN (cefotaxime sodium) may be administered intravenously or 
intramuscularly after reconstitution (see table with recommended mode of 
reconstitution according to route of administration). Dosage and route of administration 
should be determined by susceptibility of the causative organisms, severity of the 
infection and condition o f the patient.




6-8 2 grams every 6-8 hours IV
higher dosage 
(e.g., septicemia)
Life-threatening infections up to 12 2 grams every 4 hours IV
THE MAXIMUM DAILY DOSAGE SHOULD NOT EXCEED 12 GRAMS.
Administration of CLAFORAN should be continued for a minimum of 48 to 72 hours 
after the patient defervesces or after evidence of bacterial eradication has been 
obtained; a minimum of 10 days of treatment is recommended for infections caused by 
Group A beta-hemolytic Streptococci in order to guard against the risk of rheumatic 
fever or glomerulonephritis; frequent bacteriologic and clinical appraisal is necessary 
during therapy of chronic urinary tract infections and may be required for several 
months after therapy has been completed; persistent infections may require prolonged 
treatment. Doses less than those recommended should not be employed.
DOSAGE FOR PATIENTS WITH IMPAIRED RENAL FUNCTION
In patients with estimated creatinine clearance of less than 20 ml/m in/1.73m2 the dose 
of CLAFORAN must be halved (see PRECAUTIONS). If serum creatinine values alone are 
available, the following formula (based on sex, weight and age of the patient) may be 
used to convert these values into creatinine clearance.
Males: Weight (kg) x (140 -  age)
72 x serum creatinine
Females: 0.85 x above value
RECONSTITUTION
The following table is provided as a guide for reconstituting CLAFORAN (cefotaxime 











AMOUNT OF APPROXIMATE APPROXIMATE
DILUENT TO WTTHDRAWABLE AVERAGE








Parenteral drug products should be inspected visually for particulate matter and 
discoloration prior to administration. Solutions of CLAFORAN range from light yellow 
to amber, depending on concentration and diluent used. The dry powder as well as 
solutions tend to darken, depending on storage conditions.
For intramuscular use: CLAFORAN should be reconstituted only with Sterile Water for 
Injection in accordance with the volumes recommended in the preceding table.
For intravenous bolus use: 500 mg, 1 gram and 2 gram vials should be reconstituted 
with at least 10 ml of any of the solutions recommended under COMPATIBILITY/ 
STABILITY.
For intravenous infusion use: 1 or 2 grams of CLAFORAN may be reconstituted
with 50 or 100 ml of any of the solutions recommended under COMPATIBILITY/STABILITY.
ADMINISTRATION
Intramuscular: CLAFORAN (cefotaxime sodium) should be injected well within the body 
of a relatively large muscle such as the upper outer quadrant of the buttock (i.e., gluteus 
maximus); aspiration is necessary to avoid inadvertent injection into a blood vessel. 
Intravenous: The intravenous route is preferable for patients with bacteremia, bacterial 
septicemia, or other severe or life-threatening infections, or for patients who may be 
poor risks because of lowered resistance resulting from such debilitating conditions as 
malnutrition, trauma, surgery, diabetes, heart failure, or malignancy, particularly if 
shock is present or impending.
For bolus administration a solution containing 1 gram or 2 grams of CLAFORAN can be 
injected over a period of three to five minutes. Using an infusion system, it may also be 
given over a longer period of time through the tubing system by which the patient may 
be receiving other intravenous solutions. Butterfly® or scalp vein type needles are 
preferred for this type of infusion. However, during infusion of the solution containing 
CLAFORAN, it is advisable to discontinue temporarily the administration of other 
solutions at the same site.
COMPATIBILITY AND STABILITY
CLAFORAN (cefotaxime sodium) may be reconstituted with any of the following and 
should be used freshly prepared:
Sterile Water for Injection 
Sodium Chloride Injection B.P.
5% Dextrose Injection B.P.
Dextrose and Sodium Chloride Injection 
Compound Sodium Lactate Injection B.P.
If a solution must be stored, only the solution prepared with Sterile Water for Injection 
may be kept under refrigeration (below 5°C) for not longer than 24 hours. Any unused 
solutions should be discarded.
CLAFORAN is compatible with 1 % lignocaine. Only freshly prepared solutions should 
be used. CLAFORAN solutions exhibit maximum stability in the pH 5-7 range.
A solution of 1 gram of CLAFORAN in 14 ml o f Sterile Water for Injection is isotonic. 
Solutions of CLAFORAN must not be admixed with aminoglycoside solutions. If 
CLAFORAN and aminoglycosides are to be administered to the same patient, they must 
be administered separately and not as a mixed injection.
DOSAGE FORMS
CLAFORAN (cefotaxime sodium) is supplied as a sterile, white to pale yellow powder, in 
vials containing 500 mg, 1.0 gram and 2.0 grams of cefotaxime sodium (expressed as 
acid on a dry basis).
CLAFORAN in the dry state should be stored at room temperature (below 30°C), 
protected from light and heat. Solutions of CLAFORAN range from light yellow to 
amber, depending on concentration and the diluent used. The solutions tend to darken 
depending on storage conditions and should be protected from elevated temperatures 
and excessive light.
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